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The amino acid glutamate (Glu) is one of the most ubiquitous neurotransmitters in the brain 
and the chief excitatory neurotransmitter. As a neurotransmitter, Glu is integral to the normal 
workings of the brain and is involved in many functions, such as memory formation and long-term 
potentiation, via action on multiple receptors. Two primary classes of Glu receptors, metabotropic 
and ionotropic respond to the concentration of Glu in the extracellular space of the brain in a dose 
dependent manner. Large excesses of Glu have been shown to produce an excitotoxic effect, which 
can lead to the long-term neuronal damage seen in many neurological disorders including stroke 
and traumatic brain injury (TBI). Following an event such as these, methods for continuous 
monitoring of Glu concentrations in the brain can be very useful to clinicians for determining the 
best timing for pharmacological intervention, provided the acquisition of that information can itself 
be performed in a timely manner. With that in mind, this thesis focuses on the development of 
analytical methods that will provide information on the extracellular concentration of glutamate 
and other amino acids in a timely manner and thereby providing actionable information for a 
clinician.  
 
Microdialysis (MD) is an in vivo sampling method that can be used to monitor multiple 
analytes simultaneously while also enabling the delivery of a pharmaceutical intervention directly 
to the site of the probe This technique can provide a powerful window into tissue function and 
health when combined with a separation-based analytical method. However, due to the need for 
very low flow rates, a trade off exists with regard to sample concentration and time. In order to 
maximize the concentration and minimize the time required, sensitive methods of detection must 




 To minimize the time required for sample analysis (and make point of care analysis 
possible), a portable fluorescence detection system for use with microchip electrophoresis was 
developed. With this system, six neuroactive amines commonly found in brain dialysate (arginine, 
citrulline, taurine, histamine, glutamate, and aspartate) were derivatized offline with naphthalene-
2,3-dicarboxaldehyde/cyanide, separated electrophoretic ally, and detected by fluorescence. It was 
found that this system was able to detect these analytes of interest within a range of 250 nM – 1.3 
µM, which was adequate for subsequent detection in a microdialysis sample collected from the 
brain of an anesthetized rat. 
 
Finally, the design and evaluation of a microfluidic device for coupling microdialysis to 
microchip electrophoresis with on-line derivatization (MD-ME) is discussed. By coupling 
sampling directly to the microchip, elements that would otherwise delay analysis such as the need 
to transport volumes to the analysis system or the wait for the generation of larger sample volumes 
can be avoided. The MD-ME device was modeled first using COMSOL Multiphysics™ in an 
effort to optimize the device geometry, allowing on-line sampling with minimal back pressure, but 
with complete sample derivatization prior to analysis. Following this, the device was evaluated 
experimentally to detect Glu samples collected via microdialysis over an extended time period. 
While the limits of detection for Glu were found to be slightly  high for immediate use for in vivo 
brain sampling, it is hoped that modifications to materials used to construct the microchip may 
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This thesis, throughout the following chapters, represents an iterative process of design and 
experimentation. This process evolved from the rationale for monitoring glutamate (Glu) as a 
biomarker of traumatic brain injury (TBI) and neurodegeneration, an explanation of how in vivo 
measurements of Glu are acquired, through the construction of microchip electrophoresis devices, 
the development and evaluation of a portable detection system, and finally the development of an 
online system for monitoring Glu levels in near real time.  
 
In chapter two, I discuss the role of Glu as an excitatory amino acid neurotransmitter. Glu is 
ubiquitous throughout the brain and is required for many vital functions playing a role in virtually 
all excitatory events such intercell signaling, memory formation and learning. Three major types 
of glutamate receptors involved in ion transport exist in the brain: AMPA, NMDA, and Kainate. 
Each of these has a specific function which are discussed in chapter 2. In addition, several 
metabotropic receptors are mentioned that control the intracellular environment through the 
activation of G-protein coupled receptors, that in turn control pathways within the cell. The overall 
function of glutamate-glutamine cycle is also discussed as well as how this system operates to 
maintain homeostasis in the brain. Particular attention is paid to the maintenance of intracellular 
Ca2+ in neurons. Finally, because Glu plays such an important role in the development of secondary 
damage following TBI, the consequences of the breakdown of this system is discussed.  
 
Monitoring Glu in the living brain under the conditions of TBI can be challenging. A common 
method, and the method of choice for the studies covered here, is microdialysis sampling. 
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Microdialysis has many advantages over other sampling techniques. These are elaborated in 
chapter two and include the ability to sample multiple analytes simultaneously and to do so 
continuously for an extended period of time.  
 
In chapter three, the use of the electrophoresis for the analysis of biological samples is 
discussed and how this technique can be used with microdialysis sampling. Two methods in 
particular, capillary electrophoresis (CE) and microchip electrophoresis (ME), are elaborated, 
focusing primarily on ME. These methods are uniquely suited for the analysis of complex 
biological samples such as brain dialysate samples containing Glu as well as other amino acids. 
They are compatible with limited sample volumes and a requirement of high temporal resolution 
with low overall time lag. The basis for analyte separations via electrophoresis is discussed. 
Because the detection of analytes, of opposite as well as neutral charges, simultaneously relies on 
the generation of an electroosmotic flow (EOF) at the surface of the separation channel, the nature 
of the EOF is discussed as well as its dependency on material choice. The ability of CE to analyze 
exceedingly small sample volumes (on the order of 100nL) was very important to this work and 
this chapter presents a rationale specifically for the use of microchip electrophoresis as the ideal 
method of analysis for these ultralow volumes of complex samples especially when time 
constraints are of the essence and multiple analytes are of interest. The advantages of CE based 
analyses in comparison to other approaches, such biosensors and liquid chromatography, is 
discussed. The manipulation of such low volumes (on the order of 100nL) can be problematic 
however and the use of electrokinetic gating for sample injection methods with electrophoretic 




Finally, ME is introduced beginning with the similarities to capillary electrophoresis and the 
differences that are beneficial to this application. Methods for detection that can be combined with 
ME, the materials and methods used in chip construction, and modeling approaches to streamline 
ME design are also covered. Fabrication processes used for the construction of three different types 
of microchip electrophoresis (ME) devices is elaborated including devices made entirely from 
poly-dimethylsiloxane (PDMS) polymer, all glass substrates, and hybrid devices made with both.  
 
Two issues with the use of ME for monitoring TBI are the need for a fluidic connection from 
the microdialysis probe implanted in the patient’s brain to the ME assay that can simultaneously 
sample and derivatize a sample, addressed in chapter five, and the need to minimize lag time 
between sample acquisition and analysis by placing the detection system as near the patient as 
possible. This later concern was the subject of chapter four. The portable detection system 
discussed in chapter 4 consisted of a light emitting diode (LED), a photodiode based detector, and 
an inexpensive custom amplifier based on an Arduino microcontroller. Focusing of the excitation 
light and subsequent collection of the emitted light was performed using an inverted optical 
arrangement consisting of a dichroic beam splitter, which directed collimated excitation light to 
the detection point through an objective lens while allowing emission light to be focused on a 
photodiode. This light was converted into an electrical signal, amplified and then filtered, before 
being further processed by the microcontroller and connected laptop. As noted in chapter 4, the 
portable system was shown to be adequate for the detection of a series of clinically relevant 
bioactive amines in brain dialysate samples including those of primary interest for this work, Glu 




Finally, in chapter five, a microfluidic device is described that allows an online dialysate 
sample collected from an in vivo model and to be continuously monitored using microchip 
electrophoresis with fluorescence detection. This device was modeled using Comsol Multiphysics 
and then evaluated experimentally. This demonstrated that continuous sampling via microdialysis 
at 1uL per minute was possible for extended periods and with minimal time lag. 
 
As with all research, the work presented here has opened many unexplored avenues and 
presented unresolved problems. Therefore, in the final chapter, near and long-term directions for 
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2.1 Glutamate as a Neurotransmitter 
 
Glutamate (Glu) is among the most abundant amino acids in the human body making up both 
a largest percentage of the amino acids we ingest [2] as well as a large portion of other amino acids 
produced via the citric acid cycle (TCA). It is also the most ubiquitous neurotransmitter in the 
mammalian brain [3] and is critical to the normal function of the brain and is present in virtually 
every sub region. Despite the fact that Glu is ubiquitous in the brain, for many years it was thought 
that its only role was as a component of the TCA cycle. During the last quarter century however, 
it has become clear that this viewpoint was incorrect. It has been shown that Glu is be found 
throughout the brain, is a signaling molecule for many important processes, and is controlled by a 
complex array of receptors, transporters, and control mechanisms [4, 5]. Not surprisingly, the 
disruption of these control mechanisms is a common thread underlying many neurological diseases 
including epilepsy, psychosis, Huntington’s, Parkinson’s, and the secondary effects of stroke and 





2.1.1 Normal Glutamatergic Function  
 
Almost all of the neurotransmitter functions of Glu in the brain are excitatory in nature, 
including such important functions as memory formation and neural plasticity. Because Glu’s 
important role in these functions it is not surprising that, while Glu is found in all regions of the 
brain, local concentrations and receptors for Glu are at their highest concentration in regions that 
specialize in memory formation such as the hippocampus, stress responses such as the amygdala, 
and higher-level thought such as the cerebrum. Glu is released by neurons into the synapse in 
response to an action potential. When Glu concentrations in the synapse spike as a result of this 
release, receptors sensitive to Glu in nearby post synaptic neurons are triggered. If this triggering 
event is of sufficient intensity, that neuron will, in turn, undergo an action potential. Briefly, an 
action potential is the passage of an electrical impulse along the membrane of a neuron. As this 
impulse occurs, ionic gradients along the cell are rapidly altered in succession down the cell body. 
As this happens, the impulse can travel the length of the neuron until reaching another synapse 
where it results in the release of Glu. If sufficient Glu is released, the action potential begins anew 
in the neuron on the opposite side of the synapse. 
 
Once an action potential has occurred, the remaining Glu at the initial synapse must be quickly 
removed from the synaptic cleft. In contrast to other neurotransmitters there is no enzyme that 
degrades Glu in the extracellular space. Therefore its concentration is entirely determined via 
uptake and release [3]. This process is accomplished via transporters that are present on both the 
pre and post synaptic neurons, as well as on the nearby specialized glial cells called astrocytes. 
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Uptake via these transporters returns the synaptic concentration to be baseline level, leaving the 
neuron ready to fire once again. 
 
 
2.1.2 Synthesis, Release and Uptake of Glu 
 
The synthesis, release, and uptake of Glu in the brain occur in a biochemical pathway referred 
to as the Glutamine-Glutamate cycle. This cycle is not completely closed to outside sources of Glu 
(that from dietary sources for instance), however, because Glu cannot cross the blood brain barrier 
without active transport, the vast majority of Glu is synthesized within the neurons themselves [7].  
 
 In the neurons, Glu is initially synthesized from α-ketoglutarate, which itself is synthesized 
from pyruvate as a component of the TCA cycle. Pyruvate is in turn synthesized during the 
glycolysis of glucose. Studies of brain metabolism have shown that virtually all the glucose 
entering the brain is ultimately converted to Glu [4]. In addition, glutamine (Gln) within the neuron 
can be converted to Glu via the enzyme glutaminase. As is explained in the following paragraphs, 
the majority of Glu is removed from the extracellular space and recycled in this manner. 
 
Glu is transported via vesicular glutamate transporters and stored in vesicles within the 
presynaptic neuron. The release of Glu from these vesicles into the synapse occurs in a Ca2+ 




 Upon release of the Glu from the presynaptic neuron into the synaptic cleft Glu can diffuse 
to several possible destinations, including receptors on the post synaptic neuron. Additionally, to 
maintain low extracellular concentrations of Glu in the synapse, additional transporters on 
neighboring cells remove the remaining Glu from the synapse. Three glutamate transporters are 
found throughout the mammalian brain, with two additional transporters being localized to certain 
regions. The three major transporters are referred to as the excitatory amino acid transporters 
(EAAT 1-5). EAAT1 and EAAT2 are primarily expressed in astrocytes located near the synaptic 
cleft. EAAT3 is expressed in the neuron itself, and EAAT4 and EAAT5 are found in purkingje 
neurons and the retinal neurons respectively [4, 6]. The relative positions of these transporters can 
be seen in Figure 2.2. The EAAT transporters are arrayed around the synapse in such a way as to 
prevent synaptic Glu from leaking into the extra-synaptic space. This is an important detail with 
regard to Glu levels during pathological events [8]. 
 
When Glu is removed from the extracellular space via the EAAT’s, it is taken up into the 
neuron is resequestered into vesicles. The remaining Glu is removed via uptake through EAAT1 
or EAAT2 and passes into the cytosol of neighboring astrocytes. Here, Glu is converted to Gln via 
the enzyme glutamine synthase. The process from uptake to synthesis is an energetically costly 
one.  A sodium (Na+) gradient in the astrocytes is exploited to uptake Glu into the cell. For each 
molecule of Glu that is transported into the cell, three Na+ ions and one hydrogen ion (H+) are co-
transported in exchange for potassium (K+) ions. It is important following this process to 
reestablish the Na+ and H+ gradient across the cell membrane. Both the reestablishment of this 
gradient and the synthesis of Gln from Glu require energy in the form of adenosine triphosphate 
(ATP). For each molecule of Glu converted to Gln via glutamine synthase, a single ATP is used. 
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Within the astrocyte, this ATP is produced via the glycolysis of glucose into lactate resulting in 
two molecules of ATP from the recycling of two molecules of adenosine diphosphate (ADP). One 
of these ATP’s is used in the conversion of Glu to Gln, the other is used to expel three Na+ in 
exchange for two K+ [9].  
 
The conversion of glucose into lactate also has the added benefit of providing the nearby 
neuron with a molecule of lactate to use in the TCA cycle, producing an additional 34 ATP 
molecules. Finally, the Gln is transported into the neuron where a mitochondrial specific enzyme, 
glutaminase converts the Gln to Glu. The Glu is then packaged  into vesicles for future release into 
the synapse [4]. This process is shown in Figure 2.1.  
 
Figure 2.1: The release of Glu from the neuron into the synaptic cleft results in postsynaptic activation of Glu receptors as well as 
the activation of nearby transporters on astrocytes (glial cells). These transporters remove Glu into the astrocyte body where it is 
converted to Gln before transport back to the neuron where conversion in the opposite direction occurs. Each conversion step 




2.1.3 Glutamate Receptors 
 
Multiple receptors are activated by Glu at the postsynaptic neuron. Among these are three 
ligand activated ion channels that are named for ligands known to bind them specifically, and 
multiple metabotropic Glu receptors (mGluR). Among this later group, the mGluR receptors, are 
-coupled receptors effecting intracellular metabolic processes. This broad generalization of 
function however is somewhat misleading as the processes influenced by these receptors, of which 
three families and many subtypes exist, vary widely in function from control of protein 
phosphorylation to regulation of synaptic transmission [7]. Although extremely important, this 
thesis focuses on the second class of Glu receptors, those controlling ion channels. 
 
The ligand gated ion channels to which Glu is an agonist include α-amino-3-hydroxy-5-
methylisoxazole-4-proionic acid (AMPA), Kainate, and N-methyl-D-aspartic acid (NMDA). As 
with the mGluR receptors, several subclasses of these receptors (iGluRs) exist with varying local 
distributions throughout the brain. Each receptor type consists of multiple subunits conferring 
slightly different behaviors, such as the enhancement or attenuation of their respective reaction 
kinetics [2]. AMPA, for instance, consists of 4 subunits (GluR1-4); Kainate of 5 subunits (GluR5-
7 as well as KA1 and KA2); and NMDA of 7 subunits (NR1, NR2A-D, and NR3A-B) [10]. While 
the precise function of each of these subunits is beyond the scope of this thesis, what is common 
to all iGluRs is the fact that, once triggered by Glu, these receptors respond in an extremely rapid 





Figure 2.2: Glu is packaged into vesicles in the pre-synaptic neuron. Upon release into the synapse, Glu activates a variety of 
receptors on the post-synaptic neuron including metabotropic receptors (mGlu1/3) and ionotropic receptors (NMDA, AMPA and 
Kainate). The removal of Glu from the synapse by transporters into the neuron (EAAT3) and nearby astrocytes (glial cells) 
maintains tight control over Glu concentrations following stimulation. Finally, Glu is converted to Gln for transport back to the 
neuron from the astrocyte (glial cell). Reproduced with permission from.[4] 
 
 
2.1.4 Non-NMDA Receptors: AMPA and Kainate 
 
The three types of iGluRs are commonly separated into the Non-NMDA receptors and the 
NMDA receptor indicating the importance of the NMDA receptor physiologically as well as 
pathologically. Recent evidence however has shown that the AMPA receptor plays a significant 
role in initiating neural plasticity and the long-term potentiation (LTP) needed for memory 
formation. Additionally, while less is known about the function of the Kainate receptor, it too 




AMPA receptors (AMPAR) are ubiquitous throughout the brain and are the primary 
receptors involved in fast synaptic signaling [11]. AMPAR, as mentioned, consist of assemblies 
of heterodimer subunits GluA1-A4. The AMPAR, once formed, is a transmembrane receptor with 
4 ligand binding sites, specific for Glu. These binding sites show extremely fast reaction kinetics, 
responding to a spike in synaptic Glu concentrations in < 1ms. The opening of the AMPAR occurs 
when 2 of the binding sites are occupied, with the channel opening further as the remaining binding 
sites are occupied [12]. What the open receptor channel allows into the cell, however, depends on 
the subunit composition of the AMPAR. For AMPAR lacking the GluA2 subunit, an open channel 
will allow Na+, K+, and Ca2+ into the cytoplasm of the cell. However, if the GluA2 subunit is 
present, as is the case for the majority of AMPAR, Ca2+ will be prevented from entering the cell. 
Whether GluA2 is present or not, AMPAR once saturated will quickly become desensitized within 
4-8 ms after activation, resulting in a closing of the ion channel [13]. The effect of this 1-8 ms 
influx of positive ions on the neuron is significant, particularly with respect to the function of the 
NMDA receptor, covered in the next section. 
 
Less is known regarding the function of Kainate receptors (KARs), as compared with the 
other two iGluRs. Like the APMA and NMDA, KARs consist of subunits that can be assembled 
to result in specific responses to Glu binding. However, KARs appear to have both a pre and post 
synaptic function in regulating neuronal excitability. KARs exhibit reaction kinetics slower than 
AMPARs and a permeability primarily to Ca2+ ions. KARs appear to play an important role in 
neuropsychiatric disorders. However, research into the precise function of these receptors is 




Both AMPARs and KARs are active components of the excitatory response to Glu within 
the mammalian brain and each appears to play a role in both the normal functioning of the system 
as well in related chronic disease states. However, more acute disease states, such stroke or 
traumatic brain injury, tend to directly involve the third iGluR, the NMDA receptor. 
 
2.1.5 The NMDA Receptor 
 
 The NMDA receptor (NMDAR), as mentioned above, is a ligand gated iGluR, like the 
AMPA and Kainate receptors. Similar to those receptors, NMDAR consists of multiple subunits, 
each conveying specific functions. Unlike AMPA and Kainate receptors however, NMDARs 
possess sites to bind multiple different ligands, as well as a binding site for Mg2+ that is blocked 
by default, providing a much higher level of regulation than for any other GluR. No fewer than 6 
binding sites exist on NMDARs. These include binding sites for polyamines and cations, such as 
zinc (Zn2+), Mg2+ and H+. The polyamines include spermidine. Zn2+ and H+ have modulating 
effects on the permeability of NMDARs to Na+ or Ca2+.  In contrast, Mg2+ acts as a channel 
blocker, rendering the NMDAR impermeable to ion flow by default [4].  
 
The two remaining binding sites, those for Glu (on the NR2 subunit) and glycine (Gly) 
(NR1 subunit) are obligatory. The NMDAR will remain impermeable to ion flow until these sites 
are occupied. Although their affinity for Glu and Gly is very high, other substrates including D/L-
Aspartate (Asp) (although not D-Glu) can serve as a replacement for Glu ,as can D-Serine (D-Ser) 




Figure 2.3: The NMDA receptor consists of multiple subunits including NR1, NR2A and NR2B each of which have specific 
functions. To open the NMDA ion channel, Glu must bind the NR2A or B subunit while a co-agonist such as Gly binds the NR1 
subunit. Additionally, the Mg2+ channel block must be removed before ions can pass through the channel. 
 
 
Because NMDARs are blocked by default, before activation a series of events must take 
place.  When it is released into the extracellular space, molecules of Glu bind NMDARs as well 
as AMPARs and KARs. At this point, the AMPAR and KAR are activated. However, the NMDAR 
remains inactive until both the Mg2+ ion has been dislodged and Gly has bound as a co-agonist. 
The removal of the Mg2+ block is accomplished through the activation of nearby AMPARs, which 
having faster kinetics than NMDARs, rapidly respond to the increased Glu concentration, 
becoming permeable to ion transport. As these ions (Na+ and K+) enter the cytoplasm, the voltage 




This relationship between fast acting AMPARs and the slower responding NMDAR is the 
origin of the long term potentiation that is necessary for memory formation and neural plasticity 
[15]. Once the NMDAR is activated, Na+ and Ca2+ enter the cell. This process continues until, like 
AMPARs, NMDARs become desensitized to the Glu through a Ca2+ dependent feedback as one 
of the subunits (NR1) is deactivated [16, 17]. 
 
2.1.6 Calcium and the Neuron 
 
 As Ca2+ enters the neuron, it’s effects vary widely. Changes in Ca2+ concentrations are one 
of the most common cell signaling mechanisms. The use of Ca2+ as a signal can be found in 
virtually all cell types. Consequently, the cytoplasmic concentration of Ca2+ is under tight control 
and kept to a concentration of approximately  100 nM depending on the cell type [18]. This internal 
concentration is maintained in the presence of extracellular concentrations that can range from 1-
2.5 mM. The maintenance of this concentration gradient is accomplished via Ca2+ dependent 
ATPases.  
 
 Within the cell, Ca2+ is stored primarily within the endoplasmic reticulum (ER) where it is 
bound to the storage protein calsequestrin (CSQ), each of which can bind 50 Ca2+ ions. In addition 
to what is storied in the ER, Ca2+ plays a vital role in the electron transport chain used during the 
production of ATP in the mitochondria. Enumerating the many functions of Ca2+ in neurons, much 
less each cell type, is beyond the scope of this thesis. However, three broad functions within 
neurons require mention. The first is that within the neuron, signaling is initiated via the release of 
Ca2+ from the ER, which extends virtually the entire length of the neuron body. This release can 
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modify the excitability of the neuron, altering its ability to respond to an action potential [19]. 
Secondly, uniporters allow the passage of Ca2+ into the mitochondria where they are involved in 
the production of ATP. Specifically, as Ca2+ enters the mitochondria, it allows the exclusion of H+ 
ions, having the net effect of increasing ATP synthesis [20]. Lastly, at high concentrations Ca2+ 
begins to have more deleterious effects. These effects result from a poisoning of the mitochondria 
due to the production of reactive oxygen species (ROS) that can lead to lipid peroxidation. This in 
turn can cause the activation of phospholipases, proteases, and pathways responsible for cellular 
apoptosis [2, 21, 22]. 
  
2.1.7 Summary of Glu Signaling Pathways 
 
In summary, the release of Glu from the presynaptic neuron into the synaptic cleft produces 
a momentary spike in Glu concentration. A variety of nearby transporters and receptors 
immediately respond to the presence of this signal. AMPAR and KARs react rapidly to Glu by 
becoming permeable to ions. Metabotropic receptors are triggered, modifying the action of 
complex pathways within the cell. While these signals are being transmitted into the postsynaptic 
neuron, transporters located on nearby astrocytes have already begun the removal of the Glu from 
the synaptic cleft using the Na+ gradient to aid in transport. Once inside the astrocyte, that Glu is 
converted to Gln (via glutamine synthase) and the Na+ gradient is reestablished, both via 
glycolysis of a glucose molecule. The resulting lactate and Gln are transported back to the neuron 
where the subsequent respiration of the lactate molecule is used to produce enough ATP for normal 
cell function as well as the conversion of Gln, back to Glu (via glutaminase). If sufficient Glu is 
released, the depolarization of the membrane caused by activation of AMPAR and KARs will 
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allow the Mg2+ block of the NMDAR ion channel to be released. In conjunction with the co-agonist 
Gly, Glu binding the NMDAR will cause the ion channel to become permeable to Na+ and Ca2+. 









2.2 Glutamate and Calcium Under Neurological Stress 
 
Given the intricate the relationships between Glu receptors and transporters, as well as the 
strict control of Glu concentrations in the brain, it should come as no surprise that damage to any 
part of the system can result in a breakdown of the glutamatergic signaling system. This is 
especially true in traumatic brain injury (TBI) and ischemic stroke (IS). These conditions not only 
cause local cellular damage but also lead to a disruption of ATP production due to tissue hypoxia. 
As mentioned above, the cycling of Glu and maintenance of ion gradients are energy intensive 
processes without which signaling networks rapidly fail.  
 
Changes in Glu concentrations in the brain following TBI and hypoxia also play a critical role 
in secondary injuries, and subsequently affect long-term patient outcome [23]. The currently 
accepted hypothesis as to how continuing damage occurs after TBI or IS is that damaged neurons 
release Glu into the extracellular spaces following the injury at a concentration significantly above 
basal levels. The large excess of Glu overwhelms the Glu transporters that normally maintain low 
micromolar (1–3 µM) [24] concentrations in the extracellular space, resulting in rapid uptake by 
surrounding healthy neurons. This leads to an increased uptake of calcium (Ca2+) [25-28] into the 
cells, causing a cascade of events and culminating in the activation of apoptotic pathways due to 
ROS production and lipid peroxidation. Simultaneously, a disruption of the respiratory pathway 
results in a decrease in ATP production in the surrounding tissue including the neurons and 
astrocytes at precisely the moment it is required. In both cell types, this causes a failure in the 
maintenance of Ca2+ levels and the Na+ gradients required for removing Glu from the extracellular 
space. In astrocytes this situation is further complicated by the efflux of Glu as a response to 
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hypoosmotic conditions caused by the influx of Na+ and consequent swelling of the cell [29]. The 
resulting cell death that happens as excess Glu results in cascades of damage to surrounding 
neurons is referred to as excitotoxicity [30] and is among the chief causes of secondary damage 
following TBI or stroke.  
 
 
Figure 2.5: A flow chart of secondary damage following TBI. Tissue damage results in a surge in excess Glu in the extracellular 
space. This excess immediately results in activation of receptors and transporters as in the healthy system. However, the 
compromised delivery of glucose and oxygen necessary for ATP production combined with the overwhelming of Glu transporters 
results in NMDA receptors remaining open for an extended period. As calcium floods into the cell, mitochondrial dysfunction 





Since elevated Glu concentrations are the proximal cause of this excitotoxicity, the desire for 
methods to monitor extracellular Glu in a clinical setting has grown in recent years. The hope is 
that by monitoring changes in Glu concentration in the brain, rapid intervention that would prevent 
continued excitotoxicity and tissue damage may be possible. With this in mind, two methods for 
monitoring Glu in vivo have been developed: electrochemical biosensors and microchip 
electrophoresis (ME).  
 
2.3 Biosensors for the Glutamate Detection 
 
Biosensors can be broadly defined as devices that convert the recognition of a biochemical 
species into an electrical or optical signal [31]. For this to be useful, not only must the recognition 
be specific to the analyte of interest, but the sensor must be able to detect it at biologically relevant 
concentrations.  
 
The most commonly used Glu biosensors in a clinical setting are based on amperometric 
detection [28, 32]. These biosensors use an enzyme specific to Glu to generate electroactive 
species. These biosensors commonly incorporate glutamate oxidase [28] or glutamate 
dehydrogenase, which generate hydrogen peroxide or NADPH, respectively,  in the presence of 
Glu [32].  
 
These enzyme-based biosensors have many advantages for monitoring Glu in the brain. The 
biggest of these is their high temporal resolution. Biosensors can respond to changes in Glu 
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concentration on time scales from 5–10 seconds. Additionally, due to their small diameter (10–
100 µm), they exhibit excellent spatial resolution in heterogenous tissues, such as the brain [33]. 
The excellent temporal and spatial resolution offered by Glu biosensors makes them very useful 
for monitoring rapid, localized changes such as Glu release into the synaptic cleft [34]. However, 
these biosensors have the disadvantage that they can usually monitor only a single analyte at a 
time. This means that multiple biosensors with different biorecognition elements must be used to 
detect multiple species in a specific region of the brain.  
 
2.4 Microdialysis Sampling  
 
Microdialysis sampling (MD) allows for continuous sampling of both in vivo environments, 
such as the extracellular fluid (ECF) of the brain, and in vitro tissue cultures. Sampling is 
accomplished using a 100–500 µm probe containing a semi-porous membrane with a specific 
molecular weight cut-off. The probe is inserted at the biological site of interest and a perfusate 
solution, similar in composition to the ECF, is pumped through the probe at flow rates generally 
between 0.1 and 1 µL/min. Since the perfusate lacks any of the analytes of interest, a concentration-
based diffusion gradient is created across the probe membrane. Analytes smaller than the 
membrane pore size, typically those with molecular weights between 20 kDa–60 kDa [35], diffuse 
through the membrane based on their concentration gradient into the perfusate, now referred to as 
the dialysate. Slower flow rates allow longer equilibration times and higher analyte recovery 
through the probe, but lead to much smaller sample volumes. Finally, the dialysate leaves the probe 
via the exit tubing [35]. Dialysate samples can then be analyzed offline or online for the 




Microdialysis is an ideal sampling method to couple to ME for several reasons. The first of 
these is that the sampling process exhibits no net fluid loss, allowing samples to be taken for 
extended periods of time [27]. Second, strategic selection of pore size can prevent interfering 
proteins and other large molecules from entering the perfusate, effectively eliminating the need for 
further sample preparation steps. Finally, as sampling is due entirely to analyte diffusion across a 
semipermeable membrane, virtually any small molecule can be sampled using the technique. 
However, this last point can also be problematic. Because sampling is diffusion limited, the 
ultimate concentration of analyte collected is dependent primarily on the flow rate of the perfusate 
[36]. While flow rates of around 1 µL/min are commonly used, only 20–40% of the analyte is 
recovered with such a high flow rate. Thus, to recover 100% of a target analyte, flow rates of 
approximately 100 nL/min are required [24].  
 
Practically speaking, the trade-off between flow rate of the perfusate and analyte concentration 
in the dialysate, shown in Figure 2.6, dictates that any subsequent assay must either have a very 
low volume requirement, a very high mass sensitivity, or a low requirement for temporal resolution 
for analytes found at low concentrations in the ECF. An example of how perfusate flow rate can 
influence an assay can be envisioned by imagining a hypothetical assay requiring 4 µL of sample. 
If the microdialysis flow rate used to collect this sample is 1 µL/min, we can expect to recover 
only 20–40% of any target analyte present in the ECF due to the limited time available for analyte 
diffusion. If an analyte of interest—extracellular Glu at a concentration of 1 µM for instance—is 
collected at this flow rate, we can therefore expect to only recover 300–400 nM. Additionally, the 
assay could only be performed 15 times per hour. Therefore, this flow rate has dictated both the 
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temporal resolution and the minimum limits of detection our assay must have. Decreasing our flow 
rate to 100 nL/min would allow us to have higher limits of detection (with full recovery of 1 µM), 
but at the expense of worsening our temporal resolution to 40 minutes per assay [37]. 
 
Figure 2.6: Schematic of a microdialysis brain probe with regard to flow-dependent recovery of an analyte. (Left) At faster flow 
rates, more sample volume can be collected, but fewer analytes will diffuse across the semipermeable membrane. (Right) At slower 
flow rates, more analytes can diffuse across the membrane, but at the cost of collecting much less sample. In both cases, compounds 
above the molecular weight cut-off of the membrane (such as proteins) are not collected. 
 
 
The continuous sampling nature of MD makes it an extremely useful tool to evaluate the health 
of patients following traumatic brain injury or other neurotrauma. An example of this is the CMA 
Cerebral Tissue Monitoring System (CMA Microdialysis AB, Kista Sweden). The CMA system 
uses microdialysis to collect perfusate in microvials for offline analysis in a “microdialysis 
analyzer” such as the CMA 600, ISCUS or ISCUSFlex model [38]. These microdialysis analyzers 
are capable of monitoring several compounds of neurological interest including glucose, lactate, 
pyruvate, glycerol, urea and Glu from multiple patients in an offline batch mode [39]. By collecting 
and analyzing samples in this manner, the ISCUSFlex is able to make 30 discrete measurements per 
hour using sample volumes between 200 nL and 2 µL [40]. However, offline processing of samples 
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in this manner can be problematic, as evaporation from such small sample volumes can skew 
analysis, even when the system is designed to minimize such evaporation. The direct coupling of 
MD to ME (MD-ME) avoids both of these problems by enabling rapid, continuous sample 
analysis. 
 
The combination of MD and ME for continuous monitoring of drugs and neurotransmitters in 
vivo has recently been reviewed [41]. By taking continuous, online sampling into consideration 
when designing a microchip-based analysis system, nanoliters of sample can be analyzed with high 
mass sensitivity, following rapid separations and analysis of complex samples. This chapter will 
discuss the principles of ME with a focus on design considerations, along with the fabrication and 
use of ME devices. 
 
2.5 Derivatization for Fluorescence Detection 
 
Many analytes, such as Glu, are not natively fluorescent and, consequently, require a 
derivatization reaction to produce a fluorescently active product that can be detected. When 
choosing a fluorogenic compound (or fluorophore, more generally), several parameters must be 
taken into consideration. The first is the selectivity of the reagent for specific functional groups on 
the analyte of interest. In the case of amino acid analysis, the most commonly used reagents are 
selective for the primary amine group. A reagent containing a fluorophore can complicate analysis 
and require additional work to separate the fluorescent reagent from the analytes of interest. Ideally 
then, a reagent will be fluorescently active only following derivatization of the target analyte 
(fluorogenic). Another consideration when selecting a reagent is that of high quantum efficiency 
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of the reaction product at the desired excitation wavelength. Finally, when performing online 
separations using ME or CE, the rate and yield of the derivatization reaction, and its 
reproducibility, are of utmost importance. 
 
With these considerations in mind, two fluorogenic compounds that are typically used for 
the determination of amino acids are naphthalene-2,3-dicarboxaldehyde (NDA) and o- 
phthalaldehyde (OPA. This is due to their rapid reaction times, selectivity for primary amine 
groups, and compatibility with commercially available lasers. These reagents are non-fluorescent 
prior to reacting with a primary amine, eliminating additional fluorescent species that could 
complicate analysis [42]. The NDA reaction occurs in the presence of CN and takes 120–240 
seconds to complete, while the OPA reaction occurs in the presence of 2-mercaptoethanol (2-ME) 
and takes 10–30 seconds to complete [42, 43]. These reactions are shown in Figure 2.7. It should 
be noted that NDA can react in presence of thiol compounds such as 2-ME and does so at a faster 
rate than it reacts with CN. However, the fluorescent products created via this reaction are less 
stable and have a lower fluorescence quantum efficiency than those created via the reaction with 





Figure 2.7: NDA and OPA Derivatization Reactions 
 
 
In the case of an online assay, where the sample is derivatized between the microdialysis 
probe and the electrophoretic separation, the derivatization reaction does not always go to 
completion. Due to their rapid reaction rates, both NDA and OPA can be used for online 
derivatization. However, the instability of OPA can complicate the separation. Consequently, in 
further discussions here, we focus on the use of NDA.  
 
When using NDA (or OPA) for derivatization, it should be noted that both CN and 2-ME 
are highly toxic and should be handled with care. NDA is optimally dissolved in 100% acetonitrile 
(ACN) to the desired stock concentration [45] and NaCN should be dissolved in water. Stock 
solutions of both NDA and NaCN should be stored in a refrigerator and protected from light and 
atmospheric conditions when not in use. Experience has shown that fresh stock solutions of NDA 
and NaCN should be made weekly. 2-ME is both flammable and toxic and should be handled 
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accordingly. In addition, it is easily oxidized and should be stored in a sealed container. Finally, 
2-ME is extremely noisome, and should be used in a fume hood. 
 
When using NDA (and OPA), the optimal derivatization yield for amino acids normally 
occurs at a pH that corresponds to the pKa of the analyte amine group [42] . This is typically 
around pH 9.2 for amino acid analytes. Whether performing offline or online derivatization, the 
reagents used should be prepared in 10–100-fold excess of the estimated concentration of primary 
amines in the sample. Derivatization of analytes of interest can be performed in either an offline 
manner or an online manner. 
 
2.6 Offline Sample Derivatization 
 
When performing off-line analysis with ME and fluorescence detection, samples must be 
derivatized before performing the separation. As mentioned in the derivatization section, a variety 
of fluorophores and fluorogenic compounds are available for this purpose. While NDA/CN and 
OPA/2-ME are popular due to their rapid reaction rate and ease of use for online derivatization, 
offline sample preparation allows the researcher more latitude with regard to derivatization. 
Selectivity and quantum efficiency should be the chief concerns in this case, and selection of a 
fluorophore/fluorogenic compound should be made to maximize both. That said, instability of the 
products of OPA derivatization can complicate offline analysis. For this reason, we recommend 




Offline sample derivatization should be performed with at least a 10-fold excess of both 
NDA and NaCN compared to the analyte(s) of interest. A feature of using these compounds is that 
they are fluorogenic, that is, not fluorescently active prior to reacting with a primary amine. 
Fluorescent reagents that are not fluorogenic require better separations for the parent compound 
and side products that complicate analysis. However, care should be taken not to use too high a 
concentration of fluorogenic reagents since fluorescent side products can form. Typical reaction 
conditions for analyte concentrations ranging from 1–100 µM include equal volumes of NDA and 
NaCN at stock concentrations of 5 mM and 10 mM, respectively. An example of the derivatization 
of a solution containing 100 µM Glu and 100 µM aspartate (Asp) might be as follows: 
 
2.1.5 Suggested Derivatization Conditions  
 
2.1.5.1 Stock Concentrations: 
 
1. Glu stock concentration: 2 mM in H2O 
2. Asp stock concentration: 2 mM in H2O 
3. NDA stock concentration (in 100% ACN): 5 mM 
4. NaCN stock concentration (in 100% Water): 10 mM 




2.1.5.2 Volumes Used for Final Volume of 200 µL: 
 
1. Glu: 10 µL for final concentration of 100 µM 
2. Asp: 10 µL for final concentration of 100 µM 
3. NDA: 2x the volume of all amino acids or 20 µL for a final concentration of 500 µM 
4. NaCN: again, 2x the volume of all amino acids or 20 µL. Final concentration is 1 mM 
5. BGE volume: 140 µL  
 
Therefore, the limiting reagent in this hypothetical sample is the amino acids, not the 
derivatization agent. As mentioned above, high concentrations of NDA and NaCN alone can result 
in the formation of fluorescent side products. However, these are usually very low in concentration 
and do not typically complicate the assay.  
 
One thing to note regarding this derivatization procedure is the final concentration of ACN in 
the sample. A total of 20 µL of ACN was added, resulting in a sample that is 10% ACN v/v. 
Experience has shown that, due to the hydrophobicity of NDA, injecting a sample containing NDA 
dissolved in ACN into a channel containing only borate buffer (for instance) will result in NDA 
precipitating out of solution and forming a clog. To prevent this from occurring, ACN or another 
similar hydrophobic solvent must be added to the BGE at a percentage greater than approximately 





2.7 Online Derivatization 
 
The same principles are maintained for online derivatization as in offline. The differences 
between the two arise from differences in fluid mixing at the microscale and in the fact that 
reactions typically do not proceed to completion within the limited time frame available for 
mixing.  In addition, it is difficult to mix laminar flows in microfluidic devices so the design of the 
MD-ME interface should take into account mixing architectures (passive or active) to ensure full 
mixing of sample inlet and derivatization agents. These are discussed in chapter 5.  
 
As mentioned, NDA/CN and OPA/2-ME are used for many MD-ME systems because of their 
rapid derivatization reactions and the fact that they are fluorogenic. However, even these reagents 
can require several minutes to fully derivatize a sample. Consequently, when performing 
derivatization online, much lower levels of fluorescent product are likely to be created prior to 
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3.1 An Introduction to Electrophoretic Separations 
 
Electrophoresis is a separation technique whereby analytes with differing ratios of charge-to-
hydrodynamic radius can be separated using an applied external electric field. The general 
technique of electrophoresis has been in use for many years [1-3]. Briefly, an electrophoretic 
separation begins with the application of an electric potential to a conductive electrolyte solution 
containing the analytes of interest. The application of this potential results in a force on all charged 
analytes toward the electrode of opposite charge, with positive analytes migrating toward the 
negatively charged cathode and negative analytes migrating toward the positively charged anode. 
The degree that an individual analyte responds to the electric field is known as its electrophoretic 
mobility. That mobility is given by the following equations beginning with the velocity of an 
analyte in an applied electric field: 
𝜈 =  𝜇𝐸𝐸 
Equation 3.1: Analyte velocity due to an applied electric field 
 
Where 𝜈 is the analyte velocity, 𝜇𝐸is the electrophoretic mobility of the analyte, and 𝐸 is the 
applied electric filed in V/cm. The force applied to an analyte is found as a relationship between 
the force due to the applied electric field: 
𝐹𝐸 = 𝑞 𝐸 




With FE is the force due to the applied field, q is the charge on the analyte, and E is the 
applied field strength. This force is balanced however against the forces of frictional drag given 
by: 
𝐹𝐹 = −6𝜋𝜂𝑟𝜈 
Equation 3.3: The frictional forces on an analyte 
 
Which is Stokes law for frictional drag on a spherical object where FF is the frictional force, η 
is the viscosity of the solution, ν is the velocity of the analyte, and r is the radius of the ion. 
Combining these equations and solving for the analyte mobility 𝜇𝐸 we arrive at: 




Equation 3.4: Analyte mobility as a function of analyte charge, size and solution viscosity. 
 
It can be seen then that any differences in mobility between analytes is a function of the 
relative charge to size ratio of each analyte as well as their response to changes in solution 
viscosity. The problem of how to separate analytes of opposing charges or those having none at 
all is discussed in the next section. 
 
The separation of analytes based on relative differences in their electrophoretic mobilities is 
a broadly applicable technique as many analytes either possess a charge or can be induced to 
process one via changes in pH. However, the migration of charged analytes toward opposite 
electrodes can be problematic in cases where both positive and negatively charged analytes are of 
interest. In addition, low separation efficiencies and inadequate resolution make the use of slab gel 




3.2 Capillary Electrophoresis 
 
Like gel electrophoresis, capillary electrophoresis (CE) functions via the application of an 
electric potential to a conductive background electrolyte (BGE). In this case, the BGE is contained 
within a long capillary tube, typically made of fused silica and optionally coated with a polyimide 
coating that provides additional robustness. The capillary can range in length from 20 cm to over 
100 cm, with an internal diameter between 10 µm and 100 µm. The outer diameter of the capillary 
generally ranges from 200 to 375 µm. These dimensions have important repercussions that have 
resulted in vastly improved performance of this system over gel-based electrophoresis for small 
molecules. First, the high ratio of surface area to volume allows substantial amounts of heat to be 
dissipated. This in turn allows the use of higher potentials (typically on the order of several hundred 
volts per centimeter), thereby increasing separation efficiency. Secondly, the small internal 
dimensions limit sample volume requirements. Injection volumes for CE are typically on the order 
of 100 nL, although they can be larger if desired. Finally, the charged groups on the inner surface 
of the capillary can create an electrical double layer and cause the production of electroosmotic 
flow (EOF) when an electric potential is applied. This EOF makes it possible to detect all 
compounds, regardless of charge, at one end of the capillary.  
 
3.2.1 Electroosmotic Flow 
 
Electroosmotic flow (EOF), shown in Figure 3.1, is generated in the capillary as a result of an 
electrical double layer that is formed on the surface of silica capillaries when using a BGE of pH 
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3 or greater. Above this pH, silanol groups on the surface of the capillary become ionized, resulting 
in a net negative surface charge. In response to the formation of this surface charge, a layer of 
cations from the BGE forms a compact layer of positive charges near the surface. This layer 
becomes more diffuse as the distance from the negative capillary surface increases. When a 
separation potential is applied to the capillary, these diffuse cations migrate toward the cathode, 
dragging the solvent with them. If the EOF is stronger than the attraction of the analytes of interest 
to the anode (electrophoretic mobility), then all analytes, regardless of charge, will migrate toward 
the cathode where the detector is placed.  
 
 
Figure 3.1: A negative charge is generated on the surface of silica capillaries due to the use of a BGE with pH of 3 or greater. As 
an external voltage is applied to the channel, a bulk flow (µEOF) is created from anode (+) to cathode (-). Simultaneously, analytes 
begin to migrate toward their respective opposite charge (negatively charged cations toward the anode, positively charged anions 
toward the cathode). This electrophoretic mobility (µe) of each analyte is governed by its individual charge-to-mass ratio. The 
overall apparent mobility of each analyte is the resulting sum of µEOF and µe. 
 
Analyte mobility due to EOF is independent of charge and is given by: 




Equation 3.5: Analyte mobility due to EOF 
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Where 𝜀 is the dielectric constant of the solution, 𝜁is the zeta potential, and 𝜂 is the viscosity. 
 
Many variables can affect the formation of an EOF, including channel dimensions (at greater 
than ~200 µm, viscous forces overwhelm the net motion of the BGE and Joule heating increases), 
viscosity and ionic strength of the BGE, pH, and applied potential. It is through the proper 
balancing of these variables and those concerning the interaction of each analyte with the BGE 
and resulting in their individual electrophoretic mobilities (µe) that a well-resolved separation is 
achieved.  
 
Finally, the direction of the EOF can be reversed through the application of a surface coating 
of positive charge and a reversal of the polarity of the applied electric potential. Operating in 
reversed polarity can be beneficial when separating some charged species.  
 
3.2.2 Sample Injection 
 
The two primary methods by which samples are injected into a CE or ME system are 
electrokinetic and hydrodynamic injections. Electrokinetic injection uses control of the EOF and 
electroosmotic mobility generated by an applied potential difference to inject sample into the 
capillary. To accomplish this, the capillary is placed into a sample and a potential is applied for a 
prescribed amount of time. Analytes are introduced into the capillary using the same principles of 
migration that are used during a separation. Because analytes migrate at varying rates depending 
on their electrophoretic mobility, electrokinetic injection can therefore be biased toward smaller 
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analytes having opposite charge to the polarity of the separation voltage. In the extreme case where 
an EOF is not present, this bias will result in only analytes of a single charge being injected.  
 
By contrast, hydrodynamic injections exhibit no such bias. In this injection scheme, a defined 
volume of sample is injected into the capillary by first placing the capillary in the sample and then 
applying a pressure differential to the sample itself. The result is fluid displacement into the 
capillary. Following this injection, a separation potential is applied and electrophoretic separation 
proceeds normally.  
 
3.3 Microchip Electrophoresis 
 
Like CE, microchip electrophoresis (ME) has many benefits over more common separation 
methods such as liquid chromatography, including the ability to analyze extremely small sample 
volumes, high separation efficiencies, and rapid analysis times. In addition to these advantages, 
ME has several added benefits. The first of these is that ME devices have a much smaller footprint 
than existing CE systems. The decrease in length from a 75-cm channel in CE to a 5-cm channel, 
along with the smaller dimensions of the channels (15 µm deep by 50 µm wide), allows a fraction 
of the voltages to be used while preserving the 333 V/cm separation potential. The smaller 
dimensions of a ME setup can be seen in Figure 3.2. The decrease in voltage needed as well as in 
the associated instrumentation can lead to a much smaller overall system. The separation 
efficiency, which is a function of field strength, is preserved, resulting in decreased analysis times 





Figure 3.2: Schematic of a typical ME device with a simple-T design. The entire system is usually no bigger than 3 cm x 10 cm x 5 
mm thick. (a) Channel substrate. The channel’s dimensions can vary with application, but are usually on the order of 50 µm wide 
x 15 µm deep. (b) Base substrate. The channel substrate can be reversibly or irreversibly bound to the base, as discussed in Section 
3. (c) Separation channel, which can vary in length from 2.5 cm to 15 cm depending on the device design. (d) Electrokinetic gate 
(e) Sample and buffer reservoirs. The exact conditions to perform an electrokinetic injection on a ME device are discussed further 
in Figure 3.7.  
 
Another advantage of microchip electrophoresis is that modern micro-manufacturing 
techniques such as photolithography, hot embossing, injection molding, and casting make it 
possible to integrate multiple complex features into a single device [4]. These features, which can 
include gating for the introduction of sample to the separation channel, tapered geometries to 
improve separation efficiencies, the addition of electrodes for electrochemical detection, and 
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micromixers to facilitate on-chip derivatization of samples, add greatly to the utility of microchip 
systems. By integrating these functions directly into the microchip, it is also possible to radically 
decrease sample and reagent volume requirements. Finally, these techniques allow microchip 
designers to select materials based on properties such as optical clarity, surface chemistry, material 
expense, and ease of integration.  
 
In light of the limitations placed on any analytical method by a sampling technique such as 
microdialysis, as mentioned in the previous section, microchip electrophoresis represents an ideal 
method for analyzing small sample volumes and enabling high temporal resolution. To take full 
advantage of the ability to handle small volumes, a detection strategy with sufficiently low limits 
of detection (mass sensitivity) must also be used. 
 
3.4 Microchip Detection Strategies 
 
Virtually all the detection strategies used in modern analytical chemistry have been 
successfully integrated with the microchip format. The most common methods include 
fluorescence, electrochemical, and contactless conductivity detection. Additionally, mass 
spectrometry has been interfaced with ME using methods such as electrospray ionization. 
 
As with CE, the most common detection methods used with ME are optical in nature. However, 
unlike CE, in which absorbance detection is very common, the thick planar substrates used in the 
construction of microchips can make absorbance measurements difficult. Additionally, the short 
optical path length of the separation channel leads to a lack of sensitivity, although this can be 
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mitigated by the use of a specially designed detection cell [5]. Electrochemical and conductivity 
detection are popular methods of detection in the microchip format due to the ease of integrating 
electrodes directly into the microchip substrate. However, fluorescence detection is more often 
used due to its generally low limits of detection and the fact that it does not suffer from limitations 
due to pathlength, and that it exhibits a lower background than other detection methods. The 
additional ease of focusing an excitation light source such as a laser on the ME channel results in 
it being commonly used with ME. However, because the majority of compounds and, specifically, 
Glu are not inherently fluorescent, it is often necessary to first derivatize a sample with a 
fluorophore prior to separation using ME.  
 
In this chapter and, in particular, the next section, we will discuss the types of materials used 
in the construction of an ME device, the methods used, and the relative pros and cons of each. Due 
to the advantages mentioned above, our detection method of choice for Glu is fluorescence. While 
the methods discussed reflect this preference, the design and construction principles are broadly 
applicable to other detection strategies. 
 
3.5 Analysis of Complex Samples via Microchip Electrophoresis  
 
Microchip electrophoresis (ME) is based on the same principles as capillary electrophoresis 
and, thus, separates compounds based on the ratio of their size and charge. This technique is 
therefore well-suited for the analysis of small, charged molecules such as Glu. In contrast to 
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biosensors, microchip electrophoresis permits the simultaneous analysis of multiple analytes in a 
single run.  
 
Detection in ME can be accomplished using a variety of methods, the most common being 
electrochemistry, mass spectrometry, and fluorescence. Glutamate is most frequently measured 
using fluorescence detection following derivatization with a fluorescent (or fluorogenic) reagent. 
Using microchip electrophoresis, it is possible to separate Glu from other important biogenic 
amines in a brain microdialysate sample. In particular, the detection of Glu in conjunction with 
aspartate (Asp) and γ-aminobutyric acid (GABA) can provide particular insight into the status of 
the brain tissue being sampled. Arginine and citrulline are indicators of nitric oxide synthase 
activity in the brain and can be measured under the same conditions. As Figure 3.3 demonstrates, 
sample collection via microdialysis, derivatization, and separation using ME (all of which are 
described in detail later in this chapter) can provide a powerful view of multiple analytes within 





Figure 3.3: (A) An electropherogram of an NDA/CN-derivatized MD sample spiked with 5 µM arginine (Arg), citrulline (Cit), 
taurine (Tau), histamine (Hist), glutamate (Glu), and aspartate (Asp) for peak identification. Analysis performed offline using a 
15-cm ME device.  
(B) An electropherogram of a NDA/CN-derivatized MD sample from the striatum of a male Sprague Dawley rat. Sample was 
collected at 1 µL/minute-1 and derivatized offline prior to separation.  
 
3.6 Microchip Electrophoresis with Fluorescence Detection 
 
The construction and operation of ME devices, whether they are operated offline or online 
coupled to MD, is a multistep process involving photolithography, chemical etching, and high 
temperature bonding. These procedures are best performed in a cleanroom environment for the 
highest level of reproducibility, although it is possible to construct these devices in a laboratory 
setting if care is taken to maintain a clean environment. The materials, facilities and 
instrumentation listed below describe what is used in our laboratory for the fabrication of glass 
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and PDMS microfluidic devices. A detailed explanation of their use in the fabrication process is 
found in the methods section following this section. 
 
3.7 Online MD Coupling 
3.7.1 Required Equipment 
 
Online sampling using MD requires the use of precision syringe pumps capable of maintaining 
a flow at 1µL/min. For the work discussed in thesis, a CMA Model 100 syringe pump was used 
with 1 mL syringes, also from CMA (CMA Microdialysis, Holliston, MA). Polyethylene tubing 
having an internal diameter of 0.39mm and an outer diameter of 1.09 mm was used. The method 
used to connect this tubing to a microchip can vary. For the work here though, bonded port 
connectors (model C360-400 from Labsmith, Livermore, CA) was used for glass-glass devices 
while 24 gauge coupling pins were used for PDMS-glass and PDMS-PDMS devices.  
 
3.7.2 Sample Introduction  
 
The development of a microfluidic devices begins with the design process. In designing an ME 
device, it is helpful to first determine what requirements will be placed on the function of the 
device itself. Four initial questions that must be asked: (1) Will the ME device interface directly 
to a microdialysis probe in an online manner or will samples be added to the device offline? (2) 
Will sample derivatization be performed on-chip or off? (3) How will sample be injected into the 




 If sample acquisition is to be performed via online interface to microdialysis, pressure at 
the device inlet must be taken into account and channel widths adjusted accordingly. If 
derivatization will occur on-chip as well, multiple laminar flows must be mixed, either actively or 
passively, and the reactants must be given sufficient time following mixing for derivatization to 
occur. Sample injection, whether via pressure or performed electrokinetically, requires channel 
geometries that allow flow in one direction (down the separation channel) to be prevented.  
 
 Pressure injection is accomplished in ME devices by using additional PDMS membrane 
layers and the application of external positive and/or negative pressures to prevent fluid flow 
through channels. Unlike electrokinetic injection, which can result in biased injections of sample 
ions depending on their charges, pressure injection of sample is unbiased. However, due to the 
requirement of a flexible layer of PDMS, this approach is not typically used with all-glass ME 
devices. Providing a source of negative or positive pressure also further complicates the system 
design. For this reason, we focus primarily on the use of electrokinetic injection for all three types 
of ME devices described here. 
 
When using electrokinetic injection, potentials are applied to each channel in order to establish 
a “gate”, with longer channels requiring higher potentials. Additionally, asymmetrical geometries 
(such as having channels of varying lengths) can necessitate multiple high voltage supplies.  
 
Finally, the length and geometry of the separation channel itself will directly determine many 
performance characteristics of the ME device, including peak resolution, EOF magnitude, and the 
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separation voltage required. Separation channel widths greater than 200 µm should be avoided as 
viscous fluid properties begin to overwhelm those of the EOF beyond this point and Joule heating 
increases substantially. When comparing channel lengths, longer separation channels will result in 
greater separation efficiencies, assuming a comparable applied potential (measured in volts per 
centimeter). However, care should be taken when designing channels longer than 10 cm, since 
these necessitate serpentine channels that can result in a “racetrack” effect. This effect can be 
mitigated by tapering turns. Tapered turns themselves can be problematic, however, as the 
localized electric field strengths are increased. As the field strength increases, the current passing 
through that region of the channel also increases. This leads, in turn, to a resistive heating of the 
BGE termed Joule heating, which can bring about poor resolution. Despite the potential for this 
effect, optimal channel dimensions can greatly improve resolution when properly implemented for 
longer channel lengths if Joule heating is prevented [7, 8].  
 
3.8  Modeling studies and chip design 
 
Modeling of ME devices using software such as Comsol® prior to any production steps can be 
very advantageous. However, modeling entire geometries can be computationally intensive and 
time consuming. Unless it is necessary to model all parts of the chip simultaneously, the best 
practice is to model specific regions, such as the electrokinetic gate and turns, in order to optimize 
those particular geometries. The design of mixing and derivatization geometries can also benefit 
from modeling the device prior to construction to ensure that the chosen combination of mixing 
geometry and sample flow rate will result in a fully derivatized sample prior to injection and 
separation. Designs must typically be exported into a computer-aided drafting (CAD) format prior 
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to being made into a photomask, a process that may require additional review to ensure that the 
conversion of formats itself did not introduce errors.  
 
Finally, printed photomasks must be of an extremely high resolution, and these are not 
attainable without the use of a specialized photomask printer. For that reason, professional services 
such as that provided by Infinite Graphics (Minneapolis, MN) are typically used. It is more cost-
effective both in terms of printing photomasks and ultimately in terms of substrate usage to have 
multiple copies of devices on a single photomask. For reasons that will be explained in the 
following sections, these copies should be laid out in such a way that they can easily be separated 
into individual devices (i.e., easy to cut the glass substrate without scratching a neighboring device) 
while fitting the maximum number of devices onto a single glass substrate. It is important that the 
photoresist is removed along a line between the devices, due to the fact that glass cutters will not 
cut through photoresist or chrome layers. Finally, if holes are to be drilled in the device following 
development, the diameter of the drill bit must be taken into account by providing an additional 
margin to prevent the destruction of neighboring features.  
 
3.9 Material Selection 
 
Selecting a material with which to construct an ME device must begin with consideration of 
the detection method used. In the case of optical detection, the optical clarity of the material, 
including any autofluorescence of the material itself at the target wavelength, is of paramount 
concern. This can be of particular importance with plastic substrates. When using electrochemical 
or conductivity detection, the ability to integrate an electrode into the substrate must be considered. 
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The surface chemistry of materials must also be taken into account, not only when considering the 
EOF generated by the electric field but also when determining whether or not analyte adsorption 
is likely to be a problem.  
 
With this in mind, two materials have been widely evaluated and are commonly employed for 
ME: glass and polydimethylsiloxane (PDMS). A third option, which will also be discussed, is to 
combine these two materials in to a hybrid device in an effort to take advantage of aspects of each. 
These three options are by no means an exhaustive list of substrates for ME construction. Many 
other polymers, including poly (methyl methacrylate) (PMMA) and cyclic olefin copolymer 
(COC), are commonly used in device manufacture, each with their individual pros and cons. This 
chapter is focused on the use of glass, PDMS, and PDMS-glass hybrid devices because these 
substrates represent ideal material characteristics (glass) and ideal ease of use (PDMS). Their 
individual properties are described in the following sections.  
 
3.9.1 Glass ME Devices 
 
In many ways glass is an ideal substrate for an ME device. Its optical clarity is superb over a 
range of wavelengths, its surface chemistry is stable over range of pH values resulting in high 
reproducibility, and it has the ability to withstand high voltages (and subsequent Joule heating) 
associated with electrophoretic separations [9]. Additionally, because CE capillaries are typically 




The construction of glass-glass ME devices begins with the use of photolithography to transfer 
a device pattern to a borosilicate glass substrate pre-coated with chrome and photoresist. While it 
is possible to coat glass substrates manually, pre-coated substrates purchased from a company such 
as Telic (Valencia, CA) are inexpensive and consistent in performance. Following the transfer of 
the pattern, a multistep process to remove sections of the pattern followed by etching with a 
hydrofluoric acid solution is used to create the channels in the bottom glass substrate. Finally, 
holes are drilled, the glass is cut to size, and a two-step bonding process is used to permanently 
bond a blank glass piece to the etched glass. The result is an ME device that can withstand both 






Figure 3.4: Schematic of glass-glass microchip fabrication. (a) Align photomask on coated glass and expose to UV light. (b) 
Remove photomask and soak in developer to remove exposed photoresist. (c) Remove exposed chrome using chrome 
etchant. (d) Etch exposed glass with hydrofluoric acid, then confirm channel depth with profilometer. (e) Remove 
remaining photoresist with acetone. (f) Remove remaining chrome with chrome etchant. (g) Bond to another piece of 
unmodified glass to form complete chip. 
 
 
3.9.2 Polydimethylsiloxane (PMDS) ME Devices 
 
Glass microchips permit highly reproducible separations and can last for extended periods of 
time if properly cared for. However, the fabrication process is lengthy and difficult and requires 
the use of dangerous and expensive materials. As these chips are irreversibly bonded, if there are 
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any issues with the construction of the separation channel or solution reservoirs (such as clogging 
or scratches), they must be disposed of and replaced. This makes all-glass microchips a poor choice 
for prototyping methods, in which multiple chip designs are studied before settling on a final 
pattern. 
 
Polymeric substrates are often used for device development to avoid these complications and 
allow faster prototyping. A wide variety of polymeric substrates are used for microchip 
electrophoresis; however, polydimethylsiloxane (PDMS) is by far the most common and will be 
the only polymer described here. Its elastomeric properties (including the ability to seal to surfaces 
without distorting), optical transparency, low cost, and ease of fabrication make it an excellent 
candidate for microchip fabrication [10]. After a master mold with the desired microfeatures is 
made, multiple PDMS chips can be prepared using the same master for extended periods. This 








Figure 3.5: Schematic of PDMS-PDMS or hybrid microchip fabrication. (a) Spin-coat silicon wafer with negative photoresist. (b) 
Align photomask on coated wafer and expose to UV light. (c) Use developer to remove unexposed photoresist, then post-
bake and confirm microfeature dimensions with profilometer. (d) Pour PDMS over master and cure in oven for at 
least two hours. (e) Peel PDMS off of master and cover with ParafilmTM if not bonding immediately. (f) Punch holes 
for buffer reservoirs in PDMS, remove ParafilmTM , if necessary, and bond to substrate of choice (PDMS or glass). 
 
PDMS has only a very small surface charge, which means an EOF will not occur in PDMS 
channels. To achieve a separation, additives that will adhere to the walls and lend it their charge 
must be included in the BGE. The additive used depends on whether a normal or reverse polarity 
is applied. A common additive for normal polarity is sodium dodecyl sulfate (SDS), while a 




3.9.3 Hybrid ME Devices 
 
Despite the ease of fabricating PDMS microchips, they suffer in terms of longevity and 
reproducibility. A PDMS chip can often be used for only a 6 to 8-hour period before a new one 
must be made. This is especially true if using high field strengths, which can cause the PDMS 
polymer to degrade or burn. This results in many different chips being required for even the 
simplest of studies, which can produce slight changes in separation efficiency and migration times 
for the analytes of interest. This variability in chips is further exacerbated because PDMS is not 
natively charged, which means additives must be added to the buffer in order to establish an EOF. 
 
One solution to these reproducibility issues is the fabrication of PDMS-glass hybrid 
microchips. In this design, the microfeatures are prepared in either PDMS or glass; they can then 
be bonded to the opposite substrate to create the completed device. This method combines the 
strengths of glass and polymeric devices. The inclusion of glass as a substrate leads to more 
reproducible EOFs, while the inclusion of PDMS still allows rapid fabrication and easy cleaning 
of clogs [11]. 
 
When making a hybrid device, the main consideration is which substrate will contain the 
separation channel. This depends on the analytical needs of your method. If a reproducible EOF is 
required or higher field strengths are a necessity, having three walls of the channel made from 
glass will result in better separations. However, if there are no available facilities for etching and 
drilling glass or rapid prototyping of the channel design is required, a device with three walls of 




The previous sections outlined methods of preparing microchannels in both glass (Section 3.3.) 
and PDMS (Section 3.4). These methods are unchanged; the only difference in constructing a 
hybrid device is the method of bonding. For most purposes, reversible bonding will suffice, as it 
is much faster and is compatible with most separations. Irreversible bonding is required only when 
there are concerns regarding the seal of the substrates, such as when incorporating a pressure-
driven flow as the sample source. A step by step set of instructions can be found in Appendix C. 
 
3.10 Device Use 
 
As mentioned in the previous sections, the detection of Glu using ME can be performed either 
in an offline or online fashion. These two methods of operation differ primarily in terms of sample 
acquisition, derivatization and, in the case of online, the added complexity of integrating fluid 
handling into the ME device. Consequently, the following sections are divided into offline sample 
preparation and handling, online sample preparation and handling, and, finally, the sample 
injection, detection, and separation steps common to both. In either case however, as noted 
previously, ME devices have exceedingly small internal volumes on the order of 15 µm deep by 
50 µm wide, making it easy for particles to block channels. This is of less concern for online 
microdialysis samples as the process of microdialysis itself prevents larger molecules from 
entering the dialysate. Samples, stock solutions and any other solution used in the device including 
cleaning solutions, should be filtered prior to use using a 0.22 µm filter. Additionally, care should 
be taken to prevent dust from collecting in the channel inlets of glass-glass devices between use. 
Two common methods for preventing dust accumulation are wrapping the chip in Parafilm™ and 
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storing the chip under water. The latter is a popular method used to maintain the chip overnight 
while the former is used for long-term storage. New PDMS-PDMS and PDMS/glass hybrid 
devices should be made between uses, preventing this problem. 
 
3.10.1 Cleaning and Conditioning ME Devices 
 
3.10.1.1 Glass-glass ME Devices 
 
Prior to each use of a glass-glass ME device, the channels must be cleaned and conditioned 
(referred to from this point onward simply as conditioning) using a sequence of steps designed to 
remove any of a series of surface contaminants, finishing with the application of sodium hydroxide 
(NaOH) to leave the separation channel with a negatively charged surface. The following sequence 
should be applied for each full conditioning. For each step, the solution should be added to all 
wells but one, allowing the application of negative pressure at that well to pull the solutions 
through. Negative pressure can be generated using a pump or a vacuum aspirator. The sequence 
for full conditioning: 
 
1. Deionized, Millipore™ filtered water for >5 minutes  
2. 0.1 M HCl for >5 minutes 
3. Deionized, Millipore™ filtered water for >5 minutes 
4. 0.1 M NaOH for >5 minutes 
5. Deionized, Millipore™ filtered water for >5 minutes 




Between individual uses of the device, it may be possible to skip steps 2 and 3. Care should be 
taken not to add acids or bases to the device without first cleaning with water as rapid changes in 
pH can result in the formation of precipitates within the channel. Additional information regarding 
chip cleaning can be found in Section 4.5 at the end of this chapter.  
 
3.10.1.2 PDMS-PDMS and PDMS/Glass Hybrid ME Devices 
 
Conditioning a PDMS-PDMS or PDMS/glass hybrid device requires a different procedure, 
primarily because using strong acids can lead to delamination of the PDMS. Therefore, a full 
conditioning for these devices consists of only the following sequence of flushing the chip: 
 
1. Deionized, Millipore™ filtered water for >5 minutes 
2. 0.1 M NaOH for >5 minutes 
3. Deionized, Millipore™ filtered water for >5 minutes 
4. Background electrolyte (BGE) (fill channels with BGE) 
 
 
3.10.2 System Setup 
 
Just as ME designs vary, the orientation of the supporting equipment (power supplies, detection 
equipment, associated optics, etc.) is often specific to the application or laboratory. Therefore, the 
description we offer here represents only one possible implementation. We have found this 
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implementation useful for a variety of ME devices and applications, including both online and 
offline analysis. A schematic diagram of the general system setup can be seen in Figure 3.6.  
 
 
Figure 3.6: An excitation light source, here at 445 nm laser, is focused such that its output is reflected upward by a dichroic mirror 
mounted at 45º. The ME device is mounted so that the excitation light intersects the separation channel near the end of the channel. 
As fluorescent analytes pass through the beam, emitted light passes through the dichroic mirror due to its longer wavelength. 
Continuing along this path, an optical longpass filter is used to remove residual excitation light before the remaining light is 
focused onto a photomultiplier tube (PMT) for amplification and conversion to an electrical signal.  
 
 
3.10.2.1 Materials List 
 
Focusing an excitation light source on a small microfluidic channel can be challenging. For 
the work discussed here, this was accomplished using a Nikon Eclipse Ti Microscope which 
focused the beam of an Omicron PhoxX 445nm diode laser on the detection point. The emitted 
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light from the derivatized analyte was detected using a Hamamatsu PMT Model R1527 with 
Pacific Instruments Model 227 PMT Power Supply. The output of this PMT was subsequently 
amplified using a Stanford Research Labs Model SR570 Preamplifier before a USB-6229 data 
acquisition card from National Instruments converted the signal for display on a nearby PC. 
 
3.10.2.2 Optical System 
 
Briefly, a Nikon Eclipse Ti microscope is used as a stage upon which an ME device is placed. 
A 445 nm laser, specific for NDA excitation, is fired into a fiber optic cable, which is subsequently 
interfaced to the Nikon Eclipse Ti microscope. The incoming laser light passes through an 
excitation optical filter, attenuating any wavelengths of light other than 445 nm before being 
reflected upward using a dichroic mirror mounted at 45º. This dichroic mirror is chosen 
specifically to reflect wavelengths lower than that of the emitted light from the target fluorophore. 
The result is laser light reflected upward through a focusing objective lens, and intersecting the 
end of the ME device’s separation channel, which has been placed on the microscope stage. As 
NDA-tagged analytes, such as Glu, migrate toward the end of the separation channel, they pass 
through the beam of 445 nm laser light. Encountering this results in fluorescent excitation and 
emission of light at approximately 490 nm. The emission of this light occurs in all directions, 
including back down through the focusing optics. As this emitted light continues along its path, it 
passes through the dichroic mirror due to its longer wavelength. A final emission filter is used to 
remove any light having a wavelength less than a cutoff of ~490 nm (chosen to prevent excitation 




3.10.2.3 Signal Detection and Amplification 
 
A photomultiplier tube (PMT) with an applied bias voltage of 1000 V was used to detect the 
light emitted by the analytes, converting the light into an electrical current. The current produced 
by the PMT during this process is typically on the order of 1 nA to 1 µA and requires subsequent 
amplification before being converted to a digital signal for analysis. This amplification step is 
performed by a current-to-voltage amplifier (Model SR570). This particular model of amplifier 
allows the user to specify a low noise, high gain setting, which we typically set to a gain of 200 
µA/V, and a low pass filter set to attenuate high frequency noise over 3 Hz.  
 
Finally, following amplification, a National Instruments data acquisition system, model USB-
6229, was used to convert the analog output of the amplifier into a digital signal for display and 
analysis using custom Labview-based software.  
 
3.10.3 Offline Injection and Separation 
 
As mentioned in the previous sections, electrokinetic injection is our preferred method of 
sample injection due to the relative simplicity of the system. That said, the coordinated use of 
multiple high voltage (HV) potentials in a small area while maintaining optical alignment of 
microscale features can be nontrivial. Safety is a chief concern when using HV power supplies. 
Additionally, a HV supply should be chosen to have high stability over time, digital control 
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allowing potentials to be toggled on and off quickly, short circuit protection to protect both user 
and supply, and feedback to the user regarding the actual voltage and current output of the system. 
Feedback to the user is incredibly useful in diagnosing problems and is discussed in Section 4. 
With these requirements in mind, we typically use Ultravolt power supplies such as the HVRack-
4-250. Finally, for the purposes of this example, we will assume a ‘simple T’ architecture such as 
the one in Figure 3.7 that uses two HV ports and two ground ports to create a gate and separation 
potential for offline sample analysis.  
 
To begin, the chip should be mounted on the microscope platform such that the excitation light 
is focused on the gate of the chip to first determine the correct ratio of HV potentials to use to 
establish a gate. For the simple T with 2.5 cm side channels and a separation channel 5 cm in 
length such as the design in Figure 3.7, a ratio 3:4 is typically sufficient, meaning that applying 
2000 V to the “Buffer” port as a separation voltage and (2000*.75) = 1500 V to the “Sample” port 
will create a gate. This ratio will differ depending on the chip geometry used. Once established, 
this gate can be seen through the microscope by adjusting the position of the chip such that the 
excitation light is focused on the gate region of the chip, a fact that can be useful for diagnosis. 
Wires should be attached and secured with HV applied to the sample and buffer ports and ground 
wires in the buffer waste and sample waste ports. Alligator clips should be soldered to the ends of 
both the HV and ground wires, and platinum wires should be placed in the wells themselves. Once 
the presence of a gate has been established, the detection point should be moved to the end of the 
separation channel. To inject a sample, the “Buffer” voltage will need to be turned off 
momentarily, allowing the potential to float. This is not to be confused with grounding the 
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potential, which would result in sample flowing into the buffer reservoir as the EOF reversed 
direction.  
 
Figure 3.7: A) The microchip is loaded with sample (S) and buffer (B). A high voltage potential is applied, resulting in 
electroosmotic flow toward the waste ports (W). B) Buffer voltage is floated, allowing sample to be injected. C) Buffer 
voltage is reestablished and analyte separation proceeds. 
 
After sample has been allowed to enter the separation channel (a one second injection time is 
typically more than sufficient), the voltage applied to the “Buffer” port is reapplied. This has the 
effect of both reestablishing the electrokinetic gate, preventing additional sample from entering 
the channel, and applying a potential to the separation channel. It is at this point in the process of 
analysis that analytes will begin to migrate with the EOF, separating according to their individual 





3.10.4 Online (MD-ME) Injection and Separation 
 
The operation of an integrated MD-ME system is very similar in function to the offline 
example described above. As with offline analysis, the ME device is mounted over the detection 
system with the excitation light focused on the end of the separation channel. Integrating an MD 
flow to an ME device, however, requires that ports first be bonded to the surface of the device. As 
mentioned previously, UV glue is typically used in conjunction with bonded port connectors to 
create an interface capable of withstanding the pressure produced by the microdialysis flow.  
 
Once the ports have been attached, polyethylene tubing can be used to connect the syringes 
containing NDA in ACN, NaCN in H2O, and the output of the microdialysis probe to the ME 
device. The fluids from these three inlets must be given sufficient time to mix on-chip, allowing 
analytes in the dialysate to form fluorescent products.  
 
As in offline analysis, an electrokinetic gate is established at the inlet to the separation channel 
to prevent sample from continuously entering the channel. However, in the case of a coupled MD-
ME system, the MD interface must be grounded in order to prevent damage to equipment or test 
subjects. If, however, the port is grounded near the gate, a counter-flowing EOF can be created. 
Therefore, the MD flow should be grounded as far from the separation channel as possible. Once 
a grounded pressure flow has been established, a separation voltage can be applied. An example 





Figure 3.8: A) Similar to the T chip shown in Figure 3.7, the MD-ME interface shown here has sample applied to the top port via 
integration with an MD probe and run buffer added to the remaining 3 ports. A potential is applied to the run buffer reservoir 
(B), resulting in electroosmotic flow toward the waste ports (W), while pressure from the MD interface results in 
sample flow to sample waste. The MD flow must be grounded between the microdialysis probe and the ME device (not 
show in this diagram) to prevent electrocution. However, the distance to this ground must be longer than the distance 
to the ground potentials on the ME device itself to prevent a counter EOF flow. B) Buffer voltage is floated, allowing 





The first report of the use of microchip electrophoresis with fluorescence detection to detect 
Glu in microdialysis samples came from the Robert Kennedy group, who published a study 
investigating amino acids with OPA derivatization [12]. These experiments had limits of detection 
near 200 nM and achieved a separation in 95 seconds using an all-glass microchip. By using a 
different chip design and high potential field, they also managed to achieve the separation in under 
20 seconds. They continued this work using a segmented flow PDMS-glass microchip design and 
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the NDA/CN derivatization reaction [13]. This separation also occurred in under 20 seconds, and 
had improved limits of detection. This method was used to track the in vivo change of aspartate 
and Glu following the introduction of a glutamate transport inhibitor and microdialysis sampling. 
More recent work from this group has further improved separation speeds and detection limits 
using “water-in-oil” schemes that can provide excellent temporal resolution by derivatizing 
samples in discrete plugs of 8–10 nL prior to injection and separation [13]. 
 
The Susan Lunte group has also used microchip electrophoresis for Glu detection, furthering 
their earlier work using capillary electrophoresis to analyze amino acid neurotransmitters [14] and 
microchip electrophoresis to detect fluorescein in the brain [15]. This led to the development of a 
PDMS-glass hybrid microchip that allowed continuous, online, in vivo monitoring with 
microdialysis sampling, as shown in Figure 3.9 [16].  
 
 
Figure 3.9: Schematic of a basic in vivo microdialysis-microchip electrophoresis system. In a brain experiment, the perfusate is 
normally artificial cerebrospinal fluid (aCSF) pumped at a flow rate of 1 µL/min. The derivatization reaction normally 




This study used the NDA/CN reaction to detect amino acid neurotransmitters, using a 20-cm 
separation channel with on-chip mixing to facilitate derivatization. This method was used to study 
the change in concentration of fluorescein in rat brain dialysate over time, but was also capable of 
separating and detecting Glu. These results were expanded upon in an additional study, which 
improved the micromixer chip design and used a full-PDMS microchip [17]. This allowed near 
real-time in vivo monitoring of amino acid neurotransmitters, including Glu, with a 10-minute lag 
time. Further work has been done to design a robust and portable detection system with a light-
emitting diode (LED) excitation source, shown in Figure 3.10. This will allow in vivo microdialysis 
experiments to be carried out in a medical setting, where the use of a laser excitation source is 
impractical. Using this system, Glu was separated from multiple other amines and detected in brain 
microdialysis samples derivatized using the NDA/CN reaction [6]. 
 
While the bulk of published studies involving Glu detection using microchip electrophoresis 
have used either NDA or OPA for derivatization, several other fluorophores have been explored. 
Among these, a ME-based chiral separation of D/L Glu as well as D/L Asp in rat and human 
cerebral spinal fluid samples was developed by Huang et al. [18]. The separation of each 
enantiomer was accomplished through the addition of 12 mM γ-cyclodextrin to a run buffer 
containing 30 mM sodium dodecylsulfate (SDS) and 25 mM sodium borate. Pre-column 
derivatization with fluorescein isothiocyanate (FITC) was used to label the amino acids prior to 
the separation on a 7.6 cm simple-T microchip, ultimately resulting in detection limits of 40 nM 
for D-Glu. FITC, like OPA and NDA, is selective for the amine moiety of amino acids. However, 
FITC is a fluorophore and is therefore fluorescent prior to derivatization, which can complicate 
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analysis. Additionally, the long reaction times of several hours necessary for derivatization limit 
its utility for rapid assays [19].  
 
 
Figure 3.10: Schematic representation of portable LED excitation and fluorescence detection system. Given wavelengths are for a 
separation using the NDA/CN derivatization reaction. (A) Microchip. (B) In-channel detection point. (C) Focusing objective. (D) 
X-Y positioner. (E) Dichroic mirror. (F) Pinhole. (G) Collimating lens. (H) LED @ 445 nm. (Ii) Heat sink. (J) Long pass filter @ 




Another example of Glu detection via ME is the development of a system for in situ analysis 
of organic matter in Martian soil [20]. This method was first tested as a proof-of-concept study 
using soil samples from the Atacama Desert. Amino acids were first extracted and then derivatized 
using Pacific Blue succinimidyl ester, which is also selective for the primary amine of the amino 
acid. Following derivatization, an ME device with a 22.6-cm separation channel was used to 
separate the sample. With this system, a 200-fold increase in sensitivity was found compared to 
earlier techniques using fluorescamine [21]. The authors felt that the minimal increase in 
complexity from using a ME device was more than compensated by the smaller size, mass, and 






Microchip electrophoresis provides an ideal platform for rapid separation of Glu as well as 
other neuroactive amines in neurological samples. Through either offline or online methods of 
sample acquisition and fluorescence derivatization, endogenous levels of Glu can be monitored in 
near real-time and for extended periods while simultaneously monitoring other analytes of interest, 
providing an important view of brain health.  
 
Future research will focus on the development of techniques that will allow for better 
throughput, automation, and a wider analysis of neurobiological samples. The direct coupling of 
ME to continuous sampling methods still has room for improvement, as many current devices still 
suffer from irreproducibility and intensive fabrication procedures. This should also reduce the lag 
time between sampling and detection, allowing for near real-time analysis of neurobiological 
samples that can prove invaluable in a medical setting. There are already research efforts in this 
direction, such as the incorporation of microdialysis samples onto a microchip designed to be used 
on-animal [22]. Furthermore, expanding the scope of analytical analyses is important. Although 
the primary focus of this thesis is the detection of Glu, this is not the only biologically active 
neuromolecule that is of importance in assessing brain health. Since ME is primarily a separation 
technique, it has the potential to detect multiple analytes simultaneously with sufficient resolution 
for quantitation. Although there are other amines present in the brain that could be derivatized via 
the methods discussed in this chapter, a more universal method of measurement would allow for 
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a fuller picture of neurobiological methods. Studies coupling electrochemical sensors with ME 
will allow for this, but introduce their own complications regarding electrode sensitivity and 
robustness. Other detection schemes, such as bipolar electrochemical detection or the use of 







1. Smithies, O., Zone electrophoresis in starch gels: group variations in the serum proteins 
of normal human adults. Biochemical Journal, 1955. 61(4): p. 629. 
2. Li, S.F.Y., Capillary electrophoresis: principles, practice and applications. Vol. 52. 1992: 
Elsevier. 
3. Weinberger, R., Practical capillary electrophoresis. 2000: Academic Press. 
4. Landers, J.P., Handbook of capillary and microchip electrophoresis and associated 
microtechniques. 2007: CRC press. 
5. Ohlsson, P.D., et al., Electrophoresis microchip with integrated waveguides for 
simultaneous native UV fluorescence and absorbance detection. Electrophoresis, 2009. 
30(24): p. 4172-4178. 
6. Oborny, N.J., et al., Evaluation of a Portable Microchip Electrophoresis Fluorescence 
Detection System for the Analysis of Amino Acid Neurotransmitters in Brain Dialysis 
Samples. Analytical Sciences, 2016. 32(1): p. 35-40. 
7. Molho, J.I., et al., Optimization of turn geometries for microchip electrophoresis. 
Analytical Chemistry, 2001. 73(6): p. 1350-1360. 
8. Paegel, B.M., et al., Turn geometry for minimizing band broadening in microfabricated 
capillary electrophoresis channels. Analytical Chemistry, 2000. 72(14): p. 3030-3037. 
9. Jacobson, S.C., A.W. Moore, and J.M. Ramsey, Fused quartz substrates for microchip 
electrophoresis. Analytical Chemistry, 1995. 67(13): p. 2059-2063. 
10. Duffy, D.C., et al., Rapid prototyping of microfluidic systems in poly (dimethylsiloxane). 
Analytical chemistry, 1998. 70(23): p. 4974-4984. 
11. Huynh, B.H., et al., A microchip electrophoresis device with on-line microdialysis 
sampling and on-chip sample derivatization by naphthalene 2, 3-dicarboxaldehyde/2-
mercaptoethanol for amino acid and peptide analysis. Journal of pharmaceutical and 
biomedical analysis, 2006. 42(5): p. 529-534. 
12. Sandlin, Z.D., et al., Microfluidic electrophoresis chip coupled to microdialysis for in vivo 
monitoring of amino acid neurotransmitters. Analytical chemistry, 2005. 77(23): p. 7702-
7708. 
13. Wang, M., et al., Microfluidic chip for high efficiency electrophoretic analysis of 
segmented flow from a microdialysis probe and in vivo chemical monitoring. Analytical 
chemistry, 2009. 81(21): p. 9072-9078. 
14. Zhou, S.Y., et al., Continuous in vivo monitoring of amino acid neurotransmitters by 
microdialysis sampling with online derivatization and capillary electrophoresis 
separation. Analytical chemistry, 1995. 67(3): p. 594-599. 
15. Huynh, B.H., et al., On-line coupling of microdialysis sampling with microchip-based 
capillary electrophoresis. Analytical chemistry, 2004. 76(21): p. 6440-6447. 
16. Nandi, P., D.P. Desai, and S.M. Lunte, Development of a PDMS‐based microchip 
electrophoresis device for continuous online in vivo monitoring of microdialysis samples. 
Electrophoresis, 2010. 31(8): p. 1414-1422. 
74 
 
17. Nandi, P., et al., Development and optimization of an integrated PDMS based‐
microdialysis microchip electrophoresis device with on‐chip derivatization for continuous 
monitoring of primary amines. Electrophoresis, 2013. 34(6): p. 895-902. 
18. Huang, Y., M. Shi, and S. Zhao, Quantification of D‐Asp and D‐Glu in rat brain and human 
cerebrospinal fluid by microchip electrophoresis. Journal of separation science, 2009. 
32(17): p. 3001-3006. 
19. Maeda, H., et al., Reaction of fluorescein-isothiocyanate with proteins and amino acids. 
The Journal of Biochemistry, 1969. 65(5): p. 777-783. 
20. Chiesl, T.N., et al., Enhanced amine and amino acid analysis using Pacific Blue and the 
Mars Organic Analyzer microchip capillary electrophoresis system. Analytical chemistry, 
2009. 81(7): p. 2537-2544. 
21. Skelley, A.M., et al., Organic amine biomarker detection in the Yungay region of the 
Atacama Desert with the Urey instrument. Journal of Geophysical Research: 
Biogeosciences, 2007. 112(G4). 
22. Scott, D.E., et al., Development of an on-animal separation-based sensor for monitoring 




4. Evaluation of a Portable Microchip Electrophoresis 
Fluorescence Detection System for the Analysis of Amino Acid 
Neurotransmitters in Brain Dialysis Samples 
 




Republished with permission from “Evaluation of a Portable Microchip Electrophoresis 
Fluorescence Detection System for the Analysis of Amino Acid Neurotransmitters in Brain 
Dialysis Samples”, Analytical Sciences, Vol 32 (2016) No. 1, p. 35-40[1] 
 
1Department of Bioengineering, University of Kansas, Lawrence, KS, 66045 USA 
2Ralph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS, 66047 USA  
3Institute of Chemistry and Biotechnology, Federal University of Alagoas, Alagoas, Brazil  
4Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand 
5Department of Chemistry, University of Kansas, Lawrence, KS, 66045 USA  
 







Microdialysis (MD) is a popular in vivo sampling method that has been used to monitor 
neurotransmitters in both animal models and humans. In particular, microdialysis sampling has 
been employed to monitor chemicals in the brains of traumatic brain injury patients in intensive-
care units (ICU). MD sampling can also be used to monitor the extent of tissue damage and the 
efficacy of treatment simultaneously through continuous and long-term sampling of multiple 
biomarkers [2-4]. 
 
The process of a MD sampling has been described elsewhere extensively [5-7], and in chapters 
3 and 5 of this thesis. Of relevance here, however, is the fact that the recovery of any analyte of 
interest is governed by the flow rate of the perfusate liquid [8]. At a flow rate of 1 µL/min, typical 
analyte recoveries for small molecules are in the range of 10 – 40%. Lower flow rates result in 
higher analyte recoveries, approaching 100% at 100 nL/min, but with smaller volumes of dialysate 
collected per unit time [9, 10]. This tradeoff dictates which analytical technique can be used and 
how often analysis can be performed.  
 
Typically, MD samples are collected until sufficient volumes are acquired to allow the use of 
the desired analytical method with requisite sensitivity and selectivity. The most common method 
employed for the analysis of microdialysis samples is liquid chromatography (LC) coupled to 
electrochemical, fluorescence, mass spectrometry (MS), or absorbance detection [11]. However, 
the time required to obtain a dialysate sample large enough for many LC-based assays can reduce 
the temporal resolution of the technique as well as add a significant delay between the sample 
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acquisition and clinical response. In order to address a clinical need for an analytical technique 
that can continuously analyze small volume samples, and selectively detect very low analyte 
concentrations with good temporal resolution, several groups have developed on-line MD methods 
using capillary (CE) and microchip electrophoresis (ME) [12, 13]. These systems, when combined 
with a sensitive detection method, such as laser- (or light emitting diode-) induced fluorescence 
(ME-LIF and ME-LEDIF), can rapidly analyze nanoliter-volume samples in a continuous manner, 
while providing clinicians with near real-time data.  
 
There are many examples concerning the use of CE to monitor amino acid neurotransmitters 
in microdialysis samples,[14-19] and other examples have been reviewed by Poinsot et al. [20], as 
well as chapters 2 and 3 of this thesis However, these systems typically use off-line sample 
collection and precolumn derivatization, requiring samples large enough to be handled accurately 
off-line. Coupling CE or ME directly to MD makes it possible for much smaller samples volumes 
to be analyzed, leading to better temporal resolution as long as the method displays the requisite 
sensitivity [21] To this end, our group previously developed a polydimethylsiloxane (PDMS)-
based microchip electrophoresis device that was coupled to microdialysis (MD-ME) for the 
continuous on-line monitoring of amino acid neurotransmitters [18, 19]. The microchip was 
completely integrated with the MD sampling system, which provided on-line derivatization of the 
amino acids with naphthalene-2,3-dicarboxyaldehyde/cyanide (NDA/CN–), a flow-gate interface 
for injection, and electrophoresis separation using a serpentine channel with LIF detection. 
Although the chip itself was small, the associated instrumentation needed for fluorescence 




The aim of the present work is to expand on the theme of miniaturization and integration of 
the on-line MD-ME-LIF device with the goal to obtain a system that can be used for the near real-
time monitoring of amine-based neurotransmitters in the ICU or research laboratory. The particular 
focus of this report is miniaturization of the fluorescence detection system. To evaluate the system, 
figures of merit for the separation and detection of several NDA/CN-derivatized amines commonly 
found in rat brain dialysate were determined using a conventional benchtop ME-LIF system 
employing an epifluorescence microscope. These results were then compared to those obtained 
using the newly developed portable ME-LEDIF system. The portable system described here could 
potentially be placed near patients in an ICU (or next to animals for animal studies), permitting 
continuous near real-time monitoring of these neuroactive amines in injured brain tissue to assess 




4.2.1 Reagents and Chemicals 
 
Arginine (Arg), aspartate (Asp), citrulline (Cit), glutamate (Glu), histamine (Hist), and taurine 
(Tau) were obtained from Sigma Aldrich (St. Louis, MO). Standards of each amine were prepared 
at 2 mM concentrations in 18.2 MΩ /cm deionized water (Millipore, Billerica, MA). Subsequent 
dilutions of each stock solution were made prior to analysis. Naphthalene-2,3-dicarboxaldehyde 
(NDA) (Invitrogen, Carlsbad, CA) was prepared in acetonitrile (Fisher Scientific, Pittsburgh, PA) 
to a concentration of 5 mM. Sodium cyanide (NaCN) (Sigma Aldrich) was dissolved in water to a 
final concentration of 10 mM. Stock solutions of both NDA and NaCN were made weekly and 
stored at 4ºC, while being protected from light exposure. Stock solutions of sulfobutylether-β-
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cyclodextrin (SBEC) (Life Technologies, Grand Island, NY) were made on a weekly basis to a 
concentration of 10 mM in deionized water, and stored at 4ºC. The background electrolyte (BGE) 
consisted of 1.4 mM SBEC, 10% by volume HPLC-grade dimethylsulfoxide (Fisher Scientific), 
and sodium tetraborate (Sigma Aldrich) at a final concentration of 15 mM. Finally, the pH of the 
BGE was measured using a pH meter and adjusted to 9.2 with 1 M sodium hydroxide (Fisher 
Scientific). 
 
4.2.2 Animal Surgery and Microdialysis Sampling 
 
Male Sprague-Dawley rats were housed in temperature-controlled rooms with free access to 
food and water prior to surgery. Rats were fully anesthetized prior to surgery through inhalation 
of isofluorane, followed by the injection of a mixture of ketamine (67.5 mg/kg), xylazine (3.4 
mg/kg), and acepromazine (0.67 mg/kg). To maintain anesthesia throughout the surgery, doses of 
ketamine were administered by intramuscular injections. The body temperature was maintained 
using a Homeothermic Blanket Control unit (Harvard Apparatus, Holliston, MA) set at 37°C, and 
rats were given saline doses to keep them hydrated. All surgical instruments were sterilized before 
usage and after the surgical procedures. A guide cannula followed by a microdialysis probe with 
a 4 mm membrane was inserted in the striatum region at stereotaxic coordinates A/P +0.7, M/L -–
2.7, V/D –3.4 [18, 22]. Microdialysis samples were collected by perfusing the probe (CMA, North 
Chelmsford, MA) with an artificial spinal fluid (aCSF) at 1 µL/min. Animal experiments were 
performed in accordance with regulations of the Institutional Animal Care and Use Committee 
(IACUC) at the University of Kansas, which operates under accreditation from the Association for 




4.2.3 Derivatization Reaction 
 
Derivatization of the amino acid standards and MD sample was carried out using equal parts 
by volume of 5 mM NDA and 10 mM NaCN, 15 mM boric buffer (pH 9.2), and sample. NDA 
reacts with primary amines in the presence of cyanide to produce fluorescent 1-
cyanobenz[f]isoindole (CBI) products. 
 
4.2.4 Microchip Electrophoresis (ME) 
 
The glass microfluidic devices used in these studies were fabricated using standard 
photolithographic techniques, as reported previously [23, 24]. To separate the six target analytes, 
a 15-cm serpentine separation channel with 3-cm side channels (Figure 4.1) was used. All channels 
were 15 µm deep and approximately 70 µm wide. Before each use, the chip was conditioned with 
0.1 M HCl, water, 0.1 M NaOH, and then water again. Each solution was passed through the 
microchannels for 10 min via the application of negative pressure to one of the ports. Finally, the 





Figure 4.1:Top: 15 cm-length serpentine chip design with 2.7 cm-length side channels for sample waste and buffer, 0.5 cm length 
for sample inlet. All channels were 15 µm deep by 70 µm wide. Bottom: Actual glass chip used in these studies. 
 
 
An UltraVolt HV Rack high-voltage power supply (Ronkonkoma, NY) was employed for the 
electrophoresis experiments and controlled by software written in Labview (National Instruments, 
Austin, TX). In these experiments, a voltage of 10 kV was applied at the buffer reservoir and 7 kV 
at the sample reservoir for an overall separation field strength of 420 V /cm. For sample 
electrokinetic injection, the injection time was 0.7 s and the analysis time lasted  





4.2.5 Benchtop ME-LIF System 
 
Fluorescence was chosen as the detection method in these studies because it provides high 
sensitivity and, in the case of NDA/CN derivatization, selectivity for primary amines [25]. The 
cyanobenz(f)isoindole products of the NDA/CN reaction exhibit two excitation maxima in the 
visible range at approximately 420 nm and 442 nm [26, 27]. For the benchtop ME system used in 
these studies, excitation was accomplished using either a 445 nm PhoxX diode laser (Market Tech, 
Scotts Valley, CA) or a 442 nm CL-2000 diode laser (Crystal Laser, Reno, NV). The excitation 
light source was coupled to an epifluorescence microscope (Nikon, Melville, NY) via a fiber optic 
cable; it was optically filtered using a 445 nm band pass filter, and was focused on the separation 
channel approximately 0.2 cm from the waste reservoir via a long-pass dichroic mirror that 
directed the light to the chip and a 40× objective lens to focus onto the channel. The emission 
maxima for the products of the NDA/CN reaction occurs at 490 nm [26]. Once again, the 
epifluorescence microscope was used to focus the emission light through the long-pass dichroic 
mirror and long-pass edge filter (480 nm cutoff) before it was focused onto a photomultiplier tube 
(PMT). Signal acquisition from the PMT was performed using a National Instruments NI USB-
6229 data acquisition card and Labview software, following amplification and low pass filtering 
with a 3 Hz filter cutoff using a model SR570 amplifier from Stanford Research Systems 
(Sunnyvale, CA). Origin software version 8.2 (Origin Lab Corporation, Northampton, MA) was 





4.2.6 Portable ME-LEDIF System 
 
The portable system has many commonalities with the benchtop ME system but also has 
several differences. As in the benchtop ME, fluorescence detection was accomplished by filtering 
and focusing excitation light onto the separation channel, followed by filtering and focusing 
subsequently emitted light onto a detector. However, in the case of the portable system, a 420 nm 
LED (LED Engin, San Jose, CA) was used instead of a laser. The LED was powered using a 
custom current driver circuit and constructed using a frequency-controlled variable current driver, 
a MAX16836 (Maxim Integrated, San Jose CA), driven by an LM555 timer IC (Texas 
Instruments). It was found that an input signal of 1.6 kHz resulted in a stable current output of 250 
mA.  
 
A microscope stage purchased from eBay is shown mounted in Figure 4.2. This stage, which 
was originally designed to be motor driven, was modified using 3D-printed motor brackets to 
couple two NEMA 17 stepper motors to the stage. This allowed controlled movement in the X and 
Y directions as the optics mount moved along threaded rods while fixing the Z direction, such that 
the channel was at the focal point of a 100x objective. These motors were subsequently driven by 






Figure 4.2A: Close-up view of the portable system. 1. LED current driver board. 2. Optical mounting containing dichroic mirror, 
LED, objective lens, and optical filter. 3. Photodiode and preamplifier board. 4. Positioning motors, seen here from the side. 5. 
Arduino microcontroller with stacked motor driver shield and amplifier and analog to digital converter shield connected to 











As mentioned previously, an LED was employed as the excitation light source in the portable 
system and was mounted parallel to the chip. This LED was collimated using a plano-convex lens, 
followed by spatial focusing via a 1 mm pinhole. The light from the LED was directed upward 
through an objective lens via a long-pass dichroic mirror with a 470 nm cutoff (Thorlabs, Newton, 
NJ) and mounted at a 90° angle. Emission light was focused via the same objective lens through 
the long-pass dichroic mirror followed by a long-pass emission filter and was finally focused onto 
a detection point using a second plano-convex lens, model LA1951-A-N-BK7 (Thorlabs). The 
final long-pass emission filter also had a cutoff of 470 nm (Thorlabs, Newton, NJ), allowing light 
of any longer wavelength to pass on to the detector.  
 
The detector itself consisted of an OPT301 combination transimpedance amplifier/silicon 
photodiode (Texas Instruments, Dallas, TX) in a custom circuit, mounted on a 1"-dia printed circuit 
board (PCB). This PCB was subsequently mounted in the optics holder, such that the OPT301 was 
centered at the focal point of the plano-convex lens. This PCB was connected to the secondary 
amplifier via a 4-pin shielded USB cable, which also supplied the OPT301 with power. Finally, 
the output of the OPT301 was amplified by a custom second-stage amplifier circuit using an 
OPA726 IC (Texas Instruments) before passing the amplified signal to an analog-to-digital (ADC) 
converter, a Max11210 IC (Maxim Integrated). The secondary amplification and ADC circuit was 
designed in the format of an Arduino shield, which allowed it to be easily interfaced with the open 
source Arduino Uno Microcontroller used for signal processing as well as communication to a 
nearby PC via USB. While future versions of the portable system will have an integrated high-
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voltage power supply for the separation as well as electrokinetic gates, the system used for this 
study relied on the UltraVolt HV Rack high-voltage power supply previously mentioned. 
 
4.3 Results and Discussion 
 
The on-line integration of MD to an analysis method, such as ME-LEDIF, has the potential to 
provide clinicians and animal researchers with minute-to-minute data regarding the tissue health 
of patients, or to track changes in neurotransmitters in animal models. While several groups have 
successfully coupled MD to both CE [24] and ME,[13, 18] in practice, the benefits of doing so 
have been limited by the size of the associated equipment needed for the separation and detection. 
In an already crowded intensive-care unit or neurobiology laboratory, this is a significant concern, 
because any increased distance from the patient or animal could result in a significant delay in 
response due to low sample flow rates from the MD probe to the microchip. The goal of 
miniaturizing and creating the self-contained ME-LIF system described here is to reduce the time-
lag between sampling and analysis as well as the overall size of the external equipment necessary. 
The aim is to create a small, portable detection system that can be placed near the patient or animal 
for near real-time monitoring. 
 
To miniaturize the system as much as possible, several design decisions were made. The first 
of these was the choice of an LED excitation light source rather than a laser. There are three reasons 
for this. First, lasers are considerably more expensive than LEDs. Second, the mechanical 
robustness of the overall design was a consideration for portability and, typically, lasers are more 
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fragile than LEDs. Finally, while we focused on NDA/CN derivatization in this study, the easy 
availability of a wide range of LED wavelengths for use in future studies with other fluorogenic 
compounds also influenced our decision to use an LED light source. 
 
The requirements of portability and ruggedness also affected the physical/mechanical design 
of the system. Because microchip sizes and designs vary from application to application, and also 
because it is often necessary to move the chip for cleaning purposes, the alignment of the optics to 
the channel needs to be moveable in this portable system, unlike those of other miniaturized 
systems [22]. Because a high-voltage supply with wires leading to each port on the chip was 
necessary, moving the optics rather than the chip is the better option in order to avoid dislodging 
any of the high-voltage wires during alignment. 
 
The use of the OPT301 photodiode for detection is another feature of this instrument. Other 
portable fluorescence detection systems [28, 29] have used a more sensitive, but ultimately more 
complex and costly PMT for detection. In this application, however, the use of a photodiode was 
adequate for the LODs required in these studies, and simplified the design by eliminating the need 
for a high-voltage supply for the PMT.  
 
To evaluate the portable system for determining the amines in microdialysis samples, it was 
necessary to compare the function of a traditional benchtop ME-LIF system to the portable ME-
LEDIF system for the same set of analytes. For this purpose, a mixture of six neuroactive amines 
(arginine (Arg), citrulline (Cit), taurine (Tau), histamine (Hist), glutamate (Glu) and aspartate 
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(Asp)) were derivatized using NDA/CN and electrophoretically separated using microchip 
electrophoresis. For each amine, the linearity over a range of physiologically relevant 
concentrations (Table 4.1) as well as the limits of detection (LOD) and the limits of quantification 
(LOQ) were determined using both systems. Following this, rat brain microdialysis samples were 
derivatized using NDA/CN, and analyzed on both systems. For the purposes of these proof-of-
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Benchtop system       
Calibration range/µM 0.1–10 0.1–10 0.1–10 0.1–10 0.1–10 0.1–10 
Regression coefficient (R2) 0.9956 0.9897 0.9940 0.9990 0.9792 0.9854 
Limit of detection (S/N = 3) 
/µM 
0.05 0.05 0.05 0.05 0.25 0.05 
Limit of quantification (S/N 
= 10) /µM 
0.15 0.15 0.15 0.15 1.0 0.15 
Migration Time % RSD 1.81 1.46 1.26 1.34 1.85 2.61 
Theoretical Plates /m 746485 693960 872808 473232 565178 600081 
Peak Resolution 1.29 1.16 0.97 1.15 1.10 0.15 
 
Portable system 
Calibration range/µM 2.0–50 2.0–50 2.0–25 2.0–15 2.0–50 2.0–50 
Regression coefficient (R2) 0.9956 0.9834 0.9870 0.9977 0.9931 0.9904 
Limit of detection (S/N = 3) 
/µM 
0.25 0.36 0.42 0.37 1.31 1.21 
Limit of quantification (S/N 
= 10) /µM 
0.84 1.2 1.4 1.24 4.35 4.04 
Migration Time % RSD 1.71 1.8 2.52 3.22 4.75 5.23 
Theoretical Plates /m 275165 270431 331367 406943 325993 277798 
Peak Resolution 2.53 0.96 1.01 6.09 2.00 3.08 
 
 Table 4.1: Performance Parameters for the Benchtop and Portable LIF Systems 
 
As can be seen in Table 4.1, both systems exhibited a linear response over the physiologically 
relevant concentration ranges. The LOD for each amine can be found in Table 4.1. The LODs were 
lower for the benchtop ME-LIF, mainly due to the use of a PMT instead of a photodiode. Five of 
the six amines (Arg, Cit, Tau, Glu and Asp) could be detected, and were present above the LODs 
determined with the portable system. The concentrations of aspartate and histamine were below 
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the calculated LOQs and, in the case of Hist, below the LOD. A peak that co-migrated with Hist 
was consistently visible in the electropherogram and identified via standard Hist spiking. The 
presence of this peak in the MD sample implies two possibilities. The first is that a substantial 
increase in extracellular Hist occurred due to tissue inflammation as a result of probe insertion 
[31]. The second is the co-migration of an as yet unknown analyte to be identified in future studies. 
However, even though the benchtop ME-LIF system exhibited lower LODs (and LOQs) for five 
of the six amines, the performance of the portable system was adequate for their detection at 
physiologically relevant concentrations. Figure 4.4 (Bottom) shows an electropherogram obtained 
with the portable system for a representative microdialysis sample and (Top) the same sample 
spiked with 5 μM (final concentration) of amine standards. In this study, identification of the peaks 






Figure 4.4: (Top) MD Sample spiked with an additional 5 µM Arg, Cit, Tau, Hist, Glu, and Asp. (Bottom) Electropherogram of a 
NDA/CN-derivatized microdialysate sample from striatum using the portable system.  
 
4.4 Future Work 
 
 
Future versions of the system will address the need for automated positioning and variable 
chip sizes as well as further decreases in the overall size of the system, which was larger than 
necessary in this design for convenience. As mentioned, the LOQs for two of the target analytes 
were too high for quantification in the microdialysis sample. In order to improve these 
LODs/LOQs, a programmable integrated circuit (PIC)-based (Microchip, Chandler, AZ) lockin-
amplifier system is being developed for fluorescence detection and integrated into the system along 
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with a high-voltage module for sample separation. The use of lower microdialysis flow rates and 
on-line derivatization to enhance analyte recovery and fluorescence product formation, 
respectively, are also being investigated. Finally, future studies will be conducted using online 








1. Oborny, N.J., et al., Evaluation of a Portable Microchip Electrophoresis Fluorescence 
Detection System for the Analysis of Amino Acid Neurotransmitters in Brain Dialysis 
Samples. Analytical Sciences, 2016. 32(1): p. 35-40. 
2. Deibert, E. and M.N. Diringer, THE INTENSIVE CARE MANAGEMENT OF ACUTE 
ISCHEMIC STROKE. The Neurologist, 1999. 5(6): p. 313-325. 
3. Kirkman, M.A., G. Citerio, and M. Smith, The intensive care management of acute 
ischemic stroke: an overview. Intensive care medicine, 2014. 40(5): p. 640-653. 
4. Persson, L. and L. Hillered, Chemical monitoring of neurosurgical intensive care patients 
using intracerebral microdialysis. Journal of neurosurgery, 1992. 76(1): p. 72-80. 
5. Benveniste, H., Brain microdialysis. Journal of neurochemistry, 1989. 52(6): p. 1667-1679. 
6. Westerink, B.H. and T.I. Cremers, Handbook of microdialysis: methods, applications and 
perspectives. Vol. 16. 2007: Academic Press. 
7. Robinson, T.E. and J.B. Justice, Microdialysis in the neurosciences: techniques in the 
behavioral and neural sciences. Vol. 7. 2013: Elsevier. 
8. Stenken, J.A., et al., Examination of microdialysis sampling in a well-characterized 
hydrodynamic system. Analytical chemistry, 1993. 65(17): p. 2324-2328. 
9. Nandi, P. and S.M. Lunte, Recent trends in microdialysis sampling integrated with 
conventional and microanalytical systems for monitoring biological events: a review. 
Analytica chimica acta, 2009. 651(1): p. 1-14. 
10. Menacherry, S., W. Hubert, and J.B. Justice Jr, In vivo calibration of microdialysis probes 
for exogenous compounds. Analytical chemistry, 1992. 64(6): p. 577-583. 
11. Davies, M.I., et al., Analytical considerations for microdialysis sampling. Advanced drug 
delivery reviews, 2000. 45(2): p. 169-188. 
12. Zhou, S.Y., et al., Continuous in vivo monitoring of amino acid neurotransmitters by 
microdialysis sampling with online derivatization and capillary electrophoresis 
separation. Analytical chemistry, 1995. 67(3): p. 594-599. 
13. Sandlin, Z.D., et al., Microfluidic electrophoresis chip coupled to microdialysis for in vivo 
monitoring of amino acid neurotransmitters. Analytical chemistry, 2005. 77(23): p. 7702-
7708. 
14. Tůma, P., et al., Large-volume sample stacking for in vivo monitoring of trace levels of γ-
aminobutyric acid, glycine and glutamate in microdialysates of periaqueductal gray matter 
by capillary electrophoresis with contactless conductivity detection. Journal of 
Chromatography A, 2013. 1303: p. 94-99. 
15. Lorenzo, M., et al., Optimization and validation of a CE-LIF method for amino acid 
determination in biological samples. Journal of pharmaceutical and biomedical analysis, 
2013. 73: p. 116-124. 
16. Male, K.B. and J.H. Luong, Derivatization, stabilization and detection of biogenic amines 
by cyclodextrin-modified capillary electrophoresis–laser-induced fluorescence detection. 
Journal of Chromatography A, 2001. 926(2): p. 309-317. 
17. Liu, X., L.-X. Yang, and Y.-T. Lu, Determination of biogenic amines by 3-(2-furoyl) 
quinoline-2-carboxaldehyde and capillary electrophoresis with laser-induced 
fluorescence detection. Journal of Chromatography A, 2003. 998(1): p. 213-219. 
94 
 
18. Nandi, P., D.P. Desai, and S.M. Lunte, Development of a PDMS‐based microchip 
electrophoresis device for continuous online in vivo monitoring of microdialysis samples. 
Electrophoresis, 2010. 31(8): p. 1414-1422. 
19. Nandi, P., et al., Development and optimization of an integrated PDMS based‐
microdialysis microchip electrophoresis device with on‐chip derivatization for continuous 
monitoring of primary amines. Electrophoresis, 2013. 34(6): p. 895-902. 
20. Poinsot, V., C. Bayle, and F. Couderc, Recent advances in amino acid analysis by capillary 
electrophoresis. Electrophoresis, 2003. 24(22‐23): p. 4047-4062. 
21. Saylor, R.A. and S.M. Lunte, A review of microdialysis coupled to microchip 
electrophoresis for monitoring biological events. Journal of Chromatography A, 2015. 
1382: p. 48-64. 
22. Mayer, A.P., I. Osorio, and C.E. Lunte, Microperfusion of 3-MPA into the brain augments 
GABA. Epilepsy & Behavior, 2013. 29(3): p. 478-484. 
23. Coltro, W.K.T., S.M. Lunte, and E. Carrilho, Comparison of the analytical performance of 
electrophoresis microchannels fabricated in PDMS, glass, and polyester‐toner. 
Electrophoresis, 2008. 29(24): p. 4928-4937. 
24. Linz, T.H., C.M. Snyder, and S.M. Lunte, Optimization of the Separation of NDA-
Derivatized Methylarginines by Capillary and Microchip Electrophoresis. Journal of 
laboratory automation, 2012. 17(1): p. 24-31. 
25. Culbertson, C.T., et al., Micro total analysis systems: Fundamental advances and 
biological applications. Analytical chemistry, 2013. 86(1): p. 95-118. 
26. De Montigny, P., et al., Naphthalene-2, 3-dicarboxyaldehyde/cyanide ion: a rationally 
designed fluorogenic reagent for primary amines. Analytical Chemistry, 1987. 59(8): p. 
1096-1101. 
27. Melanson, J.E. and C.A. Lucy, Violet (405 nm) diode laser for laser induced fluorescence 
detection in capillary electrophoresis. Analyst, 2000. 125(6): p. 1049-1052. 
28. Mora, M.F., A.M. Stockton, and P.A. Willis, Microchip capillary electrophoresis 
instrumentation for in situ analysis in the search for extraterrestrial life. Electrophoresis, 
2012. 33(17): p. 2624-2638. 
29. Culbertson, C.T., et al., Microchip separations in reduced-gravity and hypergravity 
environments. Analytical chemistry, 2005. 77(24): p. 7933-7940. 
30. Alabadı́, J.A., et al., 7-Nitroindazole, a selective inhibitor of nNOS, increases hippocampal 
extracellular glutamate concentration in status epilepticus induced by kainic acid in rats. 
Brain research, 1999. 839(2): p. 305-312. 
31. Adachi, N., et al., Direct evidence for increased continuous histamine release in the 
striatum of conscious freely moving rats produced by middle cerebral artery occlusion. 
Journal of Cerebral Blood Flow & Metabolism, 1992. 12(3): p. 477-483. 
32. Böckelmann, R., et al., Influence of nitric oxide synthase activity on amino acid 
concentration in the quinolinate lesioned rat striatum: A microdialysis and histochemical 




5. The design, modeling and construction of a microfluidic device 
coupled to microdialysis for integrated sample derivatization 







 The relationship between patient outcomes and the initial severity of a traumatic brain 
injury (TBI) has long been established. An increase in injury severity directly leads to a decrease 
in likelihood of patient survival [1]. In recent years, it has become clear that TBI patients are at 
further risk of secondary tissue damage including inflammation, interruption of cellular 
metabolism, and hypoxia that lead to localized cell death [2]. Immediately following a TBI, these 
processes are initiated and behave in a self-reinforcing manner. As inflammation and intracranial 
pressure increase, oxygenated blood flow to tissue decreases, resulting in hypoxia and limiting 
glucose availability. The resulting deficit in ATP production leads to the destabilization of cellular 
membranes, the release of the excitatory amino acid neurotransmitters glutamate (Glu) and 
aspartate (Asp), and an influx of Ca2+ and Na+ ions. The influx of these ions ultimately results in 
apoptosis or necrosis of the neuron. As the neuron dies, the release Glu and Asp into the 
extracellular space causes the cycle to spread as nearby neurons are affected [3-6]. 
 
 In an intensive care unit, a variety of methods are used to monitor patient health including 
sensors that measure partial oxygen pressure and pH to monitor tissue hypoxia [7]. Biomarkers of 
metabolism, such as glucose, lactate and pyruvate as well as neurotransmitters implicated in 
neuronal death such as Glu, have been monitored by biosensors [8] and by microdialysis coupled 
to liquid chromatography or enzymatic reactions [9]. These techniques allow a clinician to monitor 
tissue health in near real time.  If microdialysis sampling is employed, it is possible to evaluate 
changes in several biomarkers simultaneously. Microdialysis also makes it possible to administer 
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a drug directly to the site of tissue damage, making it extremely attractive as a technique. 
Microdialysis sampling functions by passing a sterile fluid, isotonically matched to the 
environment being sampled and known as the perfusate, into a dialysis probe. As the fluid enters 
the probe, it can interact with the environment outside via a porous membrane. As analytes, smaller 
than the pore size of the membrane diffuse into the sterile diffusate, the fluid, now referred to as 
the perfusate, is withdrawn from the probe for analysis.  
 
 Microdialysis can sample virtually any set of analytes from a single location provided they 
are less than a given size dictated by the pores of the microdialysis probe. Microdialysis sampling, 
however, has the disadvantage of being a largely diffusion limited process with sample recovery 
highly dependent on flow rate. For example, at a fluid flow rate of 1 µL/min, analyte recovery is 
limited to approximately 40%, reaching 100% recovery at a flow rate of 0.1 µL/min [10]. In 
practice, this has the consequence that if a target analyte exists at a very low concentration, 
sampling must either be performed for extended period at a low flow rate to obtain enough of the 
analyte to be analyzed, or very sensitive assays must be employed. Small sample volumes can also 
be a limiting factor for timely measurements. Since flow rates from microdialysis are on the order 
of 0.1-1 µL/min, gathering 10 µL of sample can take between 10 and 100 minutes. Finally, such 
small volumes can be a challenge to manage. The most commonly used microdialysis system in 
hospital settings, the ISCUS Flex Microdialysis Analyzer for reference, is typically used at a flow 
rate of 0.3 µL/min and requires 8 µL of sample per single measurement of Glu concentration [11, 




 With this in mind, recent work has led to the development of capillary and microchip 
electrophoresis (CE and ME respectively) assays coupled to microdialysis (MD-CE and MD-ME). 
These techniques have the benefit of having extremely low sample dispersion and ability to handle 
samples on the order of tens of nanoliters (nL) in volume. Efforts to interface MD to ME and CE 
have demonstrated a decrease in overall time lag from sample acquisition to analysis to minutes 
[13].  
 
 As mentioned in chapter 1 increasing extracellular concentrations of Glu and Asp 
following TBI are not only biomarkers of spreading secondary damage but are also implicated as 
causative agents of that damage. This has, of course, made them attractive targets for monitoring 
as well as targets of pharmaceutical intervention. The fact that neither Glu nor Asp are electroactive 
or fluorescent complicates detection however, leading to the requirement of enzymatic biosensors 
[8], colorimetric assays [14], or fluorescence derivatization [13]. With regard to the latter 
technique, derivatization with a fluorogenic compound such as naphthalene-2,3-dicarboxaldehyde 
(NDA) is a common procedure for derivatizing primary amines, such as amino acids, rendering 
them fluorescently active.  
 
 The process of derivatization can be performed either offline, in which a sample is reacted 
with NDA and a nucleophile such as sodium cyanide (CN) or 2-mercaptoethanol (2ME) [13] prior 
to injection into a CE or ME system for analysis, or online where the derivatization occurs on chip 
after the sample is introduced. Online derivatization has the advantage that much smaller volumes 
of liquid can be handled as samples collected via microdialysis are derivatized and subsequently 
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analyzed all within a single device. This prevents sample loss during transfer due to evaporation. 
Online derivatization is typically performed with MD-ME, as opposed to MD-CE, due to the need 
for custom microfluidic architectures that allow several inlet fluid streams, including that of the 
MD sample, to be mixed prior to injection into the electrophoresis separation channel. However, 
the derivatization reaction can take several minutes and is complicated by inadequate mixing of 
laminar flows during this process. Should the mixing process be incomplete, or a lack of time 
result in an incomplete derivatization before the sample reaches the separation channel, the 
effective limit of detection for the assay will be negatively impacted.  
 
Derivatization using NDA/2ME has been used in the past due to its faster reaction time [13], 
however, the noxious smell of 2ME makes it undesirable in a medical (or research) setting. 
Consequently, here we use NDA/CN for sample derivatization. To address the possibility of 
incomplete mixing in the device, this work investigates the use of an extended microfluidic mixing 
geometry to enhance sample derivatization in conjunction with MD-ME. This is first explored in 
silico, followed by construction and evaluation of the microfluidic device. By integrating sample 
mixing, derivatization, and analysis into a single, standardized format, the equipment footprint can 
be dramatically reduced while simultaneously improving the overall time lag between sample 
acquisition and actionable information. To optimize the derivatization reaction, ensure mixing, and 





5.2 Materials and Methods 
 
5.2.1 Comsol Multiphysics Modeling 
 
Comsol modeling of the MD-ME device was performed using version 5.3 of Comsol’s 
Multiphysics software. Included were add-on packages for Laminar Flow in Microfluidic Devices, 
Electrostatic Potentials, and Transport of Dilute Species. Laminar flow and electric field studies 
were performed as a stationary study. Transport of dilute species studies were performed as a time-
dependent study to evaluate the production of derivatized Glu as a function of time.  
 
5.2.2 Microchip Fabrication 
 
For this study, the following chemicals and materials were used. For microchip manufacture, 
glass was purchased from Telec Co. (Telic, Valencia, CA). This glass was pre-coated with a 500 
nm layer of chrome beneath a 1.8 µm thick layer of AZ1518 positive photoresist (AZ Electronic 
Materials Corp, Somerville, NJ). Photolithography was used to pattern the AZ1518 photoresist. 
Designs of the microfluidic chips were first drawn using Autodesk AutoCAD (San Rafael, CA) 
before being evaluated using Comsol Multiphysics (Burlington, MA). Following this evaluation, 
negative transparencies were created using these designs at a resolution of 40,000 dpi by Infinite 
Graphics (Minneapolis, MN). Photolithography was performed using a UV a flood-source with 
output intensity of 21 mW/cm2 and an exposure time of 4 seconds. Following exposure, the pattern 
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was developed using MIF300 AZ1518 developer (EMD Performance Materials, Somerville, NJ) 
for 30 seconds to remove exposed regions of AZ1518. The exposed regions of chrome mask were 
removed using Chrome etchant (Cyantek, Fremont, CA) before microfluidic channels were wet 
etched into the glass substrate using a 20% hydrofluoric acid solution to a depth of 25µm. Etched 
devices were stripped of remaining AZ1518 and chrome using acetone to remove all AZ1518 and 
chrome etchant to remove the chrome layer. Finally, poly-dimethylsiloxane (PDMS) (Dow 
Corning, Auburn MI) polymer was used to seal the microchip as well as to construct the 
microdialysis interface. 
 
5.2.3 PDMS Bonding 
 
Initial work with the online mixing design discussed here focused on the construction of a 
glass-glass microchip. As the name would suggest, these devices are constructed by thermally 
bonding a glass blank to the etched glass microchip to construct a sealed device entirely made 
from glass. This method however, relies on a complete bonding of the entire surface area of the 
device. Because of the relatively large surface area of these devices, and consequent difficulties 
found in their reproducible construction, we chose to use PDMS-glass hybrid chips for this proof 
of concept microchip.  
 
PDMS was mixed to a ratio of 1 part in 10, polymerizing agent to monomer, and allowed to 
cure at 70º C for 3 hours prior to bonding. Additionally, the surface of the glass device was 
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thoroughly cleaned using Alconox glass cleaning solution (Fisher Scientific, Pittsburgh, PA) and 
water followed by drying using nitrogen gas.  
 
Bonding was performed by exposing both the PDMS and the glass surface to an electrostatic 
field, generated using a BD-20AC Laboratory Corona Treater (Electro-Technic Products, Chicago, 
IL), for approximately 30 seconds before the PDMS was placed on the glass surface and smoothed 
to eliminate bubbles. Holes were cut into the PDMS to create inlet ports to the chip using a 5mm 
biopsy punch after allowing 2 hours for the bond to form.  
 
5.2.4 Coupling to Tubing 
 
Following bonding of the PDMS top layer to the etched glass microfluidic device, a second 
PDMS layer was added over the reservoir holes. The purpose of this layer was to provide structural 
support and seal around 24-gauge metal coupling pins at the interface of the mixer section and the 
microdialysis flow. Polyurethane tubing 0.5 mm in diameter was used to directly connect the 
syringes containing NDA, CN, and stock amino acid samples to these coupling pins during tests 
of online derivatization. The coupling pins had been embedded in a permanently sealed layer of 
PDMS at the inlet to the device. To prevent leakage, a small amount of PDMS was prepared (at a 
ratio of 1:10 once again) and used as a sealant at the interface of each pin and the PDMS layer. 
The seal was allowed to cure for 3 hours at 70º C prior to use. In this way, sample leakage due to 





5.2.5 Chemicals and Reagents 
 
To calibrate the system, syringes each containing the same pre-derivatized amino acid 
standards were used. For both online and offline experiments, 3 syringes, each at a flow rate of 1 
µL/min were used to maintain a constant combined flow rate of 3 µL/min throughout the 
evaluation of the microfluidic device. 
 
Stock solutions of sodium cyanide (NaCN) (Sigma Aldrich) were prepared at a concentration 
of 10 mM in 15 mM sodium tetraborate and 50 mM EDTA (pH adjusted to 9.2 using NaOH and 
HCL). Stock solutions of naphthalene-2,3-dicarboxaldehyde (NDA) (Invitrogen, Carlsbad, CA) 
were prepared in acetonitrile (ACN) (Fisher Scientific, Pittsburgh, PA) at a concentration of 5 mM. 
Both NDA and NaCN were stored at 4º C, protected from light, and made fresh weekly. Glutamate 
(Glu) was obtained from Sigma Aldrich (St. Louis, MO) and prepared at a 20 mM concentration 
in artificial cerebral spinal fluid (aCSF) consisting of 145 mM NaCl, 2.7 mM KCl, 1.0 mM MgCl2, 
1.2 mM CaCl2, and 0.45 mM NaH2PO4. The aCSF was pH adjusted to 7.4 using NaOH and HCl. 
All buffer components were obtained from Sigma Aldrich. Dilutions of each solution were made 
prior to analysis and stored at 4ºC. Finally, a stock solution of fluorescein (Fluor) at a concentration 
of 2.5 mM was prepared in aCSF and used as an internal standard. It was also stored in darkness 




A stock solution of 200 mM sodium tetraborate (Sigma Aldrich) was diluted to 20 mM as a 
component of the background electrolyte (BGE). This stock solution was adjusted to pH 9.2 using 
1M NaOH and 1M HCL. Additionally, a 100 mM solution of sodium dodecyl sulfate (SDS) 
(Sigma Aldrich) was prepared in nanopure water. Each of these were subsequently filtered using 
a 0.22 µm filter. Prior to each use, 1.5mL of BGE was made consisting of 20 mM sodium 
tetraborate (150 µL of the 200 mM stock), 2 mM SDS (30 µL of the 100 mM stock) and 1320 µL 
of water. Finally, the BGE was sonicated for 20 minutes to eliminate dissolved gasses before use.  
 
5.2.6 Derivatization Reactions 
 
Initial tests of the derivatization microchip were performed using stock solutions derivatized 
offline to evaluate microchip function. These tests were followed by evaluating the same stock 
solutions derivatized online. The proportions of each component (sample, NDA, and CN etc.) were 
kept constant for both the online and offline tests. For each experiment, a total reaction volume of 
1.5 mL was used. This total volume consisted of a mixture of three components divided into equal 
volumes of 0.5 mL to simulate the mixing of three flows at equal flow rates.  
 
In these experiments, the first component consisted of the sample to be tested dissolved in 
aCSF. The second component was NDA at a concentration of 1mM dissolved in 50:50 ACN:water. 
The third component consisted of NaCN, EDTA, fluorescein as an internal standard dissolved in 
borate buffer. The final concentrations of each component in the total 1.5 mL volume were: 1 mM 
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NaCN with 5 mM EDTA (150 µL of stock), 25 µM fluorescein (15 µL of stock), and 20 mM 
borate (150 µL of stock).  
 
For offline analysis and optimization, these three volumes were combined and allowed to react 
for 20 minutes before being divided into three equal volumes of 0.5 mL in three 1 mL Hamilton 
1000 Series Gastight® syringes (Fisher Scientific, Pittsburgh, PA). The solutions were protected 
from light for the duration of the experiment. Each derivatized sample was then injected into the 
microchip at a flow rate of 1 µL/min for a combined flow rate of 3 µL/min.  
 
Finally, during online tests of microdialysis sampling, the syringe containing the sample was 
replaced with one containing only aCSF. This syringe was connected to a microdialysis probe 
which was then used to sample from a stock solution of Glu with the output of the probe connected 
to the inlet of the microchip. This allowed Glu to be sampled in real time and derivatized in an 
online fashion.  
 
5.2.7 Microdialysis Probe and Sampling 
 
CMA12 Microdialysis probes were used to evaluate online derivatization with MD sampling. 
These probes used a 2mm Polyarylethersulfone (PAES) membrane with a 20 kDa cutoff. The 
probe was coupled to polyethylene tubing. Prior to use, the probe was flushed with water for 20 
minutes at 5 µL/min to remove any air bubbles. 
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Sampling was performed by placing the probe in a sample containing 250 µM Glu in aCSF. 
Using a syringe pump, aCSF was then applied at a flow rate of 1 µL/min. The output of the probe 
was connected to the inlet coupling pin of the microchip using polyethylene tubing.  
 
 
5.2.8 Microchip Operation 
 
Prior to each use, the microchip was cleaned and conditioned by rinsing the channels with 
consecutive solutions of 0.1 M HCl, water, and 0.1 M NaOH, followed by water and then finally 
BGE using the application of negative pressure via a water aspirator. Each solution was passed 
through the device for 10 minutes. Finally, the channels were filled with BGE any bubbles present 
were eliminated. High voltage was generated using an UltraVolt HV rack high-voltage power 
supply (Ronkonkoma, NY). This supply was controlled by software written in Labview (National 
Instruments, Austin, TX). 
 
During both the online and offline tests, an electrokinetic gate was established using 3 voltages. 
At the top of the sample inlet, 600V was applied while 2kV was applied to the buffer waste 
channel. Finally, at the end of the separation channel a -4.85kV potential was applied creating an 
electric field of 431 V/cm. These voltage ratios were found to establish the most consistent 
electrokinetic gate. During operation, the inlet to the mixer section of the microchip was held at 
ground, as was the sample waste reservoirs. Sample injection was performed for 1 second, with 





5.2.9 Detection Instrumentation 
 
Fluorescence excitation and emission of the 1-cyanobenz[f]isoindole (CBI) product formed 
via the reaction of NDA and CN with a primary amine occurs maximally at 420nm and 442nm 
(excitation) and 510nm (emission). Consequently, for this work a 445 nm PhoxX diode laser 
(Market Tech, Scotts Valley, CA) was used for excitation during separation. This wavelength was 
not ideal for fluorescein which is maximally excited at 488nm. However, for use as an internal 
standard, its excitation at 445nm is more than adequate. 
 
 Focusing the laser on the separation channel and subsequent capture of emitted light was 
accomplished using an epifluorescence microscope. Light from the laser was reflected through a 
445nm bandpass filter, before being directed 90º upward by a long pass dichroic mirror with a 
490nm cutoff wavelength. Finally, the excitation light was focused onto the channel using a 40x 
objective lens. Emission light was captured by this same objective lens and focused downward, 
passing through the dichroic mirror and through a long pass filter, cutoff 480nm, before being 
focused onto a photomultiplier tube (PMT). The output of the PMT was amplified using a SR570 
amplifier from Stanford Research Systems (Sunnyvale, CA). Final data acquisition was performed 
using a National Instruments NI USB-6229 data acquisition card and custom Labview software. 





5.3 Results and Discussion 
 
A major limitation in the study of TBI’s has been the ability to monitor the concentration of 
multiple analytes with high temporal resolution and low limits of detection over time. To address 
this, various efforts have made, by our group [15-17] and others [13, 18-22] to interface a MD 
flow directly to an ME system. Several of these interfaces have subsequently been used to 
fluorescently derivatize samples of neuroactive amines on-chip using OPA/2ME [13] and 
NDA/2ME [17]. More recently, NDA/CN has been the derivatization agent of choice for online 
MD-ME devices [15, 16, 21, 22].  
 
As mentioned earlier in this thesis, this work focuses on the use of NDA/CN rather than 
NDA/2ME.  The reaction products of NDA with either 2ME and CN are excited by visible light 
(excitation maxima at 442nm) and is less sensitive to changes in BGE chemistry. The CBI 
derivatives exhibit higher quantum efficiencies than products with OPA/ME [23]  are more stable  
[24]. The downside to using NDA/CN is the added time necessary to complete the reaction, which 
can take up to 180 seconds [25]. Practically speaking, the requirement of 180 seconds for full 
derivatization places significant limitations on the geometry of the MD-ME device. For instance, 
at an MD sampling flow rate of 1 µL/min as mentioned previously, we can expect approximately 
10-40% sample recovery. If that inlet flow is combined with flows for NDA and CN at the same 
1 µL/min we have a resulting 3 µL/min total flow rate. As the flow enters the MD-ME device, the 
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internal volume of the microchip mixer must be at least 9 µL to accommodate a continuous 3 
µL/min flow for 180 seconds and guarantee full derivatization.  
 
The interface between the continuous MD flow and the electrokinetic sample injection into the 
separation channel of the MD-ME device also places limitations on device geometry. As 
derivatized dialysate sample arrives at the gate region, the hydrodynamic pressure of the flow must 
be balanced by the electroosmotic force generated at the gate. A theoretical model for this balance 
of forces was developed by Lin et al. [20], and was used to develop a sampling method that allowed 
for nL sized samples to be taken from a continuous MD flow. Building on, and expanding this 
method, we demonstrate a Comsol Multiphysics model of an MD-ME device including on-line 
derivatization and MD flow coupling to an electrokinetically gated ME device.  
 
5.3.1 MD-ME Design Considerations 
 
Several things must be considered when designing a complete MD-ME device. First among 
those is the substrate material used. In this case, we chose to use a glass substrate to limit fouling 
from species adsorption over time and maintain consistent device EOF and performance 
throughout usage, something that fully PDMS based devices typically lack. In our case, the glass 
devices were fabricated using photolithography and wet etching methods. Wet etching using HF 
is an isotropic process resulting in simultaneous widening and deepening of structures as etching 
occurs, a process that must be compensated for in the design and modeling. The etching process 
also creates structures of uniform depth across the entire device. Practically, this means that 
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structures cannot rise from the channel floors to aid in mixing and that all regions will have the 
same depth. Because the etching process occurs from all directions, structures of small dimensions 
such as posts tend to be etched away. To control the volume of regions and to ensure mixing for 
analyte derivatization, we were consequently limited in both the types of structures that could be 
implemented as well as the number of structures as a significant increase in the back pressure 
created by the device geometry could cause the MD-ME interface to leak.  
 
A final consideration was the fact that it would ultimately be desirable to build the device 
entirely from glass. To create a glass-glass device, the glass substrates would require bonding at 
approximately 600ºC. This, and the fact that analyte separation and mixing needed to occur in a 
single device, prevented the addition of active mixing components.  
 
In order to ensure mixing, under these design constraints we, therefore, chose to use a passive 
mixing geometry developed first by Wang et al. [26]. This geometry was well suited to our design 
constraints as it was adaptable to HF etching of glass while providing a good passive mixing 
process. 
  
5.3.2 Mixing at the Microscale 
 
Fluid mixing at micron scales can be a challenging task. For multiple reasons, including the 
need to handle the vanishingly small sample sizes produced by microdialysis sampling as well as 
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the use of electrophoresis as a separation technique (discussed in the following section), the 
channel dimensions of MD-ME devices are typically quite small. For instance, the dimensions of 
the channels in the larger regions of the device measure a maximum of 450 µm wide by 25 µm 
deep. For the separation channel, the width can shrink as small as 50 µm to 100 µm. At these scales 
and low flow rates, fluid motion can be characterized as laminar in nature.  
 
Laminar fluid flow is defined as having a Reynolds number (a measure of the turbulence of a 
given flow) where: 𝑹𝒆< 200, given by the equation: 
 
𝑹𝒆 =
𝝆 ∙ 𝑼 ∙ 𝑫𝒉
µ
 
Equation 5.1: Reynolds number 
 
Where ρ is the fluid density (
𝑚3
𝑘𝑔
), U is the average fluid velocity (
𝑚
𝑠
), Dh is the hydraulic 
diameter (m), and µ is the viscosity (Pa ∙ s). Because of the channel profile created by HF etching, 
the hydraulic radius in this case can best be approximated by a square channel given by the 
equation: 
 








In which A is the cross-sectional area of the channel (m2) and p the wetted perimeter of the 
channel (m). Under a laminar flow regime, the streamlines lines of the fluid can be thought of as 
travelling parallel to each other. These parallel streamlines can be seen in Figure 5.1 which depicts 
the intersection of two fluids, both of which are in the laminar domain. As can be seen from the 
image, because the fluid streams move in parallel, the only source of mixing (i.e. mass transport) 
between the flows is due to lateral diffusion. 
 
Figure 5.1: Modeling the intersection of two fluids, both flowing within the laminar domain. A. The streamlines of the fluid velocity 
can be seen to be parallel after the fluid meets indicating a lack of turbulent mixing. Consequently, the mixing process shown in B. 
proceeds only due to the passive diffusion of species from the inlet in the lower left of the figure to the outlets. 
 
To maximize the degree of mixing in the shortest amount of time, it is necessary to effectively 
increase the Reynold’s number associated with the fluid flow. As the Reynold’s number increases, 
the degree of convective mixing increases.  Once the value for Re > 2300, then the flow enters a 
region defined as “turbulent” flow. This type of flow is characterized by rapid, convective mixing. 








Equation 5.3: Peclet number 
 
Where D is the diffusion coefficient (m2 ∙ s-1) of the analyte being mixed. When the value of 
Pe is high (>100), it is an indication that diffusion is the primary mode of mixing and that 
consequently, channels of longer length will be necessary to ensure proper mixing.  
 
In microdevices, turbulent flow is essentially nonexistent. Mixing therefore depends on the 
diffusive flux of the dissolved solute(s) which is given by: 
 
𝑫𝒇 = 𝑫 ∙ 𝑨 ∙ 𝜵𝒄 
Equation 5.4: The diffusive flux of a dissolved solute 
 
Where 𝐷𝑓is the diffusive flux, 𝐷 is the diffusion constant, 𝐴 the interfacial area, and 𝛻𝑐 the 
concentration gradient. In microscale devices, locally increasing the diffusive flux can be 





5.3.2.1 Active Mixing 
 
Active mixing strategies, as the name would suggest, involve the addition of external energy 
to the system to disrupt flow and cause additional mixing. The method by which active mixing is 
accomplished varies but can include ultrasound, magnetic stirring, pumping, injection of bubbles, 
heat and electrokinetic forces [27]. For the purposes of this device, however, each of these was 
problematic with regard to this device due to its integrated nature.  
 
The integrated microchip presented here was designed with the goal of minimizing the lag time 
between sample acquisition and analyte detection. As a result, the derivatization step was 
necessarily located physically close to the separation channel, within a single monolithic substrate. 
A consequence of this decision was a concern that adding active mixers such as ultrasonic sound 
would disrupt the nearby electrophoretic separation. Additionally, the use of a glass substrate, 
while providing for repeated and consistent separations of our analytes of interest, limited the 
degree to which mechanisms such as pumps or magnetic beads could be integrated.  
 
Two factors also prevented the use of electrokinetic mixing as an option. The first of these was 
the fact that to facilitate full sample derivatization, a process that will be discussed in the following 
section, it was necessary that a volume of 9 µL be accommodated by the mixer. To meet this 
requirement, it was necessary that the channels be wide (450 µm). At that width, electrokinetic 
flow cannot be generated with sufficient magnitude. In addition to this, the use of electrokinetic 
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mixing at the interface between a microdialysis probe and the microfluidic device could present 
safety concerns for online animal or human experiments. Finally, while the addition of heat to the 
system would seem an ideal solution to both the problem of increasing diffusive flux and 
accelerating the rate of the derivatization reaction, this too would negatively impact the subsequent 
analyte separation. With these factors in mind, a passive mixing design was chosen for this device. 
 
5.2.3.2 Passive Mixing 
 
Passive mixing, in contrast to active mixing, deflects the energy of the flow itself to enhance 
the either the interfacial area or concentration gradient terms of the diffusive flux equation. This 
can best be accomplished by engineering the environment of the flow to force the parallel flow 
lines to intersect. Several geometries are considered as passive mixing geometries. Among these, 
are the simple T mixer geometry [28] and the Staggered Herringbone mixer design [29]. Initial 
COMSOL models of the T mixer indicated that the pressure resulting from the directly opposing 





Figure 5.2: On the left, the fluid velocity (m/s) and on the right the pressure (Pa) for a 2-dimensional cross-section of a microfluidic 
device consisting of two opposing flows meeting in a T junction. In this example, the channel dimensions are 50 µm for the inlet 
channels and 100 µm for the combined outflow with the inlet flow rate of 1µL/min. 
 
 
Figure 5.3: The velocity (m/s, on left) and pressure (Pa, right) for a simple T with inlets at 45º to the main channel. Again, the side 
inlet channels are 50 µm wide and main channel is 100 µm. Inlet flow rate is 1µL/min. 
 
The Staggered Herringbone, while having been demonstrated elsewhere to be almost an ideal 
passive mixing geometry, could not be implemented here due to its need for variation in the depth 
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of the mixer device. For these reasons, a third option was explored and ultimately implemented: 
The Triangle Baffle mixing geometry.  
 
5.3.3 Triangle Baffle Mixing Geometry 
 
As mentioned, the choice of passive mixing geometry for the integrated derivatization and 
separation chip discussed here was made under a variety of constraints. Following an extensive 
literature review, a mixing geometry based on a repeating triangle baffle design was selected. This 
design, developed by Wang et al. [26], is shown in Figure 5.4. This geometry consisted of a series 
of triangle baffles spaced at regular intervals, every 100 µm, with right triangles measuring 25 µm 
on both the base and height side extending from the channel walls and equilateral triangles having 
a base of 50 µm and heights of 25 µm we spaced in the center of the channel.  
 
 




Due to the symmetric nature of the etch profile (in the z/depth axis), it was possible to model 
the fluid flow profile as a 2D cross section, saving considerable computational time. The initial 
COMSOL simulations of the geometry specified by Wang et al. showed that with a combined flow 
rate of 3 µL/min the back pressure on the system was substantial with inlet pressures of nearly 2.5 
x104 Pa. (Figure 5.5)  
 
 
Figure 5.5: Initial test of microchip used by Wang et al. [26]  Modeled using Comsol. A. Fluid velocity is shown, 
 B. Press at the beginning of the mixer channel. 
 
Out of a concern that this back pressure would lead to leakage at the interface with the MD 
flow, or through the probe itself, the center triangles were removed. At the same time, the side 
triangles, were increased in size to 100 µm on each side such that at the narrowest point in the 
channel design, only 100 µm separated the tips of the triangles. The effect on the fluid flow can be 
seen in Figure 5.6 which shows fluid velocity streamlines as they repeatedly part and come 





Figure 5.6 A-B: The modified design shown here removes the central triangles in the original design which significantly decreases 
the back pressure on the probe. The triangular baffles on the sides however do still enhance mixing by redirecting the fluid velocity 
streamlines as the simulation shows. A: A view of the fluid velocity across the entire microchip. B: A zoomed in view of the mixer 
showing the repeating pattern caused by the triangles.C: A zoomed in view of the mixer showing fluid velocity and streamlines. 
 
 
The MD-ME device constructed based on these simulations consisted of 3 inlet ports, one each 
for the dialysate sample, NDA, and CN (as well as internal standard). These ports allowed inlet 
flows of 1 µL/min to combine and mix passively through the triangle baffle geometry in a channel 
25 µm in depth, 450 µm in width, and 80 cm long, dimensions which result in 9 µL of internal 
volume, resulted in the flow requiring 180 seconds to traverse the mixer, after which full 
derivatization of the sample had occurred [25]. Following the passive mixer, the flow was directed 
past the sample inlet of the electrokinetic gate on its way to a large waste reservoir such that a 
continuous flow could be sampled discretely. The full microchip can be seen in Figure 5.7 





Figure 5.7: The full microchip design with electric field modeled. For this model, the 3 voltage gate is modeled (discussed in the 
next section) with Vtop = 600 V, Vside = 2000 V, and Vbase = -4850V. 
 
As previously described, sample, NDA and CN (as well as the internal standard) enter this chip 
at the three inlets and proceed to mix passively. As they exit the mixer, the derivatized sample was 
electrokinetically injected when it flows by the separation channel. The separation channel itself 
consisted of a channel 15 cm in length, 25 µm in depth and 70 µm wide with channel turns tapered 
to 50 µm to prevent band broadening.  
 
Modeling the combined mixer and separation channel was performed by defining two separate 
domains within Comsol. These domains differed primarily in the wall conditions applied to each 
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(no-slip for the mixer section, electroosmotic for the separation channel section). However, the 
device itself was simulated in its entirety to ensure that 1. The applied separation field would not 
adversely affect the mixer or the upstream dialysis pumps or 2. That the pressure from the mixer 
was accounted for in the modeling of the electrokinetic gate.  
 
5.3.4 Electric Field Distribution and Electrokinetic Gate Modeling 
 
The electric field applied to the MD-ME device was modeled using Comsol’s Electrostatics 
module. Three methods of establishing an electrokinetic gate were tested. The first was to simply 
use a single high voltage source from one of the side channels to create a gate, while hydrodynamic 
pressure from the dialysate flow forced sample down the channel to the gate where it would be 
prevented from entering the separation. When the voltage was floated, sample would be forced 
into the separation channel hydrodynamically. In order to produce the target ~420V/cm separation 
potential previously established as necessary to separate the target analytes commonly found in 
brain dialysate [30], a potential of at least 7.7kV would be required. This scheme had the benefit 
of minimizing the number of high voltage supplies necessary. In practice, however, it was quickly 
apparent that too little of the dialysate sample was directed to the gate for this to be effective and 
in fact, the EOF created by the single voltage would expel sample from the separation channel 
back into the mixer. This of course could be prevented by decreasing the voltage, but at the cost 






Figure 5.8: A single voltage supply at a high enough potential to maintain a separation potential of over 420 V/cm was found to 
expel sample from the gate region. A: The concentration of derivatized sample as it is expelled from the channel. B: The fluid 
velocity as a result of EOF is shown. 
 
Therefore, rather than rely on a single voltage source, a second voltage source at was added at 
the top of the sampling channel at a potential of 5.062kV and the side channel voltage was lowered 
to 6.75kV (0.75:1 ratio). This source created an EOF from the dialysis flow to the electrokinetic 
gate and was effective in delivering the sample to the gate. However, it failed in practice because 
the high field strengths in the gate region resulted in joule heating and bubble formation. 
Additionally, as can be seen in Figure 5.9, the gate established in this fashion was unable to 





Figure 5.9: A: The gate established using the two voltage system was found to be unstable, resulting in sample leakage into the 
separation channel. B: The velocity profile of the two voltage gate. 
 
Finally, this led to the addition of a third high voltage source with a negative potential at the 
end of the channel of -4.85kV. By using a negative voltage at the base of the separation channel, 
the gate voltages could be lowered to 600V at the sample inlet, and 2.0kV in the side channel. The 
net effect of this is to preserve the overall separation potential at roughly 431 V/cm while lowering 
the field strength at the gate, thereby preventing bubble formation while still creating a stable and 
closed electrokinetic gate to prevent sample leakage. A second consequence was to create a more 
substantial injection plug as the EOF generated in the sample channel from the 600V injection 
voltage to the -4.85kV end of channel voltage was significantly higher than that from 2kV to 




Figure 5.10:  The gate established using the three voltage model was found to result in the most stable injection scheme. A: The 
concentration profile of derivatized sample at the gate. B:The fluid velocity due to EOF at the gate region. 
 
5.3.5 Derivatization Reaction 
 
To model the transport, mixing, and subsequent derivatization reaction of analytes within the 
MD-ME device, boundary concentrations of Glu (10uM), NDA (1mM), and CN (1mM) were 
defined at the entrance to each respective fluid inlet. Transport of these species was coupled to the 
fluid inflow, providing a constant source of each.  
 
Using the experimental conditions described by Shou et al. [25] under which the derivatized 
mixture of amino acids was found to have a maximal fluorescence output after 180 seconds, as 
well as the observation by De Montigny et al. [31] that in conditions of excess NDA and NaCN, 
the derivatization of amino acids by NDA can be modeled as a pseudo-first order equation, we 
calculated the rate constant for Glu derivatization as k= 25E-3 s-1. Under these conditions the rate 
of CBI-Glu (the derivatized form) production depends only on the concentration of Glu. The rate 
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of CBI-Glu formation, referred to in the following sections as GNDA, and concentration at a given 










Equation 5.6: Integrated form of the first order rate equation 
 
Where [Glu] is the concentration of Glu at a given time (t), k is the rate constant, and [GNDA] 
is the concentration of the derivatized product [GDNA]. 
 
The simulated reaction of Glu, NDA, and CN was accomplished using the reaction modeling 
capacity of the Transport of Dilute Species module within COMSOL and defining stoichiometric 
reaction equations as a pseudo first order reaction. To verify the reaction was being modeled 
correctly, the flow into the device was disabled while the initial concentrations of the three 
reactants were set to 10µM Glu, 1mM NDA, and 1mM CN respectively. The reaction was 
subsequently modeled for 200 seconds with the concentrations of Glu and GNDA (the derivatized 




The primary reason for modeling the reaction was to demonstrate that the derivatization 
proceeded to completion at the target flow rate of 1 µL/min before the analyte was injected into 
the separation channel. In fact, in an earlier version of the MD-ME device, it had been 
demonstrated that the derivatized product flowed from the chip well before the reaction could 
proceed to completion. As a result, the limits of detection for the MD-ME device were much higher 
than they otherwise would be. As mentioned, the design of this device anticipated that at a 
combined flow rate of 3 µL/min, the collected sample would have sufficient time to fully react. 
Above this rate however, the amount of derivatized sample would be limited by the flow from the 
device. This pattern can be seen in Figure 5.11 which shows the estimated concentration of GNDA 






Figure 5.11: A comparison of GNDA production vs Glu for flow rates from 500 nL/min to 3 µL/min (for each inlet channel) over 
a 300 second time period. Of note, at flow rates higher than 1.0 µL/min, a substantial quantify of Glu exits the microchip prior to 
being derivatized. Full sample derivatization in this example is 3.3µM GNDA.  
 
 
5.3.6 Construction and Evaluation of Online System 
 
To evaluate the model used in this paper, a glass-glass device was initially constructed. 
However, due to the difficulties in uniformly bonding such a large surface area, a glass-PDMS 
hybrid device was ultimately used. This device was etched to a depth of 25µm into the glass 
substrate providing three walls of a glass channel within which to generate an EOF with the PDMS 
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layer being used to seal the device. Access ports were cut in the PDMS layer for buffer and waste. 
Three coupling pins for the microdialysis inlets were mounted through the PDMS layer and sealed 
via the application of liquid PDMS, left to cure for 3 hours before use. These coupling pins were 
used for convenience during this prototyping process. It should be noted however that because 
they were 20 mm long and 0.5 mm in diameter, their use added an additional 3.9 µL of dead space 
for the fluid to fill before reaching the chip. Additionally, the wells created to in the 2.5 mm thick 
PDMS layer using a 5.0 mm biopsy punch resulted in another 49.2 µL which will be discussed 
further in the future directions section of this chapter.  
 
To evaluate the performance of the microchip, NDA, NaCN, and a series of Glu concentrations 
ranging from 5 – 50 µM Glu were used to create two calibration curves. The first of these used 
offline derivatizations followed by the application of sample directly to a sample well at the top of 
the injection channel. Following this, a second calibration curve was generated using online 
derivatization at a flow rate of 1 µL/min. These calibration curves can be seen in Figure 5.9. 
Sample injection into the separation channel began immediately to register the earliest change in 




Figure 5.12: A comparison of two calibration curves using the microchip. The first using a prederivatized sample, and the second 
via online derivatization. Of note is the departure of the two curves as concentration increases, indicating potential a departure 
from a pseudo-first order reaction rate.  
 
As Figure 5.12 shows, both pre and online derivatization schemes resulted in a linear response 
with signal intensities for both corresponding closely at lower concentrations. However, as 
concentrations increase, a clear departure was noted between the measured signal strengths. This 
difference between prederivatized sample and sample derivatized online is indicative of an 
incomplete derivatization process. Further evaluation using NDA and CN stock of double the 
concentration (2mM rather than 1mM) resolved this. 
 
  
y = 0.007x + 0.036
R² = 0.9876


















5.3.7 Online Sampling via MD-ME 
 
The calibration curves shown in Figure 5.12 demonstrate linearity over a physiologically 
relevant range of concentrations for glutamate [30]. In order to demonstrate the ability of such a 
device to function in a medical setting however, it was necessary to evaluate the device using a 
microdialysis probe identical to the probes typically used for in vivo studies as well as in an ICU 
setting. For this reason, a CMA brain cannula microdialysis probe, model CMA 12, was used. As 
mentioned, the membrane of the CMA 12 probe has a 20 kDa cutoff, which excludes large proteins 
and cellular components, while allowing the target amino acids to be sampled.  
 
The 2mm PAES membrane is a common membrane used in CNS microdialysis sampling 
and was used in these studies. Prior to use, the probe was flushed for 20 minutes at 5 µL/min using 
water according to the manufacturers specifications in order to remove any bubbles. Following 
this, the probe was placed in a sample of 250 µM Glu in aCSF. At this point, a syringe containing 
aCSF was connected to the inlet of the probe using polyethylene tubing while the outlet of the 
probe was connected to the microchip inlet coupling pin using additional tubing. For ease of use 
during the evaluation of the prototype microchip design, this tubing was approximately 4 cm long 
with an internal diameter of1.0 mm. This represented an additional 31.46 µL of dead volume 




A syringe containing NDA in acetonitrile (ACN) and another containing NaCN in 20mM 
borate buffer with 25 µM fluorescein were connected to the remaining two inlet pins of the 
microchip. By placing the fluorescein internal standard with the derivatization agents rather than 
in the sample or in the aCSF perfusate, potential loss due through the microdialysis probe could 
be prevented. It also obviated concerns regarding the presence of the internal standard in a 
perfusate entering a living subject. Once fully assembled and prepared, the sample and 
derivatization agents were delivered to the microchip at a steady rate of 1 µL/min.  
 
As mentioned, the three different potentials were applied to the device, 600 V at the sample 
inlet, 2000V to create the electrokinetic gate, and a negative voltage applied to the end of the 
separation channel of -4850 V.  This generated a separation field of approximately 431 V/cm. 
Sample was injected electrokinetically every 150 seconds for 1 second and was performed 
continuously for approximately 3 hours. A characteristic section of the resulting data, obtained 





Figure 5.13: A representative section of the datafile with the peaks for the fluorescein internal standard (which extend out of frame) 
as well as the sampled Glu labeled. This particular range of data represents a 10 minute period, 1.71 hrs. into the sampling process. 
 
Sampling was performed for 3 hours. During that time, it was evident that while the 
sampling peaks had substantial variability on an injection to injection basis, the use of the internal 
standard to correct for the Glu peak height worked well. The injection variability is a concern 
however and will be addressed in the future directions. 
 
Data collection began immediately after starting the syringe pump. However, as 
mentioned, a time lag existed in the prototype system resulting in a delay of approximately 27 





Figure 5.14: Online sampling and derivatization performed using microdialysis. The appearance of derivatized Glu appears after 
a 27 minute delay due to tubing lengths . Following an extended period of sampling, the concentration of Glu was doubled (by 
adding an additional 250 µM of Glu to the sample). An additional 27 minutes of delay pass followed by a doubling in signal. 
Finally, approximately 2.7 hours into the experiment, the microchip begins to fail. 
 
As can be seen in the figure, the added tubing significantly increased the lag time between 
increases in Glu concentration in the sample and measured changes. At a time point of 1.5 hours, 
the concentration of the Glu sample was doubled to 500 µM through the addition of 12.5 µL of 20 
mM Glu. Again, approximately 27 minutes passed before a change. As expected however, the 
signal output doubled. This doubling remained until at roughly the 2 hour time point, the 
normalized signal intensity climbed dramatically. This increase in signal was not due to a change 
in concentration however but reflected the current lifetime of the microchip. These shortcomings 




Based on the normalized signal from the device, the recovered percentage of Glu using this 
probe was found to be fairly low. Given the initial concentration in the sample of 250 µM, and a 
signal of approximately 0.1 RFU, the corresponding concentration from the online derivatization 
calibration curve would indicate a measured concentration of Glu of approximately 10 µM. This 
represents a recovery of 4% which is well below the expected value of 13% estimated by CMA 





The nature of neurological conditions such as TBI and stroke pose significant challenges in 
an ICU environment. Conditions such as these, which simultaneously require constant and timely 
monitoring for changes in multiple biomarkers. While several methods exist to monitor relevant 
biomarkers such as ATP, glucose, lactate, pyruvate and Glu, most methods either rely on 
biosensors which are limited to single analytes or MD sampling with time consuming offline 
analysis. The online derivatization method developed here demonstrates the feasibility of using 
MD coupled directly to a microchip electrophoresis assay via an online derivatization process. 
Furthermore, the data presented here validates the Comsol model used to develop the microchip. 





5.5 Future Directions 
 
The device demonstrated here has successfully been used to detect Glu sampled via 
microdialysis for an extended period of time via online derivatization with NDA/CN. Two things 
must be addressed before the utility of the microdevice can be realized. First, as mentioned in the 
opening of this chapter, the initial intention for the design of this device was to use an all glass 
substrate. The rationale for this was that glass simply cannot be matched as a substrate in terms of 
ruggedness and reproducibility of the EOF. However, attempts at consistently manufacturing such 
a device were shown to be virtually impossible. Future work should therefore focus on either 
improving the manufacturing process or decreasing the size of the device to allow for easier 
bonding.  
 
Secondly, the limits of detection for this device require improvement. This could largely be 
achieved by using an all glass device which would improve peak resolution, shape, and reduce 
background fluorescence. As mentioned, the calibration of the device was performed at 
physiologically relevant concentrations of Glu. However, the recovery of Glu via microdialysis 
can be very low as was demonstrated by this work and consequently, future efforts should continue 
to focus on improving recovery through the probe and the limits of detection, as well as limits of 
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6.1 Near Term Future Directions 
 
All discussions of the future of this project will center on what has been my primary focus for 
the last 5 years: improving the overall limits of detection for the system while maintaining or 
improving temporal resolution. By referring to the system here, I include the entire process from 
the sampling of the biomarker in tissue to the display of clinically actionable data. To fully 
understand how the system can be improved it is useful to understand its limitations. 
 
As mentioned in previous chapters, the recovered concentration of any biomarker sampled via 
microdialysis is primarily a function of the flow rate of the dialysate since the sampling process 
itself relies on diffusion. This fact has several implications. First, a tradeoff is immediately 
apparent. Either the sampling rate must be optimized for sample recovery or for the volume of 
sample generated per unit time. In the case of the latter condition, any assay subsequently used for 
analysis must have sufficiently low limits of detection to compensate for the lowered sample 
concentration. The use of microfluidic devices can allow lower flow rates to be used without 
negatively impacting overall time lag due to their small volume requirements.  
 
For the specific application described here, another constraint was placed on the time lag of 
the system by the rate at which the Glu in the dialysate sample could be derivatized. For instance, 
regardless of how high the concentration of Glu in the dialysate sample ultimately is, if the flow 
rate into the online microchip (described in chapter five) is too high to allow for the sample to be 




An example of this can be seen in Figure 6.1 below which compares flow rates vs derivatized 
Glu at the entrance to the separation channel. This image shows the effect of flow rate on the 
absolute amount of derivatized product produced. At the lowest flow rate modeled, 1.667E-11 
m3/s, the sample reaches full derivatization prior to reaching the separation channel. However, at 
a higher flow rate, 3.7495E-11 m3/s, sample is pushed from the device before full derivatization 




Figure 6.1:Shown on the upper portion of the figure is the output of derivatized Glu (GNDA) at the entrance to the separation 
channel and on the lower portion, the remaining underivatized Glu. Of note is the fact that over 1µL/min (1.6665E-11 m3/s), 





Looking at this from another perspective however, the flow rate problem becomes a limit of 
quantification (LOQ) problem. If we assume for instance that the recoverable, basal concentration 
of Glu in the extracellular space near at risk tissue is 1µM and that full derivatization using 
NDA/CN (described in chapter three) within the online microchip requires 180 seconds [1], then 
a detection system with an LOQ of 1µM would have a minimum response time of 180 seconds. If, 
however, the LOQ of the system were improved to 500 nM, the derivatization time could be 
decreased by ~50% without negatively impacting the overall system. In summary then, one way 
to decrease the time lag is to improve the LOQ of the system. 
 
The rate of the derivatization reaction is another possible point of improvement. At present, 
NDA/CN is used primarily due to its selectivity for primary amines, fairly fast reaction rate, and 
reasonably high quantum efficiency of 0.4 [2], making it a good solution to this specific 
derivatization problem. However, to decrease the overall time lag of the system, we would ideally 
have either a derivatization reagent that was either faster or brighter (higher quantum efficiency), 
while maintaining the selectivity for primary amines. 
 
6.1.1 Enhancing the Derivatization Reaction Rate 
 
The choice of NDA as derivatization agent was based on it being a good combination of several 
desirable properties. However, other, faster methods of derivatization exist that could be explored. 
Among those options is the possibility of using a thiol rather than cyanide during the derivatization 
reaction. This method has been used in the past with NDA as well as a fluorogenic compound 




NDA was designed as a replacement for OPA, an earlier fluorogenic compound that was 
specific for primary amines as well but had the downsides of being less stable over time and has 
an excitation wavelength at 350 nm. Like NDA, OPA requires a nucleophile such as cyanide or a 
thiol compound to react with a primary amine. Typically, OPA is used in the presence of a thiol 
compound such as 2-mercaptoethanol (2ME) for the derivatization reaction to take place [2]. 
However, the use of a thiol results in the formation of a much less stable fluorescent compound 
(an isoindole derivative). Despite this, it is an attractive option since the reaction of OPA/2ME is 
much faster than NDA/CN and is stable enough that, for an online system such as this, it could be 
adequate.  
 
NDA/2ME has been evaluated by Manica et al. [3] among others and was observed to have an 
extremely rapid reaction rate (less than one minute) as compared to the 180 second minimum 
reaction time for NDA/CN. This rate however came at the cost of having a half-life of 
approximately two minutes. Such a short half-life would not be a problem for rapid online 
measurements of course but it would complicate method development.  
 
The real impediment to the use of 2ME with NDA is in its noisome qualities. 2ME is used to 
give natural gas a detectable smell and its presence in any system designed for use in a hospital 
setting would be an impediment to adoption to say the least. Unfortunately, that smell is a property 




6.1.2 Derivatization using OPA-SAMSA-F 
 
A potential solution to the need for noisome thiol compounds for use with either NDA or OPA 
has been explored by Hapuarachchi et al. As they explain, by using a thiol functionalized 
fluorescein compound (5-2,3-S-acetylmercapto succinoyl amino fluorescein) (SAMSA-F) rather 
than a nucleophile such as 2ME or CN, a fluorophore with higher quantum efficiency (fluorescein) 
can be incorporated into the final product [4]. This can be seen in Figure 6.2 below. 
 
Figure 6.2: The derivatizat ion of a primary amine using OPA/SAMSA -F.  
 
The use of SAMSA-F would provide an almost ‘best of all worlds’ option with reaction times 
of 10-40 seconds and selectivity to primary amines, similar to OPA, but with an excitation 
wavelength of ~490 nM. SAMSA-F also has the added benefit of a much higher quantum 
efficiency approaching 0.9 as opposed to that of OPA or NDA at ~0.4 [2, 4]. There are two 
potential caveats to the use of OPA-SAMSA-F. First, the stability of the isoindole product is not 
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well characterized and method development may prove difficult as a result. Second, unlike NDA 
or OPA, SAMSA-F is not a fluorogenic compound but a fluorophore. This means that it is 
inherently fluorescent without reacting which complicates the electropherogram and could affect 
analyte resolution.  
 
Initial work evaluating the possibility of using NDA/SAMSA-F appears to indicate quenching 
of the fluorophore likely occurs due to overlapping excitation and emission spectra of the two 
compounds [2, 4]. Future work should therefore focus on the use of OPA/SAMSA-F.  
 
6.1.3 Improved Substrate Bonding and Separation Potentials 
 
Chapter three discussed the development and testing of a microchip electrophoresis device 
with integrated sample derivatization for online monitoring of dialysate samples. Part of that 
discussion referred to the complications inherent in guaranteeing that a reaction has reached 
completion as it flows through a microchannel. The resulting design required 80 cm of a serpentine 
channel, 450 µm wide by 25 µm deep before reaching the entrance to a separation channel. That 
channel itself was 15 cm long, 70 µm wide, and 25 µm deep. Altogether, once additional channels 
for coupling the microdialysis flow to the device were factored in, the microchip had a bonding 
surface area of approximately 97 cm2. To bond these devices, both the etched glass substrate and 
the blank had to be flat to an extremely small tolerance across that entire surface area with no 
contamination or air pockets. Ultimately, as devices failed due to clogs or breakage, or simply 
didn’t bond properly, it became clear that glass-glass devices were proving too difficult to make 
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and poly-dimethyl siloxane (PDMS)-glass hybrid devices were used. These devices had three walls 
of glass and one of PDMS and could very closely approximate the glass-glass devices.  
 
6.1.4 Separation Potential 
 
An unfortunate effect of the hybrid PDMS/Glass device is a greater susceptibility of the PDMS 
channel wall to damage either chemically or due to heat in the channel caused by joule heating as 
the electric field increases. This is particularly unfortunate as early tests on smaller all glass devices 
using separation potentials approaching 700 V/cm have shown dramatically improved limits of 
detection for the target analytes mentioned in this thesis. These improvements are due to improved 
resolution and peak shape with increasing separation potentials. The application of potentials over 
~500 V/cm to a PDMS/glass chip however will destroy the PDMS channel wall and consequently 
the separation making improvements using this method impossible. 
 
 
6.2 Long Term Future Directions 
 
One of the primary motivating factors for this work has been the lack of knowledge 
surrounding the long-term pathogenesis of TBI. This lack of knowledge would at first seem to be 
an odd thing given the long history of work in this area, going back several decades at least. After 
initial successes improving patient outcomes via interventions such as preventing hypotension 
(low blood pressure) and hypoxia (low oxygen), additional progress toward arresting the secondary 
effects of TBI has been disappointing. Part of this has been, as Park et al. [5] put it in their 
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discussion of current treatment, the “greater than anticipated complexity” of the underlying 
processes involved in secondary damage. The mechanisms involved in the excitatory amino acid 
cascade, inflammatory responses, and axonal disconnection have proven difficult to study. The 
difficulty in understanding these processes has been compounded by the high variability in clinical 
TBI cases as differing injuries can cause greatly varying types of secondary damage.  
 
The combination of a complex mechanism with a highly variable clinical presentation limits 
available approaches such as high throughput screening to develop drug targets. To address this, 
multiple animal models have been developed. These models have primarily been rats but also 
include mice, cats, rabbits, swine, and of course primates [6]. These models, which become more 
directly applicable to humans as they move from mice to primates, also become more time 
consuming, expensive, and ethically dubious. One model currently under investigation, is the use 
of zebrafish to approximate many of the same pathologies while allowing rapid and inexpensive 
studies to be conducted. Zebrafish are small, 4 cm long vertebrate fish with a rapid generation time 
of approximately 3 months. They possess significant homology with mammalian anatomy 
including analogous receptors such as 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl) propanoic 
acid (AMPA) and N-methyl-D-aspartic acid (NMDA), two receptors implicated in the excitotoxic 
glutamate cascade, as well as homologous neuron cytoskeletal proteins [7]. Compared to other 
model organisms, these fish are small, with brain volumes of roughly 2mm x 2.5mm x 3mm 
making them difficult targets for many techniques including microdialysis. However, the ability 
to perform rapid studies might make up for this difficulty. Finally, embryonic fish can directly be 
used in a high throughput (96 well plate) format when screening for drug candidates before 
proceeding to a more specific TBI model such as a concussive force model [6-8].  
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An interesting possibility for the future of this work could lie in the integration of the online 
microchip system into a higher throughput system. This method could use either immobilized 
zebra fish exposed to a TBI event and monitored directly using microdialysis, or a continuous 
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Glass-Glass ME Device Construction 
 
The following quick reference guide is a step-by-step explanation of the steps necessary to 
construct a glass-glass ME device. This process is also shown graphically in Figure A.1 of 
Appendix A. 
 
1. Required Cleanroom Facilities and Instrumentation 
 
ABM UV Flood Source and Mask Alignment System (ABM, Scotts Valley, CA) 
Brewer Science Cee 200CBX Spin Coater (Brewer Science, Rolla, MO) 
Harrick PDC-32G Plasma Cleaner (Harrick Plasma, Ithaca, NY) 
BD-20AC Laboratory Corona Treater (Electro-Technic Products, Chicago, IL) 
Tencor Alpha-Step 200 Profilometer (KLA Tencor, Milpitas, CA) 





2. Required Glass-Glass Microchip Fabrication Materials 
 
AZ1518 precoated glass substrates such as borosilicate (borofloat) or soda lime glass (Telic, 
Valencia, CA) 
AZ1518 (AZ Electronic Materials Corp, Somerville, NJ) 
MIF 300 AZ1518 developer (Emd Performance Materials, Somerville, NJ) 
Acetone (Fisher, Waltham, MA) 
Water 
Chrome Etchant, CR-75 (Cyantek, Fremont, CA) 
HF Etchant solution consisting of: 20% HF, Nitric Acid, Water 
Ultra Pure Calcium Acetate (MP Biomolecules, Solon, OH) 
Alconox™ Powdered Detergent (Fisher, Waltham, MA) 
Diamond Drill Bits (Ukam Industrial Superhard Tools, Valencia, CA) 
Programmable High Temperature Oven (Fisher, Waltham, MA) 
 
3. Photolithography (Figure A.1-a,b) 
 
1. Pre-bake glass substrate, photoresist side up, on a hotplate at 100 ºC for 2 minutes. 
Note: The prebake time will vary according to the photoresist type and thickness. Consult the 
photoresist documentation for more information. 
2. Allow glass to cool to room temperature before proceeding. 
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3. Place photomask on glass substrate such that the printed side of the photomask is in contact 
with the photoresist. Apply a vacuum to ensure minimal distance between mask and photoresist.  
4. While maintaining a vacuum, expose the photoresist to UV through the photomask. 
Duration of exposure will depend on resist type, thickness, and UV intensity. 
5. Place exposed glass substrate in developer to remove exposed area. 
6. Wash with water and dry gently with compressed nitrogen or air. 
7. Place on hotplate at 100 ºC for 10 minutes to fully evaporate developer. 
 
4. Chrome Removal (Figure A.1-c) 
 
8. Place wafer in a Pyrex™ dish of chrome etchant. 
9. Agitate gently until chrome regions are clear + 45 seconds.  
10. Rinse with water and dry using compressed nitrogen or air. 
Note: Chrome and photoresist must be removed from glass before a glass cutter will be effective. 
If making multiple devices simultaneously, it is important to include these cut lines in the 
photomask design. Additionally, chrome-coated glass will appear transparent before all chrome 
has been removed. However, a thin layer of chrome that remains will prevent glass-glass bonding. 
For this reason, allow the glass substrate to remain in the chrome etchant for 45 seconds after it 
appears that the chrome has been removed. Additional etching beyond this period will begin to 




5. Glass Cutting and Drilling 
 
11. Using a glass cutter, cut glass along exposed paths between individual devices.  
Note: Extreme care should be taken not to scratch the surface of the photoresist. If this is a problem, 
the glass cutting and drilling steps can be performed after the HF wet etching. 
12. Once separated, place individual ME devices in approximately 1 cm of water with a 
sacrificial layer under the chip to allow the drill to pass through without being damaged. 
13. Slowly drill glass, applying constant pressure. It may be necessary to use gradually 
increasing drill bit sizes. 
Note: More ME devices are destroyed in this step than any other. Using new diamond-coated bits 
can help prevent glass breakage. When choosing drill bit sizes, two things to consider are whether 
or not MD access ports will be glued into place over the holes and evaporation during operation. 
If the holes drilled in the glass to create sample and buffer wells are too small, these solutions will 
evaporate rapidly during operation. As this evaporation proceeds, ionic strength will change. This 
in turn will cause additional current draw and, consequently, alter migration times. If MD access 





6. HF Wet Etching (Figure A.1-d) 
 
14. Place glass with photoresist/chrome side up in HF etchant and agitate for duration of 
etching process. Etching time will depend on desired depth as well as glass type. 
15. Remove from HF etchant, rinse with a solution of calcium acetate to deactivate the HF 
etchant. Following this, rinse with water and dry using compressed nitrogen or air. 
16. Measure channel depth using a profilometer. If the desired depth has not been achieved, 
calculate the etch rate and place the device back in the HF for the necessary amount of time.  
Note: Due to the extreme toxicity of HF, the best practice is to minimize the number of times the 
device is taken in and out of the HF etchant if at all possible. When handling the substrate, the HF 
remaining on the device should first be deactivated by rinsing with a slurry of calcium acetate in 
water, followed by rinsing with water.  
 
7. Removal of Remaining Photoresist and Chrome (Figure A.1-e,f) 
 
17. Remove all remaining photoresist by rinsing with acetone. 
18. Rinse with water and dry with compressed nitrogen or air. 
19. Place the glass substrate in chrome etchant, agitating gently, until all remaining chrome 
has been removed + 1 minute. 
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Note: The removal of all photoresist and chrome is necessary to facilitate a glass-glass bond. 
 
8. Bonding Glass-Glass ME Devices (Figure A.1-g) 
 
20. Cut blank glass to the necessary size. 
Note: To avoid breakage due to differences in thermal expansion, blanks should be of the same 
glass type as the etched device. 
21. Clean both glass pieces using Alconox™ mixed to the manufacturer’s specifications. 
22. Rinse both sides well with deionized water (DI) water 
23. Incubate the glass surfaces to be bonded using a solution of 0.5% (w/v) calcium acetate, 
approximately 30 mM, and 0.5% (w/v) Alconox™ in DI water for no less than 30 seconds. 
24. Rinse thoroughly with DI water. 
25. Under running DI water, bring glass pieces together from bottom to top. 
Note: Force out any remaining bubbles but allow a layer of water to remain. 
26. Place the device in an oven for 1 hour at 60 ºC. 
Note: Do NOT force all water from between the layers. The evaporation from the oven will force 
the glass together. 
27. At the 1-hour mark, inspect the device for Newton rings indicating incomplete bonding of 
the surfaces. If found, separate using a razor blade and repeat steps 21–26. 
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28. Place binding clips around the device to apply additional pressure. Increase the temperature 
to 105 ºC for 2 hours. 
29. Inspect device. If Newton rings have formed, separate using a razor blade and repeat steps 
21–28.  
30. If no Newton rings are found, execute the following program, slowly increasing the oven 
temperature to 630 ºC and holding before cooling gradually to room temperature. Steps shown in 
Table A.1. 
31. If the ME device is meant to be used online (MD-ME), access ports must be glued to the 
chip to allow the flow from the syringe pump to enter the device. Polyethylene tubing connecting 
the syringe pump can be connected directly to ports glued to the surface of the device. To glue 
ports in place, a strong UV source such as the ELC-450 (Electrolite Corp, Bethel, CT) should be 
used. UV glue (Fisher Scientific, Waltham MA) should be applied carefully to the ports while 
holding them in place.  
Note: Should glue enter the channels, flush with water and methanol until the glue has been 












Time for Step, 
Hours Oven Temp, C 
Rate, 
C/Min 
    
0.00 0.00 25 0.0 
2.97 2.97 560 3.0 
3.30 0.33 630 3.5 
5.80 2.50 630 0.0 
6.16 0.36 565 -3.0 
6.77 0.61 510 -1.5 
7.27 0.50 510 0.0 
8.77 1.50 465 -0.5 
10.24 1.47 25 -5.0 
 









PDMS-PDMS Device Construction 
 
The following quick reference guide is a step-by-step explanation of the steps necessary to 
construct a PDMS-PDMS ME device. This process is also shown graphically in Figure B.1 of 
Appendix B. 
 
1. Required Cleanroom Facilities and Instrumentation 
 
ABM UV Flood Source and Mask Alignment System (ABM, Scotts Valley, CA) 
Brewer Science Cee 200CBX Spin Coater (Brewer Science, Rolla, MO) 
Harrick PDC-32G Plasma Cleaner (Harrick Plasma, Ithaca, NY) 
BD-20AC Laboratory Corona Treater (Electro-Technic Products, Chicago, IL) 
Tencor Alpha-Step 200 Profilometer (KLA Tencor, Milpitas, CA) 
Fisher Scientific Muffle Furnace (Fisher, Waltham, MA) 
  
2. Required PDMS Microchip Fabrication Materials 
 
Silicon wafer (100-mm thickness) (University Wafer, Boston MA) 
SU-8 10 photoresist (Microchem Corp, Flanders, MA) 
SU-8 developer (Microchem Corp, Flanders, MA) 
160 
 
Isopropyl alcohol (Fisher, Waltham, MA) 
Sylgard™ 184 Silicone Elastomer Base (Dow Corning, Auburn, MI) 
Sylgard™ 184 Silicone Elastomer Curing Agent (Dow Corning, Auburn, MI) 
Parafilm™ (Fisher, Waltham, MA) 
 
3. Silicon Master Spin-Coating (Figure B.1-a) 
 
1. Use nitrogen flow to clean surface of silicon wafer. 
2. Center silicon wafer on spin coater platform. 
3. Pipette 4 mL of SU-8 10 photoresist onto the exact center of wafer and spin coat at 2000 
rpm until fully coated. 
Note: The amount of SU-8 10 photoresist used directly influences its thickness and, 
subsequently, the final depth of the microfeatures. The values stated in these steps are for a 
final thickness of 15 µm with SU-8 10. Values associated with other thicknesses and 
photoresists should be calculated based on manufacturers’ specifications.  
4. Prebake silicon wafer at 65 ºC for 2 minutes on hotplate, then increase temperature to 95 
ºC for 5 minutes. 
Note: To avoid breaking the silicon wafer, it is better to start the hotplate at room temperature 
and gradually ramp up to each specified temperature before heating it for the desired length of 
time. This should be done in any step requiring heating the silicon wafer. 
 




5. Align negative photomask on top of wafer on photolithography platform; use vacuum to 
hold substrate and mask in place. 
Note: When using a printed photomask, make sure that the printed side is facing down 
(flush with the substrate). This will prevent any diffusion of light across the width of the 
transparency and avoid unwanted enlargement of the features. Make sure the silicon wafer 
has cooled to room temperature before aligning the photomask. 
6. Expose to UV light for 16 seconds. 
Note: Full UV exposure of SU-8 is dependent on the substrate thickness and light source 
intensity. In this case, a flood-source with output intensity of 21 mW/cm2 is used. 
 
5. Silicon Master Post-Exposure Processing and Profiling (Figure B.1-c) 
 
7. Post bake silicon wafer at 65 ºC for 1 minute on hotplate, then increase temperature to 95 
ºC for 2 minutes. 
8. Place developed wafer in SU-8 developer; gently swirl for 2 minutes to remove un-
developed photoresist. 
9. Remove master from developer; wash with isopropyl alcohol and dry with nitrogen flow. 
Note: Acetone will cause developed SU-8 to dissolve. Only isopropyl alcohol should be 
used for cleaning silicon masters using this photoresist. 
10. Hardback at 200 ºC for 2 hours. 




6. PDMS Curing (Figure B.1-d,e) 
 
12. Measure 12 grams total of a 9:1 ratio of Sylgard™ 184 elastomer (10.4 g) and curing agent 
(1.6 g) into a small cup; mix thoroughly.  
Note: This amount of polymer was chosen because the surface tension will be sufficient to 
hold the mixture on the master’s surface. Greater amounts can be used, but a mold will be 
necessary to hold the polymer on the wafer’s surface. Using 12 g will result in a final 
thickness of approximately 1.2 mm. 
Note: Different ratios of elastomer to curing agent can be used in order to modify the 
elasticity of the PDMS. In general, the more curing agent used, the less elastic is the final 
polymeric substrate. 
13. Place cup inside vacuum desiccator and remove all gas bubbles via repeated application of 
vacuum, being careful not to spill polymer over the edges of the container. 
14. Pour mixture onto master and allow it to settle to a uniform thickness; place in oven and 
heat at 70 ºC for at least two hours. 
Note: Make sure that the master is level once it is placed in the oven. If it is placed at an 
angle, the PDMS will cure unevenly and potentially be unusable. 
15. Use a razor blade to scrape the PDMS off of the edges of the master, then slowly peel off 
the polymer layer, being careful not to stretch or rip the substrate. 
16. Either bond immediately (see next section) or place the PDMS on a piece of Parafilm™, 
channel-side down; fold Parafilm™ over the top of PDMS to fully seal it. 
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Note: If protected from air exposure, PDMS can safely be sealed within Parafilm™ for up 
to one week. If cracks are visible in the microchannels when examined using a microscope, 
the polymer has dried out and should not be used. 
 
7. PDMS Hole Punching and Bonding (Figure B.1-f) 
 
17. Use a PDMS hole puncher to remove PDMS at reservoirs and create wells, using a 
Kimwipe to clean the puncher surface between each use. 
18. Peel Parafilm™ off PDMS. 
19. Place the PDMS with the channels facing up next to another piece of PDMS. 
Note: Although the parafilm should keep any dust or other detritus from reaching the 
PDMS surface, it can still happen. This is most easily avoided by bonding the PDMS in a 
cleanroom environment, but a piece of clear tape can be used to remove any dust from the 
surface immediately before step 4. 
20. Run a handheld plasma oxidizer over the surface with the electrode a centimeter above the 
polymer surface, spending around 30 seconds on each piece of PDMS [1]. 
Note: A conventional plasma oxidizer can also be used.  
21. Firmly press the substrates together, taking care to avoid touching the oxidized surface; run 
fingers over the PDMS to force out any air bubbles that form between the layers 
22. Apply pressure with fingertips around the edges of the microchip until sealed, usually 
within one or two minutes. 
Note: Applying pressure directly over the channels can result in forcing them closed and 
ruining the device. 
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23. Examine device using a microscope to guarantee that the microfeatures are preserved and 
that no clogs are present. 
 
Bonding of the PDMS layer to either glass or another PDMS piece can now be performed using 
either a reversible method, which allows for later separation of the device layers, or permanent 
bonding. If the device is to be used with either high voltages or high pressures, permanent bonding 
is recommended. 
 
8. Reversible Bonding 
 
24. Wipe down the glass substrate with a Kimwipe soaked in 50% isopropyl alcohol (IPA), 
then dry with lint-free paper and nitrogen flow. 
25. If necessary, use a PDMS puncher to remove PDMS at reservoirs and create wells, using a 
Kimwipe to clean the puncher surface between each use.  
Note: This step is not needed if wells have been drilled in the glass substrate.  
26. Peel Parafilm™ off PDMS 
Note: If bonding in a cleanroom facility, there should be no dust or other detritus on the 
substrate surface. A piece of clear tape can be used to remove any particulates on both glass 
and PDMS if necessary. 
27. Slowly place PDMS on glass substrate, channels facing inwards; run fingers over the 
PDMS to force out any air bubbles that form between the layers. 
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28. Examine device using a microscope to guarantee the microfeatures are preserved and no 
clogs are present. 
Note: If there is particulate in the channels or improper sealing, the PDMS can be peeled 
off the glass and re-applied after using tape to clean both substrate surfaces. 
 
9. Irreversible Bonding  
 
29. Wipe down the glass substrate with a Kimwipe soaked in 50% IPA, then dry with lint-free 
paper and nitrogen flow. 
30. If necessary, use a PDMS puncher to remove PDMS at reservoirs and create wells, using a 
Kimwipe to clean the puncher surface between each use. 
Note: This step is not needed if wells have been drilled in the glass substrate.  
31. Peel Parafilm™ off PDMS. 
Note: If bonding in a cleanroom facility, there should be no dust or other detritus on the 
substrate surface. A piece of clear tape can be used to remove any particulates on both glass 
and PDMS if necessary. 
32. Run a handheld plasma oxidizer (BD-20AC, Electro-Technic Products, Chicago IL) over 
the surface with the electrode a centimeter above the polymer surface, spending around 30 
seconds on each piece of PDMS 
Note: A conventional plasma oxidizer (Harrick Scientific, Ithaca NY) can also be used. It 
is not recommended to oxidize PDMS for more than 2 minutes, as this can result in 
degradation of the surface and potential damage to any microfeatures or improper bonding. 
166 
 
33. Firmly press the substrates together, taking care to avoid touching the oxidized surface; run 
fingers over the PDMS to force out any air bubbles that form between the layers 
34. Apply pressure with fingertips around the edges of the microchip until sealed, usually 
within one or two minutes. 
Note: Applying pressure directly over the channels can result in forcing them closed and 
ruining the device. 
35. Examine device using a microscope to guarantee that the microfeatures are preserved and 
no clogs are present. 
Note: If there is particulate in the channels or improper sealing, the PDMS must be removed 
by scraping it off with a razor blade. The glass substrate should be washed with IPA and 





Figure B.1:PDMS-PDMS Microdevice Construction 
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Experience has shown that there are many ways in which an ME separation can encounter 
difficulties. Below are the steps to diagnosing the most common problems. 
 
1. Unstable Separation Voltage or Current 
 
Changes in voltage or current during a separation can be the result of gradual evaporation from 
the sample and buffer wells. This evaporation can, in turn, change the ionic concentration and, 
consequently, the resistance of the ME system. However, sudden changes such as a spike or 
oscillation in current are indicative of the formation of bubbles (due to Joule heating) or a clogged 
channel. Should this occur once, it may only be necessary to clean the ME chip and replace the 
buffer. If bubbles are forming repeatedly, using a buffer of lower ionic strength may be necessary. 
 
2. Spikes in Signal Output 
 
Sudden signal spikes that are either too narrow to be genuine peaks or substantially higher in 
signal than the concentration would warrant can be caused by bubbles and/or particles in the 
channels. Both of these conditions can be quickly diagnosed by inspecting the channel under a 
microscope. Should particles be found during offline use, filtering the sample more thoroughly 
prior to injection using a 0.22 µm syringe filter is likely the best solution as sample volume is 
typically not a limiting factor. During online use, samples are filtered through the porous 
membrane of the microdialysis probe. Particles found in online samples could indicate that a 
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smaller pore size should be used. Despite this, particles will sometimes form in the channel itself 
due to, for instance, NDA precipitating from solution. This condition can sometimes be prevented 
by adding a small amount of ACN to the BGE.  
 
Bubbles are typically indicative of one of two conditions. The first is that the ME device was 
not properly prepared before use. To ensure that no bubbles remain in the channel, continue to 
apply negative pressure to the waste port while adding the BGE. Visually inspect prior to use to 
verify that all bubbles have been removed. Should bubbles form during the run, it is likely due to 
Joule heating boiling the BGE inside the channel itself. Decreasing the applied potential or 
decreasing the ionic strength of the BGE (and thereby lowering the current draw) will prevent 
further bubble formation. 
 
3. Gradual Increases in Baseline, No Peaks Detected 
 
Gradual increases in the baseline are indicative of an unstable or nonexistent gate, therefore 
allowing fluorescent product to gradually enter the separation channel and accumulate. This can 
be diagnosed by visually inspecting the gate using a microscope and corrected by adjusting the 
ratio of HV potentials. Additionally, a parametric search for appropriate combinations of voltages 





4. Short Circuit During Application of HV Potentials 
 
Often, this is due to a thin layer of conductive liquid between wells on the chip. Should this be 
the case, carefully drying the surface using a Kimwipe® is often sufficient to resolve the problem. 
However, if a surfactant such as SDS is present in the buffer, a conductive monolayer can still be 
present. This monolayer can be removed using methanol. Finally, it is possible for high voltage 
arcing to occur within the chip itself if bonding of the two layers was incomplete.  
 
5. Clogged or Blocked Channels 
 
The micrometer channel dimensions in ME devices make them highly susceptible to clogging. 
If any particulates get into the channels or crystals form in the buffer, there can be a variety of 
effects on the separation. If no peaks are detected or if there are inconsistencies in the separation 
current and none of the previous issues are present, the channels should be examined with a 
microscope to see if any clogs are visible. Clogs are especially common near the sample reservoir 
inlets and at the electrokinetic gate, although they can occur anywhere within the microchip. 
 
The easiest solution for clogs is to avoid them in the first place. Using lint-free paper any time 
it is necessary to physically wipe down the chip will help to avoid getting fibers in the wells. 
Additionally, any solution put into the device should be filtered to remove any particulate in the 
liquid. If the device is not in use for an extended length of time, the channels should be completely 
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filled with water and then stored within a beaker; this will prevent any evaporation within the 
channels leading to clogs.  
 
6. Removing Clogs from Glass-Glass Microchips 
 
Due to the length of time required to fabricate new all-glass microchips, cleaning a clog from 
one of these devices is often preferable to making a new one. Various solutions can be flowed 
through the channels via the application of negative pressure in order to reduce or completely 
dissolve clogs. We have previously used hydrochloric acid, nitric acid, sodium hydroxide, 
acetonitrile, isopropyl alcohol, and DMSO in order to clean clogs from chips. Unfortunately, there 
is no one specific solution that works more often than any other, so this process is mostly trial and 
error.  
 
Sonicating the chip has also successfully removed clogs. In these cases, the channels were 
filled with water before being placed in a full beaker and placed in a sonicator bath. The vibrations 
can break down any blockages to the point at which they can be washed out. We have also had 
limited success using high temperatures to eliminate clogs. Putting a clogged glass-glass device in 






7. Removing Clogs from PDMS Microchips 
 
It is often easier and faster to simply make a new PDMS device than to spend time clearing 
out clogs. If the PDMS is reversibly bound, it can be peeled off of the substrate and cleaned using 
a piece of clear tape. The substrate should also be wiped down with IPA to remove any detritus 
before attempting to re-apply the PDMS. 
 
If the PDMS is irreversibly bound, the easiest way to remove a clog is briefly flowing IPA 
through the channels via the application of a negative pressure. IPA will slowly dissolve PDMS, 
so any particulate stuck on the channel walls can be washed away. However, this also means that 
repeated use can damage device features.  
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The development of therapeutic proteins and peptides is an expensive and time-intensive process. 
Biologics, which have become a multi-billion dollar industry, are chemically complex products 
that require constant observation during each stage of development and production. Post-
translational modifications along with chemical and physical degradation from oxidation, 
deamidation, and aggregation, lead to high levels of heterogeneity that affect drug quality and 
efficacy. The various separation modes of capillary electrophoresis (CE) are commonly utilized to 
perform quality control and assess protein heterogeneity. This review attempts to highlight the 
most recent developments and applications of CE separation techniques for the characterization of 
protein and peptide therapeutics by focusing on papers accepted for publication in the in the two-
year period between January 2012 and December 2013. The separation principles and 
technological advances of CE, capillary gel electrophoresis, capillary isoelectric focusing, 
capillary electrochromatography and CE-mass spectrometry are discussed, along with exciting 
new applications of these techniques to relevant pharmaceutical issues. Also included is a small 
selection of papers on microchip electrophoresis to show the direction this field is moving with 







The characterization of protein therapeutics presents a unique analytical challenge due to the 
inherent heterogeneity of recombinant protein expression. Even small changes in the 
manufacturing process can lead to vastly different active pharmaceutical ingredients. Additionally, 
numerous physical and chemical degradation pathways can occur during manufacturing and 
storage that compromise protein integrity, leading to a potentially harmful, unstable product [2]. 
Thorough characterization of protein therapeutics is necessary at every step of the research and 
development process, from drug discovery to lot release.  
 
Due to the potential complexity of product degradation during preformulation and formulation 
studies, additional separation techniques are needed to complement the more widely used column 
liquid chromatography (LC) methods. To address this issue, capillary electrophoresis (CE) has 
become a popular choice for the separation and analysis of therapeutic proteins and peptides.  
 
CE provides several distinct advantages over LC. First, due to the faster separation times and 
the use of multi-capillary arrays, hundreds of samples can be processed by CE per day. Second, 
CE is capable of achieving very high efficiency separations due to the low diffusion coefficients 
of biomolecules. Lastly, the small dimensions of the capillary and the low sample volume 
requirements keep reagent and analyte use to a minimum, reducing the cost-per-test. The benefits 
of CE for the analysis of therapeutic peptides and proteins have been addressed in several excellent 




This review is aimed at highlighting the advances made in the field of CE therapeutic protein 
analysis during 2012 and 2013 by expanding on a paper that was recently published by Zhao et al. 
[6]. Following brief descriptions of the working principles of the different CE separation and 
detection methods, the recent technological improvements and novel applications are discussed. 
Two additional sections have been included to further explore the use of CE for the determination 
of protein glycosylation and the comparison of biosimilars. Finally, a brief introduction into 
microfluidic approaches to protein analysis is given. Microchip electrophoresis (ME) has the 
additional advantages of increased speed, high-throughput capabilities, and portability for on-site 
analyses. Tables are presented in each section to highlight the relevant CE and ME application-
based citations. 
 
2. Techniques  
 
Historically, capillary zone electrophoresis (CZE) has been the most commonly employed 
form of CE. Yet, the principles of electrophoretic separations and the benefits of capillary-based 
techniques are applicable to other CE separation modes as well. Protein analysis based on size can 
be accomplished by capillary gel electrophoresis (CGE), capillary isoelectric focusing (CIEF) can 
be used to determine isoelectric points and charge heterogeneity, and capillary 
electrochromatography (CEC), which combines the high efficiency electrophoretic separation with 
chromatographic retention, can be used for more selective separations and analysis of neutral 
species. Depending on the properties of the analyte and requirements of the assay, each of these 
separation modes can be coupled to a number of detection methods such as UV-Vis absorbance, 




2.1 Capillary zone electrophoresis 
 
Of the electrophoresis-based separation techniques, CZE is most frequently used for the 
analysis of small molecules, carbohydrates, and peptides. It is simple, easy-to-use, and requires 
minimal reagents compared to chromatographic methods. Additionally, in CZE, the separation of 
analytes is based on their size-to-charge ratio making it well suited for separations of proteins with 
post-translational modifications (PTMs) or degradations that affect the charge of the molecule [7, 
8] including deamidation, glycosylation, and phosphorylation. 
 
One example of the use of CZE for the investigation of deamidation concerns the stability of 
oxytocin. Deamidation of Asn and Gln residues is the most common chemical degradation 
pathway for peptides and proteins [2]. This process leads to the production of an ionizable 
carboxylic acid from the neutral amide (R-CONH2 → R-COOH), facilitating a separation by CZE. 
However, if peptides, such as oxytocin, contain several labile Asn and Gln sites, multiple 
degradation products of the same size-to-charge ratio are produced and a straightforward 
separation becomes impossible. To distinguish between the seven desamino degradation products 
of heat-stressed oxytocin, Creamer et al. utilized sulfobutyl ether β-cyclodextrin (SBE β-CD) as a 
pseudo-stationary phase [9]. The negatively charged SBE β-CD forms an inclusion complex with 
the hydrophobic Tyr2 residue of oxytocin, affecting the electrophoretic mobility of the peptides. A 




Unfortunately, reproducible separations of larger biomolecules using bare fused-silica 
capillaries are rare due to protein adsorption. Many proteins have large localized regions of 
positive charge that are electrostatically attracted to the negatively charged silanol groups at the 
capillary surface. Additional adsorption can be caused by hydrophobic and hydrogen bonding 
interactions. This adsorption process keeps CZE from obtaining the 106 theoretical plates that 
should be possible due to the very low diffusion coefficients of large proteins. [10, 11]. 
 
One strategy for minimizing protein adsorption is to alter either the charge density of the 
protein or the capillary wall by changing the pH or ionic strength of the background electrolyte 
(BGE). Another approach is to simply add a modifier to the BGE to reduce protein-wall 
interactions. The addition of surfactants, small amines, or anionic salts, such as phytic acid, to the 
BGE is common [12, 13]. In cases where modification of the run buffer does not obviate protein 
adsorption, dynamic and static capillary coatings have been used to create a barrier between the 
ionized silanol groups and the protein of interest. 
 
2.1.1 Dynamic coatings 
 
Dynamic coatings are buffer additives that adsorb to the surface of the capillary, shielding the 
silanol groups from analyte adsorption [14]. These noncovalent coatings are popular due to their 
simplicity, versatility, and ease-of-use. However, because of their impermanent nature, the 
coatings need to be continuously regenerated. This can be accomplished by refreshing the 
physically adsorbed layer at the capillary with rinses between runs, or adding a small amount to 
the BGE to prevent coating degradation during electrophoresis. A variety of such coatings have 
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been used for protein separations, ranging from small molecules such as ionic liquids (ILs), to 
larger molecules such as surfactants and polymers [15].  
 
ILs have been previously explored as dynamic coatings for CZE protein separations [16-18]. 
ILs are salts made up of organic cations and inorganic or organic anions that are liquid at, or 
around, room temperature. Recently, a new IL, N-methyl-2-pyrrolidonium methyl sulfonate 
([NMP]+CH3SO3
–), was used to prevent basic protein (pI 9.0-10.7) adsorption to capillary walls 
during CE separation [19]. The [NMP]+ moiety electrostatically adsorbs to the capillary surface, 
where it is able to hydrogen bond for additional stability (Figure D.1). Using this coating, the 
authors were able to achieve a baseline separation of four basic proteins (Table D.1) with an 
interday migration time RSD of less than 1.5%. The improvement in the separation after addition 
of only 0.02% w/v IL, compared to that obtained with phosphate buffer alone, is easily seen in 
Figure D.1D. 
 
Figure D.1: A) The structure of the IL [NMP]+CH3SO3−, B) the interaction between [NMP]+ and the silica capillary inner wall, 
and C) the mechanism of separation of proteins using [NMP]+ as dynamic coating material, D) Electropherograms of four basic 
proteins in bare silica capillary (bottom trace) and in the presence of 0.02% w/v IL (top trace). Running buffer: 40 mM pH 4.0 
sodium phosphate; voltage: 18 kV; detection: 214 nm; peaks: (1) cytochrome c, (2) lysozyme, (3) ribonuclease A, (4) α-




Polysaccharides are also attractive candidates for dynamic coatings for protein separations 
because they are non-toxic, readily abundant, and biocompatible [20-22]. Two novel dynamic 
coatings based on the chemical substitutions of cellulose have recently been reported [23, 24]. The 
first, a positively charged quaternarnized cellulose (QC), was synthesized through a reaction of 
cellulose with 3-chloro-2-hydroxypropyltrimethylammonium chloride. The positive charge of the 
QC leads to the electrostatic adsorption of the compound to the capillary surface, reversing the 
electroosmotic flow (EOF). Addition of 5 µg/mL QC to the BGE prevented adsorption of model 
basic proteins leading to higher separation efficiencies [23]. To increase the reverse EOF by 10%, 
and further improve separation efficiency, additional substitution of the QC was made using 
hydrophobic hexadecyl groups [24]. Both QCs were evaluated with a separation of five basic 
proteins (Table D.1). In both cases, the modified capillaries produced a migration time 






Table D.1: CZE and Capillary Coatings 
 
Despite their simplicity, buffer additives and dynamic coatings are not always the best 
approach to eliminate protein adsorption. If the modifier is highly charged, band broadening can 
occur due to high separation currents and Joule heating. Additionally, some buffer modifiers can 
interfere with protein binding assays [25], disrupt protein stability [26], or be incompatible with 
downstream detection methods such as MS. In cases where greater stability and reproducibility 





2.1.2 Static coatings 
 
Static coatings are chemically linked to the capillary wall and do not need to be added to the 
run buffer to achieve reproducible separations. Therefore, they have the potential for large-scale 
production and can be made commercial available. Several companies are already selling coated 
capillaries for protein separations including GL Sciences (FunCap®), Target Discovery 
(UltraTrol™), MicroSOLV (CElixer™), and Beckman Coulter (eCAP™).  
 
Gassner et al. performed a thorough comparison of both commercially available and lab-
generated static coatings in 2013 [27]. Eight coatings were selected—four positive: FunCap®-type 
A, UltraTrol™ HR, Hexadimethrin bromide (polybrene) (PB)-dextran sulfate-PB, and 
polyethylenimine; and four neutral: FunCap®-type D, UltraTrol™ LN, hydroxypropylcellulose, 
and polyvinyl alcohol (PVA). The coatings were evaluated for the protein recovery, isoform 
resolution, and migration time reproducibility of two monoclonal antibodies (mAbs). 
 
For the positively charged coatings, the separation was run in negative polarity. With these 
capillaries it was determined that the slower the EOF, the better the resolution. Yet, while 
UltraTrol™ HR had the slowest EOF, it had poor reproducibility (8.9% RSD) and was discarded 
from the study. For the neutral coatings run in normal polarity, the largest factor for protein 
adsorption was the presence of residual silanol groups. This was apparent by the fact that some 
EOF was still generated in the capillary. Of the four neutral coatings in this study, both commercial 
options, FunCap®-type D and UltraTrol™ LN, generated a small amount of EOF at pH 7.0, 
indicating that the coating was not uniform and there were still potential sites for protein 
adsorption. However, it is important to note that the separation performance of each coating was 
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highly dependent on the pH and composition of the BGE. Consequently, care should be taken 
during method development to fully optimize the BGE for the selected coating. 
 
Due to the varied performance of the commercially available products, new coatings for the 
separation of basic and hydrophobic proteins are still under development. One particularly 
attractive choice for static coatings is phospholipid bilayers (PLB) because of the protein resistant 
nature of the hydrophobic phosphoylcholine polar headgroup. However, the limiting factor for 
these coatings is their poor long-term chemical and physical stability. This can be remedied by 
cross-linking the PLB with bis-SorbPC which produces a stabilized phospholipid bilayer (SPB) at 
the capillary surface [28]. In a recent report, it was shown that the SPB produced a stable coating 
over a pH range from 4.0–9.3 [29]. Over the course of 45-days dry storage the migration time 
reproducibility for both model proteins (Table D.1) was marginally affected and the overall RSD 
for the EOF was only changed by 1.1%.  
 
To reduce the preparation time for the preparation of static coated capillaries, self-assembled 
bilayers and photoinitiated polymerization can be used. An example of such a process was 
described by Yu et al. using a photosensitive diazoresin (DR) in combination with either PVA [30] 
or polyethylene glycol (PEG) [31]. After exposure to 365 nm light, both the DR/PVA and DR/PEG 
coatings were able to prevent protein adsorption and achieve an efficient separation of several 





2.1.3 Evaluation of capillary coating performance 
 
Prior to assay development, the determination of capillary coating performance is 
extremely important. A previous analytical approach to determine protein adsorption in capillaries 
involves flushing the capillary with the protein of interest to allow adsorption and then measuring 
desorption on a subsequent rinse [32-34]. However, with this method, only irreversibly bound 
proteins are measured. As an alternative, de Jong et al. recently developed a more direct method 
using pressure-driven flow [35]. Briefly, a plug of sample is pressure injected into a capillary at a 
low flow rate (0.5 psi) and the Taylor dispersion of the plug is measured at two different detection 
points along the capillary. Based on these measurements, the magnitude of the protein adsorption 






Figure D.2: A) Diagram of the set-up for the dual detection pressure-based technique for assessing protein adsorption. B) Pressure-
driven propagation of 5.3 μM chromeo-labeled conalbumin detected at 10 and 40 cm. Better protection against adsorption can be 
seen in both the capillary coated with CElixir dynamic modifier and the capillary with a permanently adsorbed PVA coating. 
Reprinted with permission from ref. 34 
 
2.2 Capillary gel electrophoresis 
 
The most commonly used analytical method for size determination, purity assessment, and 
quality control of therapeutic recombinant proteins is sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). SDS is used to coat the proteins, resulting in a uniform negative 
charge proportional to their size. Under an electric field the proteins are then separated through a 
sieving gel matrix, allowing for estimation of protein molecular weight (MW). However, 
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conventional SDS-PAGE can be time-consuming, tedious, and yield irreproducible results with 
limited quantitative abilities [36, 37].  
 
Table D.2: CGE and MGE 
 
 
To improve on this important technique, the CGE equivalent, SDS-CGE, has been developed 
and utilized for the determination of size heterogeneity of therapeutic proteins [38-40]. Here the 
sieving gel is placed inside the capillary through which the negatively charged SDS-coated 
proteins are separated. SDS-CGE has many advantages over SDS-PAGE, including high 
efficiency separations, more accurate MW and concentration determination, and the ability to 




Shi et al. demonstrated these advantages of SDS-CGE over SDS-PAGE, along with the 
improved precision of migration time and peak area, for the analysis of the light chain, 
nonglycosylated heavy chain, and heavy chain fragments of a mAb [41]. Using the capillary 
format, the authors were able to achieve RSDs of less than 0.5% for migration time and less than 
5% for corrected peak area. However, for quality control of biopharmaceuticals, the precision for 
a quantitative assay needs to be lower than 2% RSD. By switching from hydrodynamic rather than 
electrokinetic injection, along with increased sample concentration, the precision of a standard 
SDS-CGE assay was improved to 0.2% RSD for migration time and between 1 and 2% RSD for 
peak area ratio [42].  
 
Another method to improve assay precision for the SDS-CGE assay is through automation of 
the sample preparation process. A large number of samples are generated during the development 
of high-quality biologics. These samples originate from every step of the development process and 
are presented for analysis in a variety of matrices. The use of an automatic robotic platform for 
sample preparation can help mitigate user error introduced in the multi-step sample preparation 
process. The PhyNexus Micro-Extractor Automated Instrument uses a ProA resin column to bind 
mAb samples prior to separation. Once bound, the instrument performs sample concentration 
normalization, removal of contaminates, desalting, and mixing with appropriate SDS-CGE 
buffers. With this method, protein recovery of Fc-fusion proteins, and IgG1 and IgG2 mAbs was 
increased to 90% [43].  
 
UV absorbance and LIF spectroscopy are the dominant detection methods for SDS-CGE. 
However, for detection of specific mAbs, Western blot immunoassay detection has also been 
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utilized. The ProteinSimple Simple Western™ (or Simon™) automates the immunoassay 
detection procedure by performing all separation steps and washes in-capillary. Following a SDS-
CGE separation, the proteins are photochemically cross-linked to the capillary wall, where they 
are exposed to a horseradish peroxidase-conjugated secondary antibody for whole-capillary 
chemiluminescence imaging (Figure D.3). Simon™ also makes quantitative Western blots 
possible. Using this instrument, a standard curve was generated for a vaccine candidate protein 





Figure D.3: A) Step-by-step overview of the SimonTM operational procedure. B) Comparison between the manual Western and 
SimonTM for duplicate runs of three proteins. Experimental details for protein and antibody conditions in ref. 31. Reprinted with 
permission from ref. 42 
 
 
Immunoassay detection methods for CGE are useful because coupling CGE with MS by 
electrospray ionization (ESI) is difficult due to the presence of nonvolatile BGE. However, CGE-
SDS has been coupled successfully to matrix-assisted laser desorption ionization (MALDI) MS by 
moving a poly(tetrafluoroethylene) membrane past the end of the capillary to collect the peaks as 
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they leave the capillary [45]. CGE-MALDI-MS has been utilized for the direct mass measurement 
of recombinant proteins [46, 47] and neoglycoproteins [48].  
 
2.3 Capillary isoelectric focusing 
 
Another capillary-based technique that was adapted from its original slab-gel format is 
capillary isoelectric focusing (CIEF). Like SDS-CGE, performing IEF in a capillary exhibits the 
benefits of faster analysis times, higher resolutions (up to 0.005 pH units [49]), lower limits of 
detection, and the capacity for high-throughput analysis [50].  
 
CIEF separates proteins based on their isoelectric point (pI) and can be used to determine 
charge heterogeneity of biogenic products [51]. The assay is typically performed in a coated 
capillary to eliminate EOF. A pH gradient is self-assembled under an electric field using a mixture 
of mobile carrier ampholytes with a distribution of pIs. The anodic end of the capillary is then 
placed in an acidic solution and the cathodic end in a basic solution. Under the applied electric 
field, the protein will migrate through the ampholyte solution toward the oppositely charged 
electrode until the pH environment equals its pI.  
 
UV detection at 280 nm is typically used with CIEF because the ampholytes exhibit strong 
absorbance at wavelengths below 240 nm [52]. Optical detection for CIEF can be accomplished 
either by a two-step method that requires mobilization after focusing to bring the analyte bands 





An important application of CIEF for the analysis of biologics is for the characterization of 
charge heterogeneity, as it is possible to identify proteins based on their unique charge profile [53] 
(Table D.3). Variations in this charge profile are often used to determine protein stability [54, 55] 
and identify degradation products or PTMs that change the charge of the protein, such as 
glycosylation and deamidation [56]. 
 
 
Table D.3: CIEF and microchip IEF (mIEF) 
 
 
As mentioned earlier, deamidation can be a major pathway of protein and peptide degradation. 
The rate of deamidation depends on both the primary and secondary structure surrounding the Asn 
or Gln residue in question [2]. Typically, characterization of deamidation sites is accomplished 
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through peptide mapping and MS analysis. However, this process can be complicated, sometimes 
impossible when a fragment contains multiple desamino sites. Shimura et al. used CIEF and site-
directed mutagenesis to determine the rates of deamidation in Fab fragments of mouse IgG1-κ 
[56]. The rate of disappearance of the parent peak of each mutant was compared to that of the wild 
type to obtain the single-residue deamidation rates. By monitoring the CIEF charge profile of the 
six Fab mutants for the additional acidic peaks, a third, previously unknown deamidation hotspot 
for the mouse IgG1-κ was identified.  
 
CIEF can be even more powerful when run in combination with an orthogonal separation 
technique such as SDS-CGE [57] or reversed-phase LC, or in tandem with MS. CIEF has been 
coupled to MS through both ESI [58, 59] and MALDI interfaces [60, 61]. Due to the presence of 
the non-volatile ampholytes in the separation buffer, coupling CIEF with ESI can be complicated 
by ion-suppression and source contamination. To cut down on the intensive sample preparation 
needed to desalt protein samples from gels, a segmented capillary has been described. In this 
design, seven segments of PEEK capillary were connected by Nafion joints, each with its own 
buffer reservoir (Figure D.4) [62]. This allowed analytes in the capillary segments to be selectively 







Figure D.4: Schematic layout of the on-line multiple junction CIEF setup; the six-port injector is shown in the sample-loop 
loading position. Reprinted with permission from ref. 60 
 
 
Additional technological advances in CIEF-MS interface development have been reported by 
Zhong et al. [63] and Wang et al. [64]. Their work is discussed further in the MS detection section 
of this review. Along with the development of new interfaces, several straightforward BGE buffer 
modifications have been described in the literature to solve the problems of high backgrounds and 
ion suppression [37, 65]. 
 
As with SDS-CGE, detection of proteins by immunoassay following separation by CIEF can 
be used to improve detection limits and specificity without the need for an MS. For example, 
Michels et al. have described the first multiplexed iCIEF immunoassay for investigation of the 
charge heterogeneity of mAbs [66]. Once the mAbs were focused, they were then photochemically 
immobilized to the capillary wall where they were then exposed to a secondary antibody, 
conjugated with horseradish peroxidase, and detected by chemiluminescence (Figure D.5). The 





Figure D.5: Schematic of the Nanopro three-step process 1) Separation by CIEF, 2) immobilization of the antibody to the 
capillary wall, 3) detection with secondary antibody by chemiluminescence. Reprinted with permission from ref. 65 
 
 
2.4 Capillary electrochromatography 
 
Capillary electrochromatography (CEC) is a technique that uses both chromatographic 
retention and electrophoretic migration for the separation of analytes, with bulk fluid flow created 
by the EOF. This combination enhances the selectivity and efficiency of the separation, drastically 
lowers the reagent use compared to LC, and enables the separation of neutral species not possible 
with CZE.  
 
In the first applications of CEC to proteins, capillaries packed with porous particles were 
utilized because of their similarity to the stationary phase materials used for conventional LC, and 
the commercial availability of particles with a variety of functionalities. However, the packed CEC 
columns have significant limitations in terms of stability and fabrication reproducibility and are 
not yet able to match the robust performance of nano-LC [67]. This limits their usefulness for 
routine protein assays on a larger industrial scale. In its place, the use of nanoparticles (NP) as a 
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pseudostationary phase (PSP), open-tubular CEC (OTCEC), and monolithic columns have gained 
momentum.  
 
The use of NP as a PSP for CEC has been thoroughly reviewed [68]. In the BGE, the NP can 
interact with the proteins during the separation, changing their electrophoretic mobility and 
generating a separation based on the difference in affinity between the analytes for the NP. A wide 
range of materials have been investigated for PSP-CEC, including polymer NP, carbon nanotubes, 
gold NP, and silica NP (SNP) [68]. To improve the stability and functionality of SNP, Gao et al. 
synthesized polyamidoamine-grafted SNP (PAMAM-SNP) and utilized them for a separation of 
basic and acidic proteins [69] (Figure D.6). With 0.01% PAMAM-SNP in the BGE, a complete 
separation of all four model proteins (Table D.4) was possible. Additionally, the PAMAM-SNP 




Figure D.6: A) Diagram of the separation of four proteins without and B) with the pseudostationary phase effect of the 
polyamidoamine (PAMAM)-grafted silica nanoparticles (SNP). Reprinted with permission from ref. 68 
 
 
OTCEC columns are a popular alternative to packed columns because of their ease of 
fabrication and excellent separation efficiency [70]. These OTCEC columns can be made by either 
physically bonding the stationary phase to the capillary wall or several layered coatings. In one 
report, OTCEC columns were fabricated through the immobilization of gold NP (AuNP) on the 
surface of the capillary that had been pretreated with a sol-gel. The gold immobilized in the sol-
gel participates in noncovalent interactions with thiol and amino groups of proteins, increasing 
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their capacity factor. Using this technique, Miksik et al. were able to separate the peptides 
generated by the tryptic digestion of native and glycosylated bovine serum albumin (BSA) and 
human transferrin [71]. Unfortunately, preparation of the AuNP modified columns required several 
days and many reaction steps, which limited its utility. To alleviate this problem, a new method 
for AuNP immobilization to the capillary wall through covalent binding using (3-
aminopropyl)triethoxysilane has been described [72]. This procedure creates a stable coating that 









Another novel OTCEC column was described by Qu et al. and was produced by immobilizing 
graphene (G) and graphene oxide (GO) sheets to the capillary wall to act as the stationary phase. 
It was found that between the two coatings, only the GO exhibited a reproducible EOF over the 
pH range of 3–9 and separate a mixture of egg white proteins [73]. The separation was achieved 
due to the reverse-phase-like interaction between the graphene coated surface and the proteins. To 
improve the stacking of GO at the capillary wall, a layer-by-layer technique to produce the GO-
modified OTCEC column was reported. In this case, GO nanosheets were adsorbed on a 
poly(diallydimethylammonium chloride)-treated capillary by electrostatic interaction. This created 
a stable coating for over 200 runs [74]. Both methods for column fabrication produced excellent 
run-to-run, day-to-day, and column-to-column reproducibility with less than 3% RSD for the EOF. 
 
Often, OTCEC separations suffer from low capacity factors because of the small active surface 
area and fewer available functional sites. This also can lead to poor separation efficiency and co-
eluting peaks. In an attempt to improve peak capacity, a new porous layer for OTCEC has been 
described that uses the in situ polymerization of a mixture of monomers in the presence of porogen 
for higher separation efficiencies [75]. A column generated from the porogen, 1-propanol, was 
able to generate a high abundance of micropores and mesopores, resulting in a large specific 
surface area. This generated an efficient separation of the two model proteins, BSA and 
cytochrome-c.  
 
Another widely explored approach for the implementation of CEC is the use of monolithic 
columns. Monoliths have high permeability, a fast mass transfer rate, and high loading capacity. 
Many commercially available monoliths are made from silica leading to a risk of band broadening 
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and sample loss due to protein adsorption. Therefore, to minimize protein adsorption during CEC 
and improve separation efficiencies, neutral and cationic monoliths have been developed.  
 
A series of neutral nonpolar monolithic columns were manufactured and tested for the 
separation of both intact proteins and peptides from protein tryptic digest. To produce the 
monoliths, various ratios of monomers C8-methacrylate, C12-methacrylate, and C16-methacrylate 
were mixed with the crosslinking polymer pentaerythritol (PETA) [76]. In these experiments, it 
was determined that when the ratio of monomer to PETA was kept constant, the C8 monolith gave 
the best separations for intact proteins. The C16 column exhibited the best efficiencies for smaller 
peptides. In their report, Puangpila et al. claim that, even in the absence of a charged surface, there 
is EOF generated by adsorption of BGE ions to the monolith and it can be controlled by changes 
in the pH and ACN content of the mobile phase. 
 
Cationic monolithic columns can also be used to reduce electrostatic interaction of basic 
proteins to the monolithic and capillary surface. Wang et al. developed a novel monolithic IL 
column that was made by a simple “one pot” approach using thermal free radical copolymerization 
[77]. Using this method, several counterions (bromide, tetrafluoroborate, hexafluorophosphate, 
and bis-trifluoromethanesulfonylimide (NTf2
−)) were tested with the cation 1-vinyl-3-
octylimidazolium (ViOcIm+) to create an IL monolith capillary columns [78]. Each IL monolith 
was capable of generating a consistent reverse EOF over the pH range 2.9–12.0. However, only 
the ViOcIm+NTf2





3 Detection methods 
 
3.1 Spectroscopic detection 
 
Spectroscopy is the most common detection method for proteins and peptides separated by CE. 
UV absorbance tends to be favored over fluorescence spectroscopy due to a natural absorbance of 
the amide bonds and aromatic residues in the near UV (214 and 280 nm). However, this approach 
suffers from poor limits of detection due to the micrometer pathlengths characteristic of CE and 
high background from the UV source. Additionally, BGE composition, pH, and ionic strength can 
have a significant effect on background. Approaches such as increasing the pathlength through 
modification of the detection window using Z-shaped capillaries and bubble-cells have been 
successful in decreasing the LOD by an order of magnitude or greater [79, 80].  
 
Fluorescence detection of proteins can be accomplished based on the native fluorescence of 
tryptophan, phenylalanine, and tyrosine residues in proteins using a deep UV light sources [81-
83]. However, with native fluorescence based detection, the signal is dependent on the number of 
excitable residues as well as their accessibility within the tertiary structure of the protein. 
Therefore, the applicability of this technique varies from protein to protein. To improve the LODs 
for native fluorescence detection of erythropoietin (EPO), Wang et al. utilized a magnetic bead-
based extraction system for pre-concentration. Using this procedure, it was possible to obtain an 
LOD of 10 nM, two orders of magnitude lower than what was possible with UV absorbance at 214 




Low limits of detection achievable by LIF can also be obtained through derivatization of the 
protein or peptide of interest with a fluorophore [85]. The most common derivatization sites for 
proteins are the primary amines and cysteine residues. These can be tagged with a variety of agents 
including Alexa Fluor-based dyes, naphthalene-2,3-dicarboxaldehyde, fluorescein isothiocyanate, 
and many others. A major disadvantage of pre-separation derivatization for proteins is the 
complexity of the derivatization process. This approach requires not only that the tag is specific 
for the functional group on the analyte of interest but also that it does not interfere with the 
separation by introducing additional fluorescent by-products. Proteins typically have several 
reactive sites that can be labeled which leads to multiple peaks for one analyte, complicating data 
analysis [86]. 
 
3.2 Mass spectrometry 
 
CE-MS is a powerful combination of high efficiency separations with selective and sensitive 
detection. This technique can provide important information on identity, glycoforms, degradation, 
and impurities of protein therapeutics [87, 88]. It is possible to couple CE to MS using different 
ionization techniques, as has been described in several excellent reviews [89, 90]. For this review, 
only the recent advances regarding the development and application of the ESI interfaces will be 
highlighted. CE was first interfaced with MS by ESI in 1987 [91] and it remains the most popular 
ionization method due to its broad applicability and commercialization.  
 
ESI is a robust soft-ionization technique that produces multiply charged ions for proteins in 
the gas phase. However, there are many considerations that must be taken into account when 
coupling it with CE. Primarily, the use of run buffers containing non-volatile salts and additives 
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can lead to their deposition within the instrument, and subsequent contamination of the source. 
While formic acid and acetate buffers have been used as BGEs for the separation of proteins by 
CE, they are not always ideal because of inadequate resolution and possible protein instability at 
low pH. Additionally, the voltages typically applied to the capillary for separation are 2–3 orders 
of magnitude higher than what is used for ESI. Toward this end, researchers have developed three 
general approaches for coupling CE to MS with ESI: sheath-liquid, sheathless, or junction-at-the-
tip interfaces.  
 
The most widely used and commercially available option is the sheath-liquid interface. This is 
accomplished by placing the outlet of the CE capillary coaxially within a tube. The tube delivers 
a MS-compatible sheath liquid (Figure D.7A) that provides easy electrical connections and a flow 
rate to the ESI of µL/min. This is beneficial because the EOF of the CE is generally much slower 
(nL/min) than what is compatible for a stable spray.  
 
The compatibility of separation and detection parameters for CE-ESI-MS with a sheath-liquid 
interface was evaluated for eight model proteins and several EPO isoforms [92]. It was found that 
the BGE composition and capillary coating play the largest role in the quality of the separation. 
For all analytes, the best signal was obtained with a sheath flow rate between 2-5 µL/min and a 
sheath flow liquid composed of 1% acetic acid in 1:1 organic:water; in this study, 2-propanol was 
chosen over MeOH or ACN. The optimal gas pressure was determined to be 0.2 bar, since anything 
lower lead to a loss of analyte intensity and anything higher was shown to affect the resolution of 
the separation. As an added benefit, the nebulizer gas pressure can create suction at the capillary 




An obvious disadvantage of the sheath-liquid interface is the loss in detector sensitivity from 
dilution of the eluting peaks. To improve detection limits, a sheathless interface was developed. 
The largest downside of this approach is the difficulty in properly completing the electrical circuits 
for the CE and the ESI. While many attempts have been made, these interfaces were limited by 
stability and ease of application [90, 93].  
 
Recently, Moini and Whitt developed a sheathless interface based on a porous junction [94, 
95]. In this interface, the end of the capillary was made porous to small ions by drilling a well into 
the polyamide coating and etching the remaining material with hydrofluoric acid. The capillary 
was then placed within an existing ESI needle filled with BGE, allowing electrical connection to 
both the CE and ESI (Figure D.7B). The tip of the capillary could then be used for electrospray 
when voltage is applied. The only drawback to this technique was the difficulty in reproducibly 
etching the capillary end. To improve the applicability and availability of the Moini and Whitt 
sheathless interface, Beckman Coulter developed a prototype that has been successfully applied to 
the analysis of intact proteins [96], protein glycoforms [97], and protein tryptic digests [98, 99]. 
 
In a recent report, both CE- and LC-MS were compared for the analysis of a particular 
therapeutic mAb [99]. With LC-MS, 11 small peptides eluted in the void volume and could not be 
detected, including two fragments that were critical for the identification of the binding domain of 
the mAb. The same digest was analyzed by CE-MS employing both a traditional sheath-liquid 
interface and the Beckman Coulter sheathless interface using a BGE consisting of 10% acetic acid 
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at pH 2.3. Sixty of 61 peptides were detected with the sheath-liquid interface, while all 61 peptides 
were detected with the sheathless system with higher separation efficiencies and better sensitivity. 
 
Another alternative to the sheath-liquid interface is the junction-at-the-tip design developed by 
Chen’s group. In this interface, the capillary end is placed within a hollow needle that forms a 
“flow-through microvial” [100] (Figure D.7C). The hollow needle is filled with a chemical 
modifier that provides the necessary electrical contacts for the separation and ESI voltages. Similar 
to a sheath-liquid interface, this modifier increases the CE BGE compatibility with the ESI. 
However, because the flow rates are much lower (< 1 µL/min), the dilution factor is not significant. 
Chen’s group has extensively characterized the performance of this interface in several 
publications [63, 100-103].  
 
 
Figure D.7: Diagrams of four CE-ESI-MS interfaces. A) Sheath-flow, B) Moini and Whitt sheathless flow, C) Chen junction-at-






Perhaps the most exciting new use of these interfaces is in coupling MS to more complex CE 
modes, such as CIEF and capillary isotachophoresis (CITP) which require high concentrations of 
non-volatile components to achieve a separation. In 2011, Zhong et al. described a CIEF-MS 
approach for the analysis of several model peptides and proteins using the junction-at-the-tip 
interface with coated and uncoated capillaries [103]. Unfortunately, the ampholytes used for the 
separation were still able to reach the detector, leading to high backgrounds and ion suppression. 
To prevent this from occurring, a new sheathless interface was developed by Wang et al. that uses 
a large bore separation capillary for sample loading and a sheathless interface with a porous emitter 
for its application with CITP [64] (Figure D.7D). This system was then utilized for the analysis of 
test peptides spiked into tryptic digests of BSA (Table D.5). They were able to obtain a linear range 
over 4.5 orders of magnitude and a five-fold sensitivity improvement compared to the sheath-
liquid interface for two test peptides, kemptide and angiotensin II.  
 
 






In addition to assessing protein pharmaceutical products based on their size and charge 
heterogeneity and the presence of impurities, the analysis of biologics poses two additional 
analytical challenges: 1) how to characterize and better understand the complicated cellular 
process of glycosylation, and 2) preparing for the onset of biosimilar drugs to the market and how 




Glycosylation is one of the most prevalent PTMs of therapeutic proteins. In vivo, glycosylation 
plays several important roles, including protection against degradation and non-specific 
interactions as well as orientation for the binding domain. The two major types of glycosylation 
that occur involve N-linked and O-linked carbohydrates. N-linked glycans are attached to the 
protein backbone at the amine side of Asn and are found in the well-defined amino acid sequence 
of Asn-X-Ser/Thr, where X is any amino acid but proline. O-linked glycans are not sequence-
specific and are found attached to the protein backbone at the OH group of Ser or Thr.  
 
Monoclonal antibody-based therapeutics of the IgG1 sub-type make up a 100 billion dollar 
annual market [104]. These mAbs consist of 2–3% carbohydrate by mass. Most of the 
glycosylation occurs as N-linked glycans located on the Asp297 in the CH2 domain of the Fc region 
of each heavy chain. A number of factors can affect the composition, structure, and frequency of 
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these glycans, posing an interesting challenge for the manufacturing of a homogeneous product. 
To ensure a homogeneous product and avoid potentially immunogenic glycans, each step of 
biotherapeutic production from clone selection to lot release needs to be well characterized. This 
characterization requires fast, high-throughput analytical methods to accurately screen the 
numerous samples generated per day.  
 
The size and charge characterization of glycoproteins can be accomplished by the various 
electrophoretic separation techniques mentioned in the previous sections of this review. Several 
methods and protocols for CZE, SDS-CE, and CIEF separations of glycoproteins have been 
compiled by Rustandi et al. [105]. A typical downside to CE-based methods is the characteristic 
migration time irreproducibility. To address this, freely available software, glyXalign, was 
developed based on a set of rapid algorithms that enables automatic correction of distortions in 
CGE-LIF data to improve peak identification [106].  
 
For further understanding of the nature, location, and composition of the glycans, methods for 
the removal and analysis of the sugars themselves are also needed. The majority of these 
carbohydrate analyses are performed by LC. In particular, hydrophilic interaction chromatography 
(HILIC) coupled to LIF and MS detection has been useful for the sensitive analysis of glycans 
[107]. 
  
CE-LIF is an excellent orthogonal technique to HILIC-LIF for separation of glycans, and in a 
comparative study it was shown that they were able to detect an equal number of glycans removed 
from an IgG [108]. An advantage of CE-LIF for glycan analysis is that it can be used to distinguish 
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both lineage and positional isomers [109, 110]. Using CZE-LIF, carbohydrate sequencing can be 
performed by both top-down digestion and bottom-up identification using a series of sugar-specific 
exoglycosidases. Typically, glycans are enzymatically removed, fluorescently labeled, and 
separated by size or charge. There are several charged fluorescent reagents commercially available 
for tagging glycans. The most common reagent used in conjunction with CE-LIF is 8-
aminopyrene-1,3,6-trisulfonic acid (APTS). However, recently, Kuo et al. published a rapid 
method for labeling aldoses with 2,3-naphthalenediamine to produce highly fluorescent 
naphthimidazole derivatives [111]. Using this reagent, it was possible to perform composition 
analysis and enantioseparation of the glycans using CE with cyclodextrin in the BGE. 
 
An important advantage of CE-LIF over HILIC-LIF is the ability to multiplex 48- and 96-
capillary arrays for high-throughput analysis. Callewaert et al. were the first to perform glycan 
analysis using a commercially available multiplexed CE-based DNA analyzer [112]. Later, this 
same technique was used along with a 48-capillary array to perform high-throughput analysis of 
glycans from IgG. In this application, glycans were removed by digestion and labeled with APTS 
in 96-well plates and then subjected to simultaneous analysis by capillary array. This approach 






Table D.6: CE-based analysis of protein glycosylation 
 
In the research and development of mAbs, a particular area of interest is the study of 
immunogenic non-human glycans. The frequency and type of non-human glycans attached to the 
therapeutic protein during production differ from cell line-to-cell line [114]. It is well known that 
the non-human oligosaccharides galactose-α-1,3-galactose (α1,3-Gal) and N-glycolylneuraminic 
acid (Neu5Gc) can illicit an immune response. In fact, in response to enteric bacteria, 
approximately 1% of all human antibodies are against the α1,3-Gal epitope [115].  
 
Detection of both α1,3-Gal and Neu5Gc non-human glycans was performed by partial filling 
affinity CE. In this method, a plug of either anti-Neu5Gc antibody or α-galactosidase (dissolved 
in BGE) was injected on capillary prior to injection of the APTS-labeled glycans (removed from 
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the target antibody) [116]. Once the electric field was applied, the higher mobility sugars in the 
sample pass through the antibody or enzyme plug, causing a reaction. This reaction produced 
additional product peaks upon LIF detection, allowing specific detection and quantification of the 
two immunogenic sugars. 
 
In another study, six commercially available mAb pharmaceuticals produced in nonhuman 
mammalian cell lines were analyzed by CZE-LIF, in parallel with LC-ESI-TOF-MS, to determine 
the presence of nonhuman N-glycans [117]. By CZE, forty-six fluorescently labeled N-glycans 
were separated using a tris-borate BGE containing 5% PEG to slow the EOF. Of the six mAb 
pharmaceuticals, three were found to contain nonhuman N-glycan residues. To obtain additional 
information regarding the attachment of nonhuman N-glycans to therapeutic proteins, CZE-LIF 
with exoglycosidase digestion and fluorescent tagging was used to achieve LODs of 1 μg allowing 
characterization of the low-abundance α1,3-Gal epitope [118].  
 
CE-MS can also be used in conjunction with CGE-LIF [119] to obtain additional structural 
information and identify unknown glycans [3]. For example, Bunz et al. described both alkaline 
and acidic BGE systems that could be used for the determination of APTS-labeled mAb glycans 
by CE-TOF-MS [120, 121]. The CE-MS methods were then compared against to two CGE-LIF 
methods commonly used for routine glycan analysis. While both CE-MS and CGE-LIF were able 
to resolve and detect the glycans, because of the difference in the separation mechanisms they had 
different migration orders, making it difficult to directly compare the two electropherograms 




The downside of glycan analysis by MS is the likelihood of unwanted fragmentation of sugars 
during the ionization process. This can lead to large amounts of difficult-to-interpret data and 
misidentification [122]. For this reason, it is important not only to insure careful optimization 
during MS method development but to provide orthogonal analyses such as CZE-LIF or CGE-LIF 
to validate the findings.  
 
4.2 Biosimilars  
 
Follow-on biologics, also known as biosimilars or biobetters, is the term for the “generic” 
biopharmaceuticals that have recently entered the market. The European Medicines Agency 
published regulatory guidelines for biosimilars in 2005, and by 2012 there were 14 products 
approved for sale in Europe [123]. In 2013 the first mAb biosimilar, Hospira’s Inflectra, hit the 
European market, and more than a half-dozen prospective biosimilars are in the pipeline. In 2015, 
as the majority of the leading biologics go off patent, there will be ample opportunity for 
established and start-up companies to begin producing biosimilars.  
 
While production of biosimilars is an inherently less risky venture, due to the established 
market and tested safety of the innovator product, proving comparability to regulatory agencies 
still poses a significant challenge. Unlike chemical synthesis of small molecule generics, the 
composition of biologics is highly dependent on the manufacturing process. Small changes in 
production can have significant implications on the quality. In particular, the addition of 
impurities, aggregation products, and/or PTMs such as glycans can cause the protein to be 
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immunogenic. Without detailed knowledge of how the innovator was produced, it can be very 
difficult to create an identical product. 
 
Fortunately, dozens of analytical techniques exist to verify the physicochemical and functional 
comparability of the biosimilar to the innovator [124]. As discussed in the previous sections of this 
review, electrophoretic techniques are widely used for characterization of size and charge 
heterogeneity, product degradation, and PTMs. The appropriate method is generally chosen based 
on protein complexity, which varies from small non-glycosylated proteins like insulin and HGH 
to large, heterogeneous glycoproteins and mAbs [125].  
 
EPO is a glycoprotein with approved biosimilars making up 12% of its market [123]. EPO has 
three complex N-glycosylation sites and one O-glycosylation site, which introduce a high level of 
heterogeneity into the protein. To be able to differentiate between the various formulations of EPO, 
or prove similarity between innovator and biosimilar, Taichrib et al. evaluated two multivariate 
statistical approaches for the analysis of CE-MS data [126] (Table D.7). The data were generated 
using a CE-ESI-TOF-MS method developed previously that exhibited high separation efficiencies 
and high selectivity for 14 commercially available preparations of EPO [92]. Both statistical 
approaches proved useful for analyzing the similarity or difference between large sets of 
glycosylated biologics that were generated under different production conditions, cell lines, and 





Table D.7: CE-based analysis of biosimilars 
 
 
With the upcoming mAb biologic patent cliff, much of the biosimilar research has focused 
on the comparability of antibodies from various sources. Towards this end, CZE [127] and SDS-
CGE [128] techniques can be used to determine charge heterogeneity of mAbs. Using CZE, 
rituximab (Kikuzubam® and Reditux®) and trastuzumab biosimilars were analyzed with respect 
to existing commercial products, Mabthera® and Herceptin®, respectively [127]. The CZE 
methods were then compared to existing CIEF and chromatographic methods (HILIC and cation 
exchange chromatography). They found that, not surprisingly, a single method was not sufficient 
to resolve and characterize a protein, putting the emphasis on orthogonal techniques. However, 
they did report that CZE and CIEF gave better resolution of the mAbs than either HILIC and cation 
exchange chromatography, especially when using coated capillaries, since protein adsorption tends 
to lead to band broadening. 
 
With the multitude of assays that exist, reproducibility and ruggedness is essential for 
widespread biosimilar production and regulation. The innovator, the biosimilar manufacturer, and 
216 
 
the regulatory agency need to be certain that, despite the various laboratory conditions, the 
experimental results are comparable. To help facilitate this, Salas-Solano et al. evaluated an iCIEF 
method in 12 different laboratories across the world using several analysts, a variety of 
ampholytes, and multiple instruments [129]. The combined precision for the 12 labs was 0.8% 
RSD for the pI determination and 11% RSD for the percent peak area values for the charge variants 
of a therapeutic mAb. This study compared these values to those obtained using conventional 
CIEF, where the RSDs for pI and peak area were of 0.8% and 5.5%, respectively [130].  
 
5. Microchip electrophoresis 
 
Many aspects of CE, such as low sample volume requirements, speed, efficiency, and the 
ability to use physiologically appropriate BGEs, make it an attractive method for the analysis of 
biopharmaceuticals. The advantages CE offers over chromatography are a function of the small 
inner diameter of the capillary. Consequently, there has been an effort to further miniaturize bench-
top CE instrumentation to a microfluidic format. This has decreased samples sizes needed for 
analysis from mL to µL, reduced analysis times from minutes to seconds, increased separation 
efficiencies, decreased costs, and added the ability for portable point-of-care analysis. 
Additionally, multiplex ME systems can be designed to handle high-throughput analysis on a 
greater scale than CE systems, making them an attractive technology for drug discovery and 
analysis [131, 132]. 
 
While most CE separation modes can be transferred to ME, the majority of the current 
published assays have dealt with analysis of biomarkers and small molecule drugs. Recent 
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advances in N-glycan profiling by ME have also been made for clinical chemistry applications 
[133, 134]. However, as the field of protein analysis on-chip grows, so does the possibility that the 
use of these devices will soon be accepted by the FDA as a validated method, allowing them to be 
incorporated into industry protocols.  
 
5.1 Microchip gel electrophoresis  
 
The LabChip® GXII, a commercially available microchip gel electrophoresis (MGE) system 
from PerkinElmer, is used frequently in the pharmaceutical industry [135, 136]. The commercial 
procedure, which uses indirect fluorescence and a HT Protein Express gel matrix [137], was 
compared against two new SDS-MGE methods, one for “high-sensitivity” and the other for “high-
resolution” [138]. In the “high-sensitivity” method, direct LIF detection of fluorescently labeled 
proteins was investigated. Two labeling schemes were compared, and it was reported that 
performing the labeling step prior to protein denaturation improved the signal up to 50-fold for a 
loading concentration LOD of 1 ng/mL. In the “high-resolution” method, the sieving effect of the 
commercial gel was increased by the addition of a 6% poly(N,N-dimethylacrylamide) (PDMA) 
solution. With an optimal ratio of 2:1, gel:PDMA, the assay achieved resolution between Fab 
heterodimers without increasing the separation time. Additional high-throughput analysis is 
available to process 96 samples in less than an hour.  
 
SDS-MGE has also been integrated with Western blot immunoassay detection [139]. The 
separation of a series of test proteins with a MW range of 11–155 kDa (Table D.2) was performed 
on-chip by Jin et al. [140]. Following the separation, the sample was eluted from the chip onto the 
Western blot membrane. In order to maintain the discrete zones accomplished during the 
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separation, the chip was held in place vertically while the membrane moved below the outlet on 
an X-Y stage for spotting (Figure D.8). By carefully controlling the membrane spotting rate and 
the flow from the SDS-MGE chip, separation efficiencies of 40,000 theoretical plates were 
possible. With this set-up, the throughput capabilities were improved with a total analysis time of 
less than 32 min for the separation and immunoassay. This is a dramatic improvement over the 







Figure D.8: A) Microchip overview. Samples are Samples are loaded in different sample reservoirs (S). Samples are injected by 
floating the buffer reservoir (BR) and sample waste (SW) with voltage applied between the desired sample reservoir and the Al 
block at the exit. During separation, flow from the sample reservoir is gated to the sample waste reservoir (SW) using the voltages 
as shown. During these operations, other sample reservoirs are floating. Sieving media is pumped through the sheath channels to 
give stable current. Channel lengths are indicated by double arrow lines and direction of flow during separation is indicated by 
solid, single arrows. B) Size-dependent separation of FITC-labeled protein ladder in microchips. Detection window was set at the 
end of separation channel, 300 μm away from the chip outlet. Electric field during separation was 240 V/cm. C) Relationship of 





5.2 Microchip isoelectric focusing 
 
ME-based systems have also been used to verify the charge heterogeneity of mAbs with 
microchip isoelectric focusing (MIEF). Using a commercially available MCE-2010 system with 
whole-channel imaging from Shimadzu, Kinoshita et al. were able to analyze the charge variants 
of several mAbs [141]. The microchip consisted of two sample wells, one containing an anolyte 
and the second containing a catholyte, separated by a 2.7 cm channel. Following the separation, 
the whole channel was imaged with UV detection. To reduce the EOF, 0.2% 
hydroxyproplymethylcellulose was added to the BGE allowing greater focusing while preventing 
the non-specific adsorption of protein to the capillary wall. Using the optimized conditions, the 
authors were able to separate charge variants of three commercially available mAbs (bevacizumab, 
trastuzumab, and cetuximab) within 200–300 s. These separations were very reproducible (< 0.5% 
RSD) and were roughly 10 times faster than the corresponding CIEF assay.  
 
To further improve the utility and throughput of MIEF assay a single-channel microchip device 
where separation, immobilization, and subsequent immunoblot rinse steps could all be performed 
has been reported [142]. Once the proteins were separated within the pH gradient they were 
exposed to UV light and covalently cross-linked to a light-activated volume-accessible gel present 
in the microchip. This technique gave similar capture efficiencies (≈ 0.01%) to previous reports 
where proteins were immobilized on the inner surface of the capillary [44, 143]. Wash steps were 
performed by electrophoretic transport on the immobilized protein without concern of sample loss. 
Using this technique, it was possible to complete an isoform assay in less than 120 min, up to 15x 
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faster than the conventional slab-gel followed by Western blot. Such rapid purity assays illustrate 
the significant advantage ME has over CE and other techniques. 
 
5.3 Microchip electrophoresis-mass spectrometry 
 
As with CE, even more specific and selective detection of analytes is possible by coupling ME 
to MS. The most common ionization interface for ME with MS is ESI, but MALDI is also possible 
[144]. The major benefit of ME-ESI-MS is that the flow rate on-chip is compatible with ESI and 
can therefore be seamlessly interfaced without disrupting the electrophoretic separation. When 
constructing an ME-MS interface, the geometry of the outlet and flow rate through the capillary 
must be taken into account given their monolithic construction and integration.  
 
An advantage of ME over CE is that sample preparation and multiple separation methods can 
be integrated onto a single device prior to the ESI interface. Therefore, the excess dead volumes 
that are characteristic of conventional systems are eliminated, reducing the band broadening and 
sample dilution. The Ramsey group reported a fully integrated LC/CE microchip that terminated 
in an ESI source off the corner of the device in 2011 [145]. The potential combination of LC and 
ME for a more selective and specific separation is very powerful. In addition, the microchip flow 
rates are compatible with the ESI. However, a major disadvantage of fully integrated microchips 
is that the increased complexity of the device makes them difficult to fabricate.  
 
As noted in a subsequent Ramsey paper, the fully integrated chip described above could not 
handle pressures over 200 bar. Therefore, to improve on the earlier design, a glass microchip that 
could be integrated with an off-chip UPLC was designed (Figure D.9) [146]. This allowed higher 
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pressures to be reached than were possible with the LC on-chip. The new device produced 
significant improvements in reproducibility and peak capacity when evaluated for the analysis of 
digested N-glycosylated proteins. Additionally, the authors point out the utility of the new design 
in its ability to integrate to existing LC equipment that is already ubiquitous in industry.  
 
 
Figure D.9: Schematic of the hybrid capillary LC microchip CE-ESI experimental setup. The orange line represents a transfer 
capillary connecting the LC column to the microfluidic device. The dashed green lines represent electrical connections between 
the high voltage power supply and the microfluidic reservoirs. Reprinted with permission from ref. 146 
 
6. Conclusions and future perspectives  
 
The development of protein and peptide therapeutics is a complex and high-risk venture, as 
products produced by recombinant expression are inherently heterogeneous. However, with 
advances in analytical techniques, thorough protein characterization is possible. In particular, CE-
based separation techniques such as CZE, CGE, CIEF, and CEC provide versatile, efficient, and 
fast analyses of proteins. Additionally, CE-based techniques have the potential for high-throughput 
analysis using capillary arrays. The wide range of capillary-based separations can assess many 
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aspects of protein stability, process impurities, and PTMs such as glycolysis, each of which is 
essential in providing a safe, effective, and quality product.  
 
Microchip based formats have the potential for increased speed, higher throughput, and 
portability of CE. While the development of ME devices is still primarily an academic research 
area, there is considerable promise for this miniaturized technique in the future of on-site 
pharmaceutical analysis. Pharmaceutical applications of ME and CE to therapeutic protein analysis 
will be further expanded through the development and commercialization of specialty capillaries, 
BGEs, and detection techniques. This is especially true for CE-MS and ME-MS interfaces. With 
numerous reviews already existing on this topic alone, coupling of MS with these techniques show 
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